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Summary 
 
In the present work nanogels and hydrogels composed of functional hydrophilic 
polymers or proteins crosslinked with degradable crosslinkers are prepared and 
characterized. The nanogels and hydrogel systems could be modified with targeting 
molecules for the delivery of peptides or proteins. 
As building blocks shaped poly (ethylene oxide-stat-propylene oxide) (sP(EO-
stat-PO)), linear poly(glycidol) (PG) and α-Elastin polypeptide are used. Linear PG was 
synthesised via anionic polymerization and then functionalizated with thiol groups. 
sP(EO-stat-PO)) was received from Dow chemicals and was functionalised with thiol 
and acrylate end groups. While α-Elastin was used as recived. Bulk hydrogels were 
prepared by crosslinking of HS-sP(EO-stat-PO) and HS-PG via oxidation of thiol 
groups to disulfide bonds as well as by Michael addition with PEG-diacrylate. The 
disulfide bonds formed in the process are known to be cleaved in the reductive 
environment of the cytosol and the ester bonds formed in the Michael addition process 
can be hydrolyzed over a period of several days or weeks depending on pH. Thus the 
presence of these two segments ensures the biodergadability of such hydrogels. To 
show the biodegrability and use of such hydrogels, HS-sP(EO-stat-PO) hydrogel 
crosslinked by oxidation and Micheal addition was loaded with engineered chemokines. 
Under the cytosolic condition the hydrogels showed triggered release of chemokines 
which to a considerable extent could prevent injury extension after myocardial 
infarction.  
The oxidation in air normally takes several hours which in many cases is too 
slow in order to maintain stable miniemulsion for the production of nanogels. Therefore 
hydrogen peroxide was used as an oxidizing agent and studies were performed in 
order to optimise the parameters for the synthesis of nanogels in the inverse 
miniemulsion. The formed gels were characterized for their size, dipersity, degradation 
behaviour, in vitro cytotoxicity and hemocmpatibility. Scanning electron microscopy 
(SEM), dynamic light scattering (DLS) in the water solution and scanning force 
microscopy (SFM) in the dry state were used to characterize the gels size and 
polydispersity. The stability of nanogels was monitored by DLS measurements.The 
live/dead viability/cytotoxicity assay was used to examine the cytotoxicity of nanogels 
and hemocompatibility tests were performed according to 1SO 10993-4. 
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Further different formulation strategies were used to control the particle size and 
polydisperstiy of crosslinked PG nanogel prepared via inverse miniemulsion. 
Comparative investigation of the use of alloxan, a mild oxidation catalyst, and hydrogen 
peroxide is discussed. Going a step further horseradish peroxidase (HRP) one of the 
most studied oxidation-catalyzing enzymes was used for synthesis of hydrogel and 
nanogels from HS-PG polymers. Nanogels were shown to entrap two different 
enzymes HRP and β-Galactosidase without affecting the enzyme activity and cells 
were successfully encapsulated in the hydrogel. 
Biohybrid nanogels were constructed by immobilization of protein ovalbumin by 
crosslinking acrylate functionalized star shaped poly (ethylene oxide-stat-propylene 
oxide) (Acrylate-sP(EO-stat-PO)) resulting in the formation of biohybrid nanogel. 
Biohybrid nanogels systems based on soluble α-elastin polypeptides were also 
prepared by using two different amine-reactive cross-linkers; poly(ethylene glycol) 
diglycidyl ether (PEG-DGE) and bis(sulfosuccinimidyl) suberate (BS3). Thermo- and pH 
responsivity of such nanogels was explored. An elastase-triggered degradation profile 
of such nanogels was monitored by DLS measurements against time, while the 
colloidal stability was investigated by sedimentation analysis. Texas Red conjugated 
dextran was used as a model drug to load the nanogels and its loading and release 
kinetics was studied. 
In the last part of the thesis synthesis of radiolabeled nanogels for nuclear 
molecular imaging is reported using HS-sP(EO-stat-PO). Simple and efficient 68Ga-
labeling procedure was used to radiolabel the nanogels containing chelating groups for 
68Ga with high radio chemical yield and in vitro studies were performed to study the 
biocompatibility of the nanogels. 
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Zusammenfassung 
 
Im Rahmen dieser Arbeit werden Nanogele und Hydrogele aus funktionalen 
hydrophilen Polymeren oder Proteinen, die mit abbaubaren Vernetzungseinheiten 
verknüpft sind, hergestellt und charakterisiert. Diese können mit Zielmolekülen 
modifiziert werden für die Abgabe von Peptiden und Proteinen. 
Als Bausteine werden Poly(ethyleneoxid-stat-propylenoxid) (sP(EO-stat-PO)), 
lineares Poly(glycidol) (PG) und α-Elastinpolypeptid eingesetzt. Das lineare PG wurde 
über anionische Polymerisation hergestellt und danach mit Thiolgruppen 
funktionalisiert. sP(EO-stat-PO) stammt von Dow Chemicals und wurde mit Thiol- und 
Acrylatendgruppen funktionalisiert. α-Elastin wurde wie erhalten eingesetzt. 
Makroskopische Hydrogele wurden durch die Vernetzung von HS-sP(EO-stat-PO) und 
HS-PG erreicht, entweder durch Oxidation von Thiolgruppen zu Disulfiden oder über 
eine Michaeladdition mit PEG-Diacrylaten. Es ist bekannt dass sich die bei diesem 
Prozess gebildeten Disulfid-Bindungen in reduktiver Umgebung des Cytosols spalten 
lassen. Die Esterbindungen aus der Michael-Addition lassen sich abhängig vom pH-
Wert innerhalb von Tagen oder Wochen hydrolysieren. Somit gewährleisten beide 
Segmente die biologische Abbaubarkeit solcher Hydrogele. Zum Beweis der 
biologischen Abbaubarkeit und der möglichen Anwendbarkeit solcher Hydrogele wurde 
das Hydrogel HS-sP(EO-stat-PO) oxidativ und über Michael-Addition vernetzt und mit 
veränderten Chemokinen beladen. Unter den Bedingungen im Cytosol ermöglichen die 
Hydrogele eine kontrollierte Freisetzung von Chemokinen, wodurch sich Folgeschäden 
nach einem Herzinfarkt erheblich vorbeugen lassen sollten. 
An Luft dauert die Oxidation zu Gelen mehrere Stunden. Daher lassen sich in vielen 
Fällen die zur Herstellung von Nanogelen erforderlichen Miniemulsionen nicht stabil 
aufrechterhalten. Demzufolge wurde Wasserstoffperoxid als Oxidationsmittel 
eingesetzt und weitere Studien durchgeführt um die Synthese der Nanogele in inversen 
Miniemulsionen zu optimieren. Die dabei entstandenen Gele wurden nach Größe, 
Dispersität, Degradationsverhalten, in vitro Cytotoxizität und Blutverträglichkeit 
charakterisiert. Zur Bestimmung der Größe der Gele und ihrer Polydispersität wurden 
die Rasterelektronenmikroskopie (Scanning Electron Microscopy, SEM), Dynamische 
Lichtstreuung (DLS) in  wässriger Lösung und die Rasterkraftmikroskopie (Scanning 
 vii 
 
Force Microscopy, SFM) im trockenen Zustand eingesetzt. Die Stabilität der Nanogele 
wurde über DLS kontrolliert. Zur Bestimmung der Zelltoxizität der Nanogele und der 
Blutverträglichkeit wurden Zellviabilität/Zytotoxizitäts-Tests- nach ISO 10993-4 
durchgeführt. 
Weitere Strategien wurden angewandt, um die Partikelgröße und Polydispersität 
quervernetzter PG-Nanogele aus inverser Miniemulsion zu kontrollieren. Eine 
vergleichende Untersuchung der Verwendung von Alloxan, einem milden 
Oxidationskatalysator und Wasserstoffperoxid wird diskutiert. Zudem wurde 
Meerrettichperoxidase (HRP) als eines der am meisten erforschten katalytischen 
Enzyme zur Synthese der Hydrogele und Nanogele aus HS-PG-Polymeren eingesetzt. 
Beobachtet wurde, dass die Nanogele zwei Enzyme, HRP and β-Galactosidase, 
einschließen ohne deren Aktivitäten zu beeinflussen. Die Zellen wurden erfolgreich in 
Hydrogele eingeschlossen. 
Biohybridn-Nanogele wurden durch Immobilisierung des Proteins Ovalbumin über 
Vernetzung von acrylatefunktionalisiertem sternförmigem Poly(ethylenoxid-stat-
propylenoxid) (Acrylate-sP(EO-stat-PO)) hergestellt. Biohybrid-Nanogel-Systeme aus 
löslichen α-Elastin-Polypeptiden wurden mit Hilfe von zwei gegenüber Aminen 
reaktiven Vernetzern, Poly(ethylenglycol) Diglycidylether (PEG-DGE) und 
Bis(sulfosuccinimidyl)suberat (BS3), hergestellt. Die thermische pH-Beständigkeit 
wurde untersucht. Zeitabhängige DLS-Messungen zeigten ein durch Elastase 
ausgelöstes Abbauprofil solcher Nanogele. Gleichzeitig wurde die Stabilität der 
Kolloide durch Sedimentationsanalyse ermittelt. Die Nanogele wurden mit Texasrot-
konjugiertes Dextran als Modellverbindung beladen. Untersucht wurde die Kinetik des 
Beladens und der Freilassung. 
Der letzte Teil dieser Arbeit beschreibt die Synthese radioaktiv markierter Nanogele 
für die nuklearmolekulare Abbildung (Imaging) mit Hilfe von HS-sP(EO-stat-PO). Ein 
einfaches und effizientes Verfahren zur Isotopenmarkierung mit 68Ga wurde 
eingesetzt, um Nanogele mit chelatisierenden Gruppen mit einem hohen Anteil an 
68Ga zu versehen. In vitro Untersuchungen zur Biokompatibilität der Nanogele wurden 
durchgeführt. 
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CHAPTER 1 
 
Introduction  
 
Rapid progress in synthetic and recombinant DNA technology, as well as in peptide 
and protein production technologies has resulted in the availability of a wide variety of 
protein- and peptide-based drugs targeting poorly controlled diseases. Several hundred 
protein drugs are currently undergoing clinical trials. However, the use of these 
potentially beneficial compounds as drugs may be severely limited by their fragile 
structure and the body’s ability to rapidly remove them from the bloodstream. The 
structure, physicochemical properties, stability, pharmacodynamics, and 
pharmacokinetics of these new bio pharmaceutics place stringent demands on the way 
they are delivered into the body. More specifically, peptides and proteins must retain 
their structural integrity until they reach their target site and should not be degraded 
enzymatically. 
Targeted drug delivery is emerging as a powerful tool for the treatment of various 
ailments compared to the conventional methods as it enhances the specificity of 
delivery to a particular site, protects the active agent of the drugs and controls the 
release kinetics. Over the last 30 years different types of nano-carriers were proposed 
as drug carriers and have received growing attention since due to their stability, loading 
capabilities and physicochemical properties. With respect to the emerging field of the 
delivery of peptides and proteins, the most crucial challenges are: 
 Creating a delivery vehicle for the polymeric, hydrophilic molecules that protects 
them from degradation without irreversibly affecting their native structure. 
 Improving the stability of peptide and protein drugs in vivo as well as the specificity 
of their transport to the intended delivery site. 
 Decreasing the nonspecific delivery to non-targeted tissues as well as the dose that 
has to be applied and their immunogenicity. 
Nanogels, hydrophilic, cross-linked polymeric particles, are an extremely interesting 
class of materials for the delivery of peptides and proteins. They can be tuned 
regarding their chemical composition and three-dimensional physical structure enabling 
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control over water content, mechanical properties, and biocompatibility. Moreover, 
microgel particles offer significant opportunities for targeted applications as a 
consequence of their tuneable size and their large surface area which enable 
multivalent bio conjugation. In addition, biodegradability of nanogels can be tailored to 
respond to external stimuli such as enzymes, pH change, ion strength or redox 
potential, which offers a number of benefits for their use as selective drug delivery 
carriers. This could facilitate controllable release of encapsulated molecules from the 
interior of nanogels and ensure the removal of empty vehicles after the drug release. 
The aim of this thesis is to prepare and characterize nanogel carriers composed of 
functional hydrophilic polymeric / proteinic building blocks that are crosslinked with 
degradable crosslinkers and can be modified with targeting molecules for the delivery 
of peptides or proteins (Figure 1.1). 
 
 
Figure 1.1: Underlying concept of this thesis. Biodegradable gels for targeted delivery 
of drugs. 
 
Chapter 2 gives a literature overview on current approaches for targeted delivery of 
drugs, as well as nanogel systems and the disulfide crosslinking chemistry that is used 
in this study. 
 
Chapter 3 deals with synthesis of thiol functionalized polymers, and use of HS-sP(EO-
stat-PO) based hydrogel for chemokine delivery. Chemokine-derivatives Met-CCL5 
and recombinant protease-resistant CXCL12 (S4V) were used for the inhibition of 
neutrophil infiltration and concomitant improvement of hematopoietic stem cell 
recruitment to sustain neovascularization after myocardial infraction. 
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Chapter 4 describes the preparation of the nanogels via inverse miniemulsion and their 
characterisation regarding particle size distribution, degradation behaviour and 
chemical composition, in vitro cytotoxicity as well as hemocompatibility studies. 
 
Chapter 5 focuses on the comparative investigation of alloxan, a mild oxidation 
catalyst, and hydrogen peroxide as oxidation catalyst for the formation of disulphide 
cross-linked hydrogels and nanogels. Further  formulation strategies to control the size 
of the disulphide cross-linked poly(glycidol) (PG) nanogel prepared via inverse 
miniemulsion for both catalyst systems is presented and the  differences are discussed. 
Investigations on nanogel stability and degradation behaviour in presence of 
glutathione as well as in vitro cytocompatibility studies are shown.  
 
Chapter 6 deals with enzymatically mediated cross-linking of redox-sensitive, 
reversibly crosslinked hydrogel and nanogels and to embed (bio-)functional moieties 
such as peptide sequences. Self-encapsulation of the enzyme horseradish peroxidase 
(HRP) into the nanogels in functional form is shown. Double encapsulation of HRP with 
β- galactosidase was done in the nanogels. Further in vitro cytocompatibility of 
nanogels and cell encapsulation in the hydrogel are studied. 
 
Chapter 7 focuses on nanogels that are constructed by immobilization of the protein 
Ovalbumin by crosslinking with a reactive prepolymer, acrylate functionalized star 
shaped poly (ethylene oxide-stat-propylene oxide) (Acrylate-sP(EO-stat-PO)) in 
inverse miniemulsion which results in the formation of a biohybrid nanogels. This type 
of biohybrid nanogel introduces hydrophobic pockets into the hydrophilic nanogels 
which can be a potential candidate for drug delivery application.  
 
Chapter 8 is concerned with enzyme degradable novel biohybrid nanogels/nanogels 
systems based on α-elastin polypeptides via facile inverse miniemulsion approach 
using two different amine-reactive cross-linkers; poly(ethylene glycol) diglycidyl ether 
(PEG-DGE) and bis(sulfosuccinimidyl) suberate (BS3). Nanogels were fabricated at 
various compositions of the precursors (elastin and cross-linker), drug loading and dual 
stimulus responsivity (temperature and pH) were studied. 
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Chapter 9 reports the synthesis of radiolabeled biodegradable nanogels and the 
physiochemical and biological properties relevant to nuclear molecular imaging. 
Nanogels were synthesized by self-assembly of HS-sP(EO-stat-PO) prepolymers in 
aqueous medium without using organic solvents and surfactants, and crosslinked via 
disulfide bonds. 
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CHAPTER 2 
 
Literature Overview on Nanoparticles as Controlled 
Drug Delivery Devices 
 
Part of this chapter is reproduced from Adv Polym Sci, 2011, 234, 65 with copyright 
permission from Springer eBook. 
 
2.1 Role of the Drug Delivery Systems 
Way back to early civilisations, humans have put tremendous efforts to 
overcome ailments, discomfort and pain. This led them to use and test substances 
occurring in nature against the diseases. Significant advancement in science has 
resulted in the identification of these active ingredients of the long used natural 
products and their structure and mechanism of action were elucidated. With the 
progress of humanity more and more effort is being put to find new or more potent tools 
against diseases. Although the exact mechanism of how a drug works may not be 
known for all the known compounds but it has been understood that their functions are 
highly specific and complex. Mostly drug activity is the result of their induced molecular 
interaction in specific cells. Therefore it is utmost important that the drug reaches the 
site of action, in right concentration and for the right period of time. When it is not 
possible to achieve it by simple administration (oral, intravenous, local, transdermal 
etc.) or if such administration causes patient discomfort, strategies based on the 
association of the drug with a carrier (a drug delivery system-DDS) have to be 
considered.1,2 The idea behind DDS is to control the pharmacokinetics, 
pharmacodynamics,3,4 non-specific toxicity, immunogenicity, bio-recognition and 
efficacy of the drug for minimising drug degradation and loss, prevention of harmful-
side effects, increase drug bioavailability, counter problems arising from low drug 
solubility, fast clearance rates, non-specific toxicity, inability to cross biological barriers, 
just to mention a few.2,5 For tackling these challenges various drug delivery and drug 
targeting systems are currently under development like microcapsules, liposome, 
micelles, nanogels made from synthetic or natural polymers and dendrimes.1,6 These 
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systems are exploited for therapeutic purpose to carry drug in the body in a controlled 
manner from the site of application to the therapeutic target.  
 
2.2 Targeting Drug Delivery System 
2.2.1 Passive Targeting:  
Passive targeting refers to targeting of the systemic circulation due to 
physiochemical or pharmacological factors. When the tissue is diseased, variety of 
pathological conditions can alter its physiology and result in its vascular remodelling 
and permeability (Figure 2.1 (left)). This allows extravasation and selective localisation 
of long circulating drug carriers from the blood to these sites, as was shown by 
Lamprecht et al. that polymeric carrier administered orally could target the inflamed 
colonic mucosa in inflammatory bowel disease.7 In tumors, this condition is more 
pronounced as rapidly growing tumors develop new blood vessels through active 
angiogenesis to meet the nutritional demands of increasing number of cells. These 
newly formed blood vessels are irregular, defective or leaky and unlike the tight 
endothelium of normal blood vessels, these are disordered creating large fenestration 
(≤ 300 nm).8 This increased vascular permeability along with impaired or absent 
lymphatic drainage in tumors allows an enhanced permeability and retention (EPR) 
effect of the carrier in the tumor.9 But several factors are important for passive tumor 
accumulation using the EPR effect, like long blood circulation time of carrier and activity 
of loaded drug for that time, degree of tumor vascularization/angiogenesis and the size 
of the carrier system. But EPR effect is only applicable for high-molecular-weight drugs 
since low-molecular-weight drugs can rapidly diffuse into the circulating blood followed 
by renal clearance. Although leaky vasculature and modelling of carrier system can 
enhance passive targeting, a major part of the nanosystems injected intravenously are 
lost to reticulo-endothelial system (RES), mainly by fixed macrophages in the liver and 
spleen after opsonization by proteins present in the blood stream.10 This tendency of 
the RES can excellently be used for passive targeting of drugs. 
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Figure 2.1: Passive versus active targeting. (Left) In passive targeting, particles tend to 
passively diffuse through the leaky vasculature of the tumor bed and accumulate 
primarily through the enhanced permeability effect. (Right) In active targeting, once 
particles have extravagated in the target tissue, the presence of ligands on the particle 
surface facilitates their interaction with receptors that are present on tumor or other 
cells, resulting in enhanced accumulation and preferential cellular uptake through 
receptor-mediated processes. This approach can be used either for vascular targeting 
and/or tumor cell targeting purposes. Reprinted from Ref.11 
 
2.2.2 Active Targeting: 
Since passive targeting approaches are limited, tremendous effort has been put 
towards developing active approaches for drug targeting which focuses on specific 
modification of a drug carrier nanosystem with ligands or engineered homing devices to 
increase receptor mediated localisation of the drug.12  
Drug targeting to specific cells has been explored in this way by taking the advantage 
of various receptors, antigens/proteins present on the plasma membrane of cells and of 
different lipid components of the cell membrane (Figure 2.1 (right)). Active agents, 
such as ligands specific for the receptors have been used extensively to target specific 
cells which also facilitates the uptake of the carrier via receptor mediated endocytosis.13 
Targeting molecules can be either an antibody or non-antibody ligands like peptides, 
sugars or vitamins which are of low cost and easily available. But relatively unselective 
expression of non-antibody ligands to the targeted receptors could be major drawback 
of their use. On the other hand antibodies are higher specific and a wide range of 
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binding affinities can be achieved by them. However, the production of antibodies is 
expensive and time-consuming, and problems with stability and storage have to be 
overcome.14  
 
2.3 Cellular Uptake 
Uptake and internalisation nano carrier can occur through receptor-mediated 
bio-events once it reaches the targeted tissue or cell population, either passive or 
active targeting or a combination of both. Along with receptor mediated endocytosis 
phagocytosis and pinocytosis can contribute to the uptake and internalisation of the 
drug. Receptor-mediated endocytosis has higher selectivity in cellular targeting, since 
the cellular membrane is decorated with number of receptors, which upon extracellular 
binding to their respective ligands (or to nanoparticles whose surface is functionalized 
with ligands), transduce a signal to the intracellular spaces which can in return trigger a 
multitude of biochemical pathways. This may also cause internalization of the ligand 
and its appended nanoparticle via endocytosis. Cross-linking of receptors via ligands 
attached to nanoparticles also results in a pronounced pit in the membrane which is 
followed by subsequent enfolding and reunification of the cellular membrane forming an 
endosome. It has been reported that nanoparticle in the range between 25 and 50 nm 
are most suitable for optimal endocytosis and intracellular localization.15-18 
Furthermore, on selective active targeting of nanocarriers several other bio-
events are possible (Figure 2.2). After the endocytosis of a DDS either in a receptor-
mediated or in an unspecific way results in a significant drop in pH from the 
extracellular 7.2 to 7.4 to 6.5 to 5.0 in the early stages in the endosomal processing 
pathway. Another drop in pH to about 4.0 occurs upon fusion with lysosomes which 
additionally contain a great number of enzymes, e.g. phosphatases, nucleases, 
proteases, esterases, that become active at acidic pH.19,20 This environment is 
developed for protein processing via proteolysis and disulfide bond reduction21,22 and 
therefore is extremely harmful for most active substances, which could also lead to 
degradation or inactivation of the therupatic agent. On the other hand, these are the 
properties which are widely used for release of the DDS/drug from the endosome into 
the cytosol. For example, using pH sensitive peptides like glutamic acid-alanine-
leucine-alanine (GALA)23,24 which results in the destabilization of the endosome 
through carrier-membrane interaction or use of dioleoylphosphatidylethanolamine 
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(DOPE)25,26 a fusogenic phospholipids which fuses the liposomal carrier with the 
endosomal membrane or by using amine-containing polymers which can be highly 
protonated during endosome acidification, causing chloride influx into the vesicle 
resulting in osmotic swelling and vesicle lysis.27 
 
Figure 2.2: Cytosolic delivery of therapeutic agents via nanoparticle carriers. (1) 
Endocytosis resulting into internalisation of nanoparticles, (2) endosomal escape of 
nanoparticles (3) lysosomal degradation of nanoparticle, (4) recycling of the receptors 
(5) drugs freely diffuses into cytoplasm and cytoplasmic transport of therapeutic agent 
to target organelle. Reproduced and reprinted from Ref. 20. 
 
Apart from endocytic pathway to deliver drugs directly to the cytosol, another method 
most widely explored is using cell-penetrating peptides like the HIV-1 derived TAT 
protein transduction domain.28, 29 Use of cell-penetrating peptides bypasses the 
endocytic pathway completely and facilitates cytoplasmic localization; increasing the 
bioavailability of a drug in cytosol.  
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2.4 Nano Drug Carriers 
Nano drug carriers are a major class of DDS.1,5 They are mainly defiend as 
colloidal particles in the range of 10 to 1000nm. Administration of the nano carriers in 
the body can be done by different routes like intravenous, intramuscular or 
subcutaneous.The carrier should be small to access all locations in the body by these 
administration routes as the diameter of the smallest blood capillary in human boday is 
about 4µm. Carrier larger than a few micrometers accumulate in the lung capillaries, 
while sufficiently small structures could escape from circulation through intercellular 
junctions of healthy endothelium (e.g. lymph nodes endothelium30), or may be removed 
by the sinus endothelium of the bone marrow.31 It should be bioacceptable, should be 
able to carry an optimal drug load and should have a long circulation time for effective 
targeting.32,33 Ultimately physiological properties of drug and the therapeutic goal 
influence the final choice of a nano carrier. 
Nanocarriers in general protect a drug load from degradation and hence enhances 
cellular uptake, modify pharmacokinetic and drug distribution and improves intracellular 
penetration. Nanocarriers have also been widely used to improve the performance of 
imaging techniques applied for the in vivo diagnosis of tumors. Many of the current 
“nano” drug carriers used as drug delivery systems are liposomes, polymeric micelles, 
nanoparticles, dendrimers, and nanocrystals (Figure 2.3). 
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Figure 2.3: Designing nanoparticles for intracellular applications. Nanoparticles can be 
modularly assembled from different materials composition with different physical and 
chemical properties and functionalized with a myriad of ligands for biological targeting. 
Such flexibility in design freedom enables researchers to tailor nanoparticle for specific 
intracellular applications as contrast agents, drug delivery vehicles, and therapeutics. 
Reprinted from Ref. 34.  
 
2.4.1 Liposomes  
Liposomes are nano size artificial vesicles of spherical shape consisting of a 
lipid bilayer (or multiple bilayers) composed generally of phospholipids and internal 
aqueous pools. Lipids self assemble to liposomes by spontaneous self-organization, 
during this process drugs are incorporated. Hydrophilics drugs get trapped inside the 
liposomal cavity while hydrophobic drugs are incorporated within lipid bilayer but similar 
to biological membranes liposomes have low permeability to hydrophilic drugs and high 
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permeability to hydrophobic drugs. This bilayer of liposomes can fuse with other 
bilayers such as the cell membrane, which promotes release of its contents.  
A number of anticancer and antibacterial agents have been effectively entrapped 
in liposomes eg. Doxorubicin was loaded by ion-trapping methods. At present, number 
of liposomal formulations are available in the market like DaunoXome® loaded with 
daunorubicin for the treatment Kaposi’s sarcoma, breast, ovarian.35 Epaxal-Berna 
Vaccine loaded with inactivated hepatitis A virions for active immunization against 
hepatitis.36 Liposomes acting as drug depots take the advantage of the EPR effect to 
reach the tumor. But many drugs cannot cross cell membranes to gain access to their 
intracellular site of action, to achieve this liposomes are modified with membrane active 
lipide or membrane active peptides which fuse with or disrupt the cell membrane to 
result in the cytoplasmic delivery of the drug. Extensive studies have been done on 
liposomal drug delivery systems to increase the solubility and therapeutic index of 
chemotherapeutic agents while minimising the side effects.37 However, several 
disadvatages have been shown with these conventional vehicles like physical/chemical 
drug leakage, short biological activity, low therapeutic index and dose effectiveness, all 
of which have limited the use of the conventional liposomes in clinical applications.38,39 
 
2.4.2 Polymeric Nanoparticles 
Nanoparticles are solid colloidal drug carriers ranging from 10 to 100 nm in 
diameter, typically made of a single material. The drug is either attached or entrapped 
to nanoparticles and depending upon the method of preparation, they can be obtained 
in different forms and shapes.40  
The majority of microparticle preparation techniques have been tailored for the 
fabrication of nano - sized particles. Conventialy they are formed either by 
polymerization of monomers or by dispersion of preformed polymers. In spite of 
development of various synthetic and semi synthetic polymers, natural polymers like 
chitosan, gelatin, albumin, sodium alginate are widely used in drug delivery. A variety of 
materials have been employed for the synthesis of the synthetic polymeric nanoparticle 
as delivery of therapeutic agents. Main requirement of using such materials is they 
must be non-toxic, chemically inert and free of leachable impurities with suitable 
physical structure, good processiablity and undesired aging. Nanoparticles posses a 
stable structure, in contrast to self-assembled systems.41
 
This advantageous stability 
must however be coupled to a long-term degradation under physiological conditions, in 
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order to prevent undesired body accumulation. Ideally, nanoparticles should break 
down into non-toxic products which can have renal excreation, or are absorbed by the 
body.42 Some nanoparticles in market are Risperidal® Consta, Nutropin® and Trelstar® 
Depot.  
 
2.4.3 Polymeric Micelles 
Amphiphilic copolymers with large solubility difference between hydrophilic and 
hydrophobic segments self assemble in aqueous medium to form micelles. The size of 
the micelles can range from few to tens of nanometer. They consist of a densely 
packed hydrophobic inner core capable of physically entrapping lipophilic substances 
and a dense hydrophilic shell which serves as as a stabilizing the micelle in external 
aqueous environment.43 Furthermore the hydrophilic shell of the micelle prevents 
protein adsorbtion and hence recognition by the immune system in the body. 
Compared to surfactant micelles, polymeric micelles are generally more stable, with a 
lowered critical micellar concentration and slower dissociation rate. This not only allows 
longer period of retention of loaded drugs but also higer accumulation at the target site 
particularly due to EPR effect. Active targeting of the micelles is also possible by 
modifying the peripheral chain ends of the polymer with conjugating ligands further the 
polymer can also functionalized with crosslinkable groups which can increase the 
stability of the micelles. Moreover control of the size and morphology of the micelles 
can be easily be adjusted by changing the chemical composition, molecular weight and 
block length ratios of the copolymer. Several micellar compositions for various 
applications are under clinical study eg. Genexol PM® Samyang, Novavax® Estrasorb, 
Medicelle® NanoCarrier, Flucide® NanoViricides, Basulin®, Flamel Technologies.44 
 
2.4.4 Dendrimers  
Dendrimers are tree like macromolecules branching out from central core unit. 
Dendrimers have a uniform size, well-defined molecular weight, highly functionalized 
terminal surface and water solubility. With modification of the cavities inside the core 
and branches successful encapsulation of hydrophobic or hydrophilic drugs could be 
attained. The terminal groups on the surface can be adapted to carry drugs or 
antibodies for neutralizing or targeting purpose.45 They are prepared either from the 
central initiator core, layer by layer or are built from small building blocks that end up at 
the surface of the sphere, reaction in this case proceeds inward and the block are 
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finally attached to a core. With each subsequent growth step a new "generation" of 
polymer is formed which has larger molecular diameter, more reactive surface sites, 
and approximately double the molecular weight of the previous generation. Dendrimers 
thus provide platforms for drug attachment and have the ability to encapsulate or bind 
drugs via several mechanisms such as electrostatic interaction, physical encapsulation 
and covalent conjugation. The encapsulation / complexation of drug molecules into/with 
dendrimers can be widely used in different routes of drug administration. Use of 
dendrimers as parenteral injections is most common, either directly into the tumor 
tissue or intravenously for systemic delivery.Some of the marketed products are 
Vivagel® a vaginal Gel for preventing HIV, Starpharma, Stratus CS® a cardiac marker, 
Dade Behring SuperFect® for gene transfection. 
 
2.4.5 Nanogels 
Another emerging class of nanodevice which could be used for the drug delivery 
are nanogels suggested to be used as carriers to carry the cargo\drug. These gels are 
insoluble in water, but swell when immersed. In recent years, these carriers have been 
considered in sustained and controlled release devices for the delivery of water soluble 
drugs. Thus minimising the toxic effect caused by the use of organic solvents.46 
 
2.4.5.1 Nanogels via Disulphide Bridging 
The nanogels properties can be tailored by using different polymers and co-
polymers or proteins. The new strategies use synthetic polymers with biodegradable 
conjugation like disulphide and from natural products such as chitosan, hyaluronic acid, 
heparin, dextran and albumin or combination of both.47 
In a novel approach stable biodegradable nanogels cross-linked with biodegradable 
disulfide linkages were prepared by inverse miniemulsion atom transfer radical 
polymerization (ATRP) by Matyjaszewski et al.48,49 In this process, water-soluble 
monomer oligo(ethylene glycol) monomethyl ether methacrylate (OEOMA) with 
different molecular weights were crosslinked in the ATRP reaction with the disulfide-
functionalized crosslinker. The nanogels formed were considered to have a uniformly 
cross-linked network, which was supposed to improve, control the release of 
encapsulated agents, and the nanogels were shown to be biodegradable into water-
soluble polymers in the presence of a biocompatible glutathione tripeptide, which is 
commonly found in cells. The biodegradation of nanogels thus could trigger the release 
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of encapsulated drugs, as well as facilitate the removal of empty vehicles. Cytotoxicity 
assays of nanogel loaded with drug on HeLa cancer cells was performed. Results 
obtained from this suggested that the released drug molecules penetrated cell 
membranes and could suppress the growth of cancer cells. Further, OH-functionalized 
nanogels were also prepared to demonstrate facile applicability toward bio conjugation 
with biotin. Stable PEG/DNA nanogels were prepared by using a thiol-functionalized 
six-arm branched PEG for DNA solubilization in DMSO followed by oxida-tive cross-
linking.50 In the presence of a reducing agent, intact plasmid DNA was released from 
the nanogels. The PEG/DNA nanogels exhibited appreciable gene transfection 
efﬁciency. Morimoto et al. prepared dual stimuli-responsive nanogels based on 
polysaccharides lightly grafted with thiol-terminated poly(N -isopropylacrylamide) 
(PNIPAM), which was synthesized via RAFT polymerization of NIPAM using 2-(1-
isobutyl)-sulfanylthio-carbonylsulfanyl-2-methyl propionyl acid chloride conjugated 
pullulan followed by aminolysis.51 Moore and coworkers developed chymotrypsin and 
reduction responsive polyacrylamide microscopic hydrogels using a tetra-peptide 
sequence, Ac-Cys-Tyr-Lys-Cys-NH2 (CYKC), as a cross-linker.52 These microscopic 
hydrogels dissolved when exposed to a solution of R-chymotrypsin, while control 
hydrogels cross-linked with the tetrapeptide, Ac-Cys-Ser-Lys-Cys-NH2 (CSKC), were 
not affected by R-chymotrypsin. Both the CYKC and CSKC cross-linked hydrogels 
were eroded in the presence of the disulﬁde reducing agent tris(2-carboxyethyl) 
phosphine (TCEP). Galaev et al. prepared biodegradable macroporous PHEMA 
cryogels by combining two crosslinkers, PEG diacrylate and a disulﬁde-containing 
water soluble crosslinker, N,N’-bis(methacryloyl)-L-cystine (MAS-S).53 Aliyar et al. 
describe nanogels prepared by intramolecular crosslinking of high molecular weight 
polyacrylamide.54 Thiol-functional polyacrylamide was synthesized by copolymerization 
of acrylamide and N,N’ -bisacryloylcystamine, and subsequent reduction of the 
obtained gel using DTT. Dissolution of the thiomer in water at very low concentrations 
followed by air oxidation at pH 7.5 resulted in crosslinked particles. Diluted solution 
conditions favored the formation of intramolecular crosslinks so that mainly single-chain 
nanogel particles were obtained. Recently, a report on nanogels prepared from star-
shaped poly(ethylene oxide-stat-propylene oxide) (sP(EO-stat-PO)) or from linear PG55 
was published. Nanogels were prepared in inverse miniemulsion and the disulﬁde bond 
formation was accelerated by addition of catalytic amounts of the hydrogen peroxide. 
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The group of Bernkop-Schnürch describes the preparation of thiolated chitosan (CS) 
microparticles loaded with insulin as a potential carrier for nasal delivery. Thiolated CS 
showed higher mucoadhesive and permeation-enhancing properties than unmodiﬁed 
CS,56-58 which makes them ideal precursors for nasal or oral drug delivery systems. 
Thiolated CS/DNA complexes have been prepared in aqueous solution.59 In 
comparison to the particles prepared by complexation of DNA with thiol -free CS, the 
oxidized particles with DNA showed an increased stability to artiﬁcial intestinal  ﬂuid, a 
triggered release in a reducing environment, and improved transfection efﬁciency. 
Chitosan-N-acetylcysteine (CS-NAC) nanoparticles were investigated as a nonviral 
gene carrier.60 The CS–NAC/DNA particle have been prepared in water and the 
oxidation of free thiol groups was catalyzed by the addition of hydrogen peroxide. They 
showed enhanced stability in comparison to the non-crosslinked particles against 
polyanionic heparin as well as alkaline pH. The same thiolation of CS was applied by 
Atyabi et al.61 Lee at al. describes the preparation of thiolated CS/pDNA 
nanocomplexes using an aqueous homogeneous chemical gelation process.62 
Although the non-crosslinked thiolated CS provided higher transfection efﬁciency in 
vitro, the disulﬁde-crosslinked complexes showed a more sustained pDNA release 
proﬁle and signiﬁcantly higher gene expression in comparison to non-crosslinked 
systems, especially at 14 days post-intranasal administration in a mouse model. 
Another strategy was pursued by Shu et al., who prepared CS-based disulﬁde solidiﬁed 
polyelectrolyte nanogels through mild ionic gelation.63 The resulting coacervates were 
covalently ﬁxed by chloramine-T-mediated disulﬁde formation. Such nanogels were 
successfully loaded with insulin and showed a pH-dependent size variation, indicating a 
suitability of these particles for oral drug delivery applications. Preparation of 
erythropoietin (EPO)-loaded hyaluronic acid (HA) nanogels was described by Hahn et 
al.64 Lee et al. demonstrated the preparation of disulﬁde-crosslinked nanogels for 
entrapment of green ﬂuorescence protein siRNA. These nanogels effectively protected 
the encapsulated siRNA from enzymatic degradation.65 The siRNA/HA nanoparticles 
showed a considerable gene silencing effect in serum conditions. Recently, dual 
stimuli-responsive disulﬁde-crosslinked nanogels were prepared by covalently linking 
sulfanylthiocarbonylsulfanyl (STS) to 100 kDa Pullan and subsequent grafting of short 
PNIPAM chains through reversible addition-fragmentation chain transfer (RAFT) 
polymerization of NIPAM.66 Aminolysis of the STS functionalities at the PNIPAM chain 
ends with isopropylamine yields thiol groups. Disulﬁde-crosslinked heparin nanogels 
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were prepared for efﬁcient cellular uptake of heparin in order to induce apoptotic cell 
death.67 The obtained stable nanogels, with an average diameter of 250 nm in water, 
rapidly disintegrated and released free heparin upon reduction with GSH. These 
nanogels enhanced the internalization of heparin and, in addition, signiﬁcantly reduced 
the proliferation of mouse melanoma cells.  
Self assembled acrylate group-modified cholesterol-bearing pullulan (CHPANG) were 
crosslinked with thiolated poly (ethylene glycol) (PEGSH) by Michael type addition 
yielding nanogels (A-CHPNG) in the size range of 40–120 nm depending on the 
concentration of CHPANG and PEGSH. A-CHPNG was shown to be degraded by 
hydrolysis under physiological condition and dissociate back to original nanogels with 
efficient encapsulation of interleukin-12 (IL-12).68 Poly(N-isopropylacrylamide) 
(PNIPAAm) grafted Dex nanogels with dodecyl and thiol end groups was synthesized 
by RAFT polymerisation. Dodecyl-terminated polymers (Dex-PNIPAAm) can be readily 
self-assembled to form nanogels. Dex-PNIPAAm nanogels showed volume phase 
transition due to PNIPAAm side chains which was dependent on PNIPAAm chain 
length and polymer concentration. Aminolysis of trithiocarbonate groups rendered thiol 
functionality in the polymer resulting into crosslinking of the nanogels though disulphide 
bond formation (SS-Dex-PNIPAAm). Dual responsiveness of the Dex-PNIPAAm 
nanogels make them intriguing candidate for coating on different nanomaterials.69 
Dually functionalized HA by hydrazine and thiol (HA-hy-SH) was ﬁrst converted by click 
chemistry to HA-hy-pyrene. HA-hy-pyrene self assemble in water and lead to the 
formation of physical nanogels which were chemically cross-linked by amide coupling 
between the hydrazide and carboxylate group. 
Physically associated nanogels composed of HA with 5% of the pyrene-tethered 
disaccharide units were decreased in size from 450 nm to 390 nm upon the EDC 
mediated crosslinking. When the pyrene content was decreased to 0.5% the size of 
nanogels reduced to 248 nm. DOX was physically loaded into nanogels either by 
electrostatic binding of cationic DOX in salt form or by entrapment of the neutral DOX 
within the hydrophobic pyrene cores. The loading efﬁciency of 66% and 82% was 
achieved respectively. Nanogels loaded with DOX showed an anti-proliferating effect 
on cell analogous type. Further an enzymatic degradation approach was reported to 
obtain the nanogels via degradation of the pyrene-immobilized HA hydrogel.70 HA-
based nanogels with positive and negative charges on the surface prepared using an 
aqueous solution of linear HA in a sodium bis(2-ethylhexyl) sulfosuccinate (AOT)-
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isooctane microemulsion system. The prepared HA particles were post modified to 
aldehyde (HA-O) by NaIO4 treatment and then particles were reacted with cysteamine 
(CY) to obtain thiol groups on the surface. The thiolated HA particles (HA-CY) were 
further exposed to radical polymerization with an anionic monomer, 2-acrylamido-2-
methyl-1-propanesulfonic acid (AMPS), and with a cationic monomer, 3-
acrylamidopropyl-trimethylammonium chloride (APTMACl), to generate HA-based ionic 
hydrogel particles, HA-CY-AMPS and HA-CY-APTMACl, respectively. The prepared 
HA-based anionic and cationic particles illustrated strong pH dependent size variations. 
Trimethoprim (TMP) and naproxen (NN) were used as model drugs in the drug delivery 
experiments.71 
Different proteins have been used as building blocks for the synthesis of biohybrid 
nanogels. Nanogels with diameter of 250nm were prepared by complexation of 
thiolated heparin and poly (ethylene glycol) (PEG) in DMSO followed by intermolecular 
crosslinking induced by disulfide bond formation between adjacent heparin molecules. 
Under reductive environment nanogels disintegrated and released free heparin. These 
nanogels showed signiﬁcant inhibition in proliferation of mouse melanoma cells by 
inducing caspase -mediated apoptotic cell death.72 The RNase A-loaded heparin–
Cystamine–Pluronic–cRGDfC nanogels with mean diameter of 116 nm were prepared 
according to the direct dissolution method. The heparin–Pluronic (HP) conjugate was 
coupled via redox-sensitive disulphide. Heparin was conjugated with cystamine (Cys) 
and the terminal hydroxyl groups of Pluronic were activated with the vinyl sulphone 
(VS) group, followed by coupling of VS groups of Pluronic with cystamine of heparin. 
Cyclo(Arg–Gly–Asp–D-Phe–Cys) (cRGDfC) peptide was efficiently conjugated to VS 
groups of HP nanogel and exhibited higher cellular uptake than unmodified nanogels.73   
 
2.5 Disulfide Crosslinking in Drug Delivery 
Thiols oxidise to form disulphide bond, relatively this bond is quite stable in 
oxidising environment but can be readily cleaved under reductive condition to generate 
free thiols. Since disulphide bond formation is initiated by deprotonation of thiols in 
neutral or basic conditions, acidic conditions stabilize free thiols. For reduction of 
disulﬁdes to thiols in an aqueous environment, dithiothreitol (DTT), 2-thioethanol, 
triscarboxyethylphosphin (TCEP), or glutathione (GSH) are commonly used as 
reduction reagents. GSH is a tripeptide composed of L- Glutamate, L-Cysteine and 
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Glycine with an unusual peptide linkage between the γ-carboxy group of glutamate and 
the amino group of cysteine.74,75 In mammalian cellular fluids it is present in the range 
of 0.5 - 10 mM76-78 and acts as major protection against oxidants such as reactive 
oxygen species. When reacting with oxidants, GSH itself is oxidized and forms 
disulﬁdes (GSSG). In a healthy cell, 90% of GSH is present in the reduced form. In 
contrast to its concentration in the cytosol, the concentration of GSH in plasma and 
other extracellular fluid is only in micromolar (20 - 40μM) and even lower in the blood 
(about 2 µM). This high redox potential difference between the neutral or oxidizing 
extracellular space and the reducing intracellular space makes disulﬁde-crosslinked 
nano and nanogels especially attractive as drug delivery systems due to the possibility 
of controlled biodegradation of the crosslinked network, and thus quantitative drug 
release in the cytosol.79-82  
Disulﬁdes can form spontaneously by autoxidation of thiols upon exposure to air. This 
process is, however, relatively slow and not useful for most microgel preparation 
techniques. Thus, oxidizing catalysts such as diamide,83 peroxides,84 alloxan,85 and 
sodium tetrathionate,86 or a catalyst based on Fenton chemistry,87 are often applied in 
order to shorten the oxidation time. 
 
2.6 Emulsions as System for the Nanoparticle Synthesis  
An emulsion is defined as a system of two immiscible liquid phases mostly oil 
and water, where one of the phase is dispersed in the other as microscopic or colloidal 
size drops typically around 1 µm: there are two kinds of simple emulsion, oil-in-water 
(o/w) and water in oil (w/o), depending on which phase comprises the disperse 
phase.88 Unstable emulsions are formed if they are made just by stirring of the pure 
immiscible liquids. Such emulsions tend to break promptly into their respective phases 
either due to molecular diffusion degradation (Ostwald ripening) or coalescence. To 
protect the emulsion from destabilisation surfactants should be added which provide 
either electrostatic or steric stabilization to the formed droplets and protect the 
emulsions against coalescence. Although surfactants provide stabilisation, preparation 
emulsion leads to size distribution which is determined by Laplace pressure difference 
between droplets of different size resulting in a net mass flux by diffusion between the 
droplets thereby reducing the total free energy of the system. If the droplets are not 
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stabilized against diffusional degradation, Ostwald ripening occurs which is a process 
where small droplet will disappear leading to an increase of the average droplet size.89  
There are three different types of emulsions, based upon the size of the dispersed 
particles (1) macroemulsion, opaque emulsion with particle size >400 nm, easily visible 
under microscope; (2) microemulsion, transparent dispersions with particles <100 nm in 
size and (3) mini- or nanoemulsion with a particle size between 100-400 nm. In the 
formation of macroemulsion one of the two immiscible liquids is broken up into particles 
that are dispersed in the second liquid. Since the interfacial tension between the two 
immiscible pure liquids is always greater than zero, this dispersion of the inner liquid, 
which produces a tremendous increase in the area of the interphase between them, 
results in a correspondingly large increase in the interfacial free energy of the system. 
The macroemulsion produced is highly unstable therefore an emulsifying agent is 
added to stabilize this basically unstable system. Microemulsions are transparent 
dispersions containing two immiscible liquids with particles of 10-100 nm diameters. 
The main difference macro-/miniemulsions and microemulsions are that the former, 
although exhibit excellent kinetic stability, are thermodynamically unstable. In addition, 
there are marked differences in their method of preparation in terms of energy input to 
make them. Miniemulsions are prepared by shearing a system of oil, water, a 
surfactant and a hydrophobe. The dispersions formed are of stabilized disperse phase 
with droplets in the size range of 50 and 500 nm. The emulsifier is generally 1-3 % of 
the oil phase, in contrast to the 15-30% in microemulsions.90 Miniemulsions have been 
used widely used for the synthesis of the nanoparticles. On careful preparation, 
polymerizations in such miniemulsions results in monodispersed latex particles which 
have about the same size as the initial droplets since the polymerization time is usually 
shorter than the growth of the droplets by collisions. This implies that the appropriate 
formulation of a miniemulsion suppresses coalescence of droplets or Ostwald ripening. 
The principle of miniemulsion polymerization is schematically shown in Figure 2.4. The 
density of the surfactant layer controls the growth of droplets by collision. Freshly 
prepared miniemulsions are critically balanced and show a gradual but marked growth 
whereas a miniemulsion in equilibrium exhibit constant particle size on longer time 
scales. Polymerization in the dispersed droplets of such miniemulsions has turned out 
to be very promising for the synthesis of nanoparticles and has drawn attention towards 
their use as containers for drug delivery. 91,92-96  
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Figure 2.4: Schematic of miniemulsion polymerization. Mechanical agitation of a 
heterogeneous fluid containing surfactants always leads to a distribution of droplet 
sizes results. 
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CHAPTER 3 
 
Synthesis of Thiol Functionalized Polymers, and use 
of HS-sP(EO-stat-PO) based Hydrogels for 
Chemokine Delivery  
 
Part of this work which deals with chemokines delivery form the hydrogels was 
performed in the work group of Prof. Christian Weber, Institute for Molecular 
Cardiovascular Research (IMCAR), RWTH Aachen and Institute for Cardiovascular 
Prevention (IPEK), Hospital of the LMU Munich. 
 
3.1 Introduction 
Disulfide bonds as key features in drug delivery systems are being investigated 
in a wide variety of forms and applications. Because of the easy reversibility but relative 
stability, disulfide bonds have mostly been used to attach functional moieties to an 
already existing drug delivery system. However, these exact same properties also 
present an interesting opportunity as a basis for a reductively degradable bulk carrier 
material. In this chapter first we investigate the possibility to functionalize branched star 
shaped poly(ethylene oxide-stat-propylene oxide) (sP(EO-stat-PO)) and poly(glycidol) 
(PG) macromolecules with thiol groups, in order to then crosslink them via formation of 
disulfide bonds  or by Micheal addition to form hydrogels. PG was synthesized via poly 
(ethoxyethylglycidylether) by anionic ring-opening polymerisation followed by 
subsequent deprotection. Thiol functionalization was introduced by Steglish 
Esterification of prepolymers. The prepolymers were first crosslinked via esterification 
to form disulphide crosslinked hydrogels. The hydrogels formed were subsequently 
reduced by cleaving the disulfide cross-linkage (–S–S–) to thiol groups (–SH HS–) by 
using tris(2-carboxyethyl) phosphine (TCEP) as reductant. Secondly we show the 
release of engineered chemokines from HS-sP(EO-stat-PO) hydrogel crosslinked by 
oxidation and Micheal addition to prevent injury extension after myocardial infarction. 
The hydrogel was loaded with two chemokine-derivatives, Met-CCL5 (7.98 kDa) and 
recombinant protease-resistant CXCL12 (S4V) (8.07 kDa), for the inhibition of 
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neutrophil infiltration and concomitant improvement of hematopoietic stem cell 
recruitment to sustain neovascularization after myocardial infraction.  
Myocardial infarction (MI), following the occlusion of an atherosclerotic coronary artery, 
causes death of the cardiomyocytes and initiation of an inflammatory reaction, 
activation of the nuclear factor (NF)-κB and toll like receptor (TLR)-mediated pathways, 
which up-regulates chemokines, cytokines as well as adhesion of molecules in 
endothelial cells and leukocytes.1 All these processes lead to the infiltration of 
polymorphonuclear cells, monocytes and lymphocytes into the infarcted area and are of 
crucial importance in the proper healing and scar formation. The cardiac repair, or so-
called "remodeling", of the heart muscle is in fact the replacement of the adjacent 
myocardium with connective tissue and consecutive dilation of the ventricles.  
Neutrophil and macrophage derived inflammatory signals initiate the phagocytosis of 
dead cells and degradation products from matrix. During this proliferation phase, the 
expression of inflammatory mediators is inhibited; which causes the infiltration of 
fibroblasts and endothelial cells into the infarcted area, resulting into promotion of 
collagen deposition and angiogenesis.2 Current clinical therapies include only cause-
dependent interventions, which are not always efficient in reducing myocardial necrosis 
and optimizing cardiac repair following infarction. New strategies have been proposed 
such as progenitor cell therapy, which was considered as a very promising therapeutic 
approach to provide an alternative way to regenerate the heart structure after MI. 
Animal studies have shown that transplantation of adult stem cells after acute MI 
improves neovascularization and reduces fibrosis, preserving the left ventricular heart 
function.3-5 Unfortunately, these promising results were not obtained in clinical studies 
in patients,6-9  probably due to incorrect translation of the knowledge from animal to 
human system. New data suggest that the main mechanism of improving the heart 
function by cell therapy is in fact due to the inflammation and its consecutive effects.10 
These findings are of notable significance, since they selectively control and 
manipulate the inflammatory reaction through chemokines.11  
Chemokines are small signaling proteins that trigger migration (chemotaxis) of different 
cells. They can both prevent apoptosis of cardiomyocytes and promote angiogenesis in 
the infarcted area.11 The inhibition of neutrophil infiltration by blocking CCR1 or by Met-
CCL5 treatment leads to improved left ventricular function and reduction of infarct 
extension,12,13 possibly by decreasing myeloperoxidase expression and preventing 
further expansion of the resulting tissue damage.14  CXCL12 (Stromal Cell-Derived 
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Factor 1/SDF-1) and its protease-resistant mutants are well established agents for 
recruiting hematopoietic stem cells from the circulating blood, resulting in a significant 
increase in vessel formation, vascularization in the scar tissue, and a consecutive 
improvement of left ventricular function after MI.15-18 
In this study, combined approach implementing Met-CCL5 and recombinant protease-
resistant CXCL12 (S4V), for the inhibition of neutrophil infiltration and concomitant 
improvement of hematopoietic stem cell recruitment to sustain neovascularization is 
provided. To avoid any unwanted effects of a systemic administration, the chemokine-
derivatives were added to biodegradable hydrogels and administered locally in the 
infarcted myocardium.  
 
3.2 Experimental  
3.2.1 Materials and Methods 
Six arm, star shaped sP(EO-stat-PO) with a backbone consisting of 80% ethylene 
oxide and 20% propylene oxide (Mn = 12000 g/mol, Mw/Mn=1.12 g/mol) was 
purchased from Dow Chemicals. Prior to functionalization sP(EO-stat-PO) has been 
purified by precipitation in THF/cold diethylether as solvent/non solvent system. 1, 3-
dicyclohexylcarbodiimide (DCC), (99%) was purchased from Acros and used as 
received. 4-Dimethylaminopyridine (DMAP) (99 + %), 3, 3’-dithiopropionic acid (DTPA), 
tris(2-carboxyethyl) phosphine (TCEP) (99%), dichloromethane (HPLC grade), DMSO 
(Biotech grade) (99.9 + %), potassium tert-butoxide (1 M solution in THF) were 
purchased from Aldrich and used as received. HCl and p-toluene sulphuric acid were 
purchased from VWR and used as received. THF used was distilled over LiAlH4 and 
dried with n-BuLi, 2,3-epoxypropan-1-ol (glycidol) (99%, Fluka) was dried over 
molecular sieves (4Å) and distilled over CaH2 under reduced pressure and ethyl vinyl 
ether (99%, Fluka) was purified by distillation at atmospheric pressure under dry 
nitrogen atmosphere, ethoxy ethyl glycidyl ether (EEGE) was synthesized from glycidol 
and ethyl vinyl ether according to Fitton et al.19 Hydrogen peroxide 30% (p.A) (VWR), 
PEG diacrylate (Mn = 700 g/mol) (Sigma) were used as received. Phosphate buffered 
saline (PBS) from Sigma has been dissolved in water to 0.01 M concentration (pH 7.4). 
Dialysis membrane, MWCO = 3500 and 1000 Dalton, has been purchased from 
Spectrum Laboratories, Inc. Demineralised water was used throughout the work. 
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1H-NMR spectra were carried out on a Bruker DPX 300 at 300 MHz. DMSO-d6 with 
TMS as internal standard was used as solvents. 1H spectra were recorded in D2O, 
DMSO-d6 and CDCl3 with a Bruker spectrometer operating at 400 MHz (Bruker AV 
400). Tetramethylsilane was added as the internal standard. Chemical shifts are 
reported in parts per million (ppm) relative to the internal standard.  
 
Size Exclusion Chromatography (SEC) was performed in THF with addition of 250 
mg/L 2, 6-di-tert-butyl-4-methylphenol. A high pressure liquid chromatography pump 
(PL-LC 1120 HPLC) and a refractive index detector (ERC 7515A) were used at 35 °C 
with a flow rate of 1.0 mL/min. Five columns with MZ gel were applied. The length of 
the first column was 50 mm, and 300 mm for the other four columns. The diameter of 
each column was 8 mm, the diameter of the gel particles 5 mm, and the nominal pore 
widths were 50, 50, 100, 1000, and 10 000 Å, respectively. Calibration was achieved 
using poly(methyl methacrylate) standards.  
For PG and HS-PG, SEC analyses were carried out at 80°C using a high-pressure 
liquid chromatography pump (Bischoff HPLC 2200) and a refractive index detector 
(Waters 410). The eluting solvent was N,N-dimethylacetamide (DMAc) with 2.44 g L-1 
LiCl and a flow rate of 0.8 mL min-1. Four columns with MZ-DVB gel were applied. The 
length of each column was 300 mm, the diameter 8 mm, the diameter of the gel 
particles 5 mm, and the nominal pore widths were 100, 1000, and 10000 Å. Calibration 
was achieved using poly(methyl methacrylate) standards. 
 
Raman Spectroscopy Raman spectra were recorded on Bruker RFS 100/S 
spectrometer. The laser used was Nd:YAG at 1064 nm wavelength at a power of 250 
mW. On an average 1000 scans were taken at a resolution of 4 cm-1. For sample 
holding aluminium pans of 2 mm bore were used. Software used for data processing 
was OPUS 4.0. 
 
3.2.2 Synthesis of Protected Glycidol (Ethoxy Ethyl Glycidyl Ether)  
The monomer, ethoxy ethyl glycidyl ether (EEGE) was synthesized as follows. Under 
inert gas conditions 117 mL (1.75 mol) of freshly distilled glycidol and 567 mL (5.93 
mol) of ethyl vinyl ether were added in a 1000mL 3-neck flask. To prevent overheating 
the reaction mixture was cooled in ice bath to 0°C followed by addition of 2.66 g 
(0.0153 mol) of p-toluene sulphuric acid added drop by drop with constant stirring. The 
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reaction was continued under stirring at room temperature for 4h. After which, the 
reaction mixture was extracted with an excess of saturated NaHCO
3
. The organic 
phase was collected and dried over magnesium sulphate. The solid was filtrated off 
and excess of ethyl vinyl ether was removed under vacuum. The crude product ethoxy 
ethyl glycidyl ether (EEGE) (Scheme 3.1) was fractionated under reduced pressure 
and stored over CaH
2
. Yield: 97% of crude product, 72% after fractionation.  
1H NMR (CDCl3): δ = 1.1-1.5 Hz (t, 3H, CH3-7), 1.2-1.25 Hz (q, 3H, CH3-5), 2.5-2.8 
Hz (m, 2H CH2-6), 3.1-3.8 Hz (m, 5H, CH2-1, 3, CH-2), 4.7-4.75 Hz (m, 1H, CH-4). 
 
Scheme 3.1: Schematic representation of ethoxy ethyl glycidyl ether (EEGE) 
3.2.3 Synthesis of Linear Poly(glycidol) acetal 
Anionic polymerisation of EEGE was initiated by t-BuOK according to Dworak et al.20 to 
form poly(glycidol) acetal (PEEGE) (Scheme 3.2). Schlenk flask used for reactions was 
evacuated and flushed with nitrogen prior to polymerization. Under nitrogen 
atmosphere EEGE (50 mL, 342 mmol) was mixed with 50 mL of dry THF. t-BuOK (0.43 
mL of a 1 M solution in THF, 0.43 mmol) was added and the reaction mixture stirred at 
60 °C for 24 h. On completion of polymerization the reaction was cooled down to RT 
and polymerisation was terminated by addition of excess of methanol. Solvents were 
removed in vacuum. From SEC (THF): Mn = 9500 g/mol, degree of polymerization (DP) 
= 60, Mw/Mn = 1.11. 
1H NMR (CDCl3): δ = 1.21 Hz (s, br, 9H, CH3-1), 3.34-3.67 Hz (m, 7 H, CH2-2, 4, 7, 
CH-3), 1.18 Hz (t, 3H, CH3-8), 1.29 Hz, (d, 3 H, CH3-6), 4.70 (q, 1H, CH-5). 
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Scheme 3.2: Schematic representation of anionic polymerization of ethoxy ethyl 
glycidyl ether to poly(glycidol) acetal.  
 
3.2.4 Deprotection of Poly(glycidol) acetal to Poly(glycidol) 
PEEGE was dissolved in 5 L of THF to the concentration of 4 g/L. 100 mL of 
concentrated HCl was added to this solution and after 2 h of stirring at RT the 
deprotected polymer was precipitated. THF was removed and the polymer was 
dissolved in minimum quantity of methanol followed by drying under vacuum for 12 h. 
Poly(glycidol) was obtained in good yields of 85%. The deprotection reaction is 
presented in Scheme 3.3. SEC (DMF): Mn = 4500 g/mol, Mw/Mn = 1.06. 
1H NMR (DMSO): δ = 1.25 Hz (s, br, 9H, CH3-1), 3.37-3.64 Hz (m, 5 H, CH2-2, 4, CH-
3). 
 
Scheme 3.3: Schematic representation of deprotection of poly(glycidol) acetal to 
poly(glycidol) 
 
3.2.5 Synthesis of Thiol Functionalized Star-shaped Poly(ethylene oxide-stat-
propylene oxide) (sP(EO-stat-PO)) 
The thiol functionalized sP(EO-stat-PO)) (HS-sP(EO-stat-PO)), (Scheme 3.4) has 
been prepared in a two step synthesis. In the first step sP(EO-stat-PO)) have been 
crosslinked with disulfide crosslinker followed by the reduction of disulfide bonds to thiol 
groups in the second step. Typically the functionalization of four –OH groups has been 
performed. This lead to unreacted two -OH groups which can be used for further 
functionalization, for example with targeting molecules or drugs. 
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Step 1. For crosslinking of four -OH groups of sP(EO-stat-PO)), a solution consisting 
of 3,3’-dithiopropionic acid (DTPA) (1.0 eq with respect to one –OH) (0.1051 g, 0.5 
mmol) in dried THF (4 mL) was added drop wise to a solution consisting of the puri fied 
sP(EO-stat-PO) (M=12000 g/mol, 3g, 0.25 mmol  4 –OH = 1.0 mmol), 
dicyclohexylcarbodiimide (DCC) (1.1 eq with respect to one -COOH) (0.2269 g, 1.1 
mmol) and dimethylaminopyridine (DMAP) (1.1 eq with respect to one -COOH) (0.1343 
g, 1.1 mmol) in CH2Cl2 (6 mL) in an ice bath at 0 °C over 10 min. The resulting mixture 
was allowed to stir at RT for 12 h. The formed hydrogel was washed three times with 
CH2Cl2, twice with THF, ethanol and water followed by evaporation of remaining 
solvents on the rotary evaporator. Finally, the product was dried in a vacuum oven at 
35 °C for 12 h. 
 
Step 2. Tris (2-carboxyethy) phosphine (TCEP) has been used for the reduction of 
disulfide bonds. TCEP (1.5 eq. with respect to the disulfide units) (0.429 g, 1.5 mmol) 
was reacted with the crosslinked polymer in PBS buffer at room temperature for 2 h 
(pH of the solution ~ 4) under inert gas atmosphere. Subsequently, the solution was 
dialyzed (membrane pore size MWCO = 3500 Da) for two days at RT against aqueous 
HCl solution at pH ~ 3.5. Finally, the polymer solution have been lyophilized and stored 
at +4 °C for further use. The free thiol content of the polymer was determined by NMR. 
SEC (THF): Mn = 12900 g/mol, Mw/Mn = 1.12. 
1H NMR (D2O): δ = 1.21 Hz (s, br, 9H, CH3-1), 3.34-3.67 Hz (m, 7 H, CH2-2, 4, 7, CH-
3), 1.18 Hz (t, 3H, CH3-8), 1.29 Hz, (d, 3 H, CH3-6), 4.70 (q, 1H, CH-5). 
 
Scheme 3.4: Schematic representation of Thiolated six armed sP(EO-stat-PO)  
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3.2.6 Synthesis of Thiolated Poly(glycidol) 
Functionalization of 25% of –OH groups in PG (Mn = 4500 g/mol, DP = 60) was done in 
a similar way as done as with sP(EO-stat-PO). However, since the PG is not soluble in 
CH2Cl2, DMF was used as a solvent instead. The thiol content has been determined by 
1H-NMR. 
1H NMR (D2O): δ = 1.13 Hz (s, br, 9H, CH3-1), 3.4-3.9 Hz (m, 7 H, CH2 2, 7, 9, CH-3, 
8), 2.65 Hz (t, 4H, CH2-5, 6) 
 
Scheme 3.5: Schematic representation of Thiol functionalized linear poly(glycidol) (HS-
PG). 
 
3.2.7 Synthesis of Hydrogels.  
The synthesis of hydrogels from thiol-functionalized biodegradable sP(EO-stat-PO) 
and PG prepolymer was performed as: 
HS-sP(EO-stat-PO) (0.025 g, 2.08×10-3 mmol, 6.25×10-3 mmol with respect to SH 
groups (3 SH per molecule)) was dissolved in PBS buffer pH 7.4 (63µL). The solution 
was mixed followed by the addition of the oxidation catalyst H2O2 (3 × 10
-3 mmol). 
Gelation time was qualitatively determined by the vial inversion method. 
HS-sP(EO-stat-PO) (0.025 g, 2.08×10-3 mmol, 6.25×10-3 mmol with respect to SH 
groups (3 SH per molecule)) was dissolved in PBS buffer pH 7.4 (63µL) and was mixed 
thoroughly. To this solution PEG diacrylate (0.00218 g, 2.0×10-3 mmol with respect to 
acrylate (ACR) groups (2 ACR groups per molecule)) was added. This equals a molar 
ratio 1:1 SH: ACR functional groups. All the components were homogenized fast.  
HS-PG (0.025 g, 4.1×10-3 mmol, 6.14×10-2 mmol with respect to SH groups (15 SH per 
molecule)) was dissolved in PBS buffer pH 7.4 (63µL). The solution was mixed followed 
by the addition of the oxidation catalyst H2O2 (3 × 10
-3 mmol). Gelation time was 
qualitatively determined by the vial inversion method. 
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HS-PG (0.025 g, 4.1×10-3 mmol, 6.14×10-2 mmol with respect to SH groups (15 SH per 
molecule)) was dissolved in PBS buffer pH7.4 (63µL) and was mixed thoroughly. To 
this solution PEG diacrylate (0.0215 g, 3.07×10-2 mmol, with respect to ACR groups (2 
ACR groups per molecule)) was added. This equals a molar ratio 1:1 SH: ACR 
functional groups. All the components were homogenized fast. 
 
3.2.8 Procedure for Hydrogel Synthesis with Chemokines 
HS-sP(EO-stat-PO) hydrogels were prepared in similar manner as described above. 
H2O2 crosslinked hydrogels were used to encapsulate Met-CCL5 mentioned as FDH 
(fast degradable hydrogels) while diacrylate crosslinked hydrogels were used to 
encapsulate CXCL12 (S4V) mentioned as SDH (slow degradable hydrogels) further in 
the text. The FDH was prepared by dissolving HS-sP(EO-stat-PO) (0.0125 g, 1.04×10-
3 mmol) in PBS buffer pH 7.4 (31.5µL) supplemented with Met-CCL5 1.47μg ( 1.83 × 
10-3 µmoles). The solution was mixed followed by the addition of the oxidation catalyst 
H2O2 (1.5 × 10
-3 mmol). While SDH was prepared by dissolving HS-sP(EO-stat-PO) 
(0.0125 g, 1.04×10-3 mmol) in PBS buffer pH 7.4 (31.5µL) supplemented with CXCL12 
(S4V) 8.8μg ( 1.09 × 10-2 µmoles) followed by addition of PEG diacrylate (0.00109 g, 
1.0×10-3 mmol). 
 
3.2.9 Biocompatibility of CXCL12 (S4V), Met-CCL5 and HS-sP(EO-stat-PO) 
HUVECs were seeded in collagen-G coated 96-well plates with Endothelial Cell Growth 
Medium (PromoCell, Heidelberg, Germany) and cells were allowed to attach prior to 
treatment with 5 µg/mL Met-CCL5, 30 µg/mL CXCL12 (S4V) and 0.45 g/mL HS-sP(EO-
stat-PO). Proliferation between 0-72h was determined using BrdU Proliferation Assay 
(Novagen / Merck Bioscience, Darmstadt, Germany) and cytotoxicity was detected 
using the CellTiter-Blue® cell viability assay (Promega, Mannheim, Germany) at time 
points ranging from 0-24 h. All procedures were performed according to the 
manufacturer’s instructions. The data were expressed as the relative signal (RFU) after 
subtraction of the relative signal of the appropriate buffer or medium controls. 
 
3.2.10 Release of CXCL12 (S4V) and Met-CCL5 from HS-sP(EO-stat-PO) 
Hydrogels. 
FDH (15µL) containing 3 µg CXCL12 (S4V), were incubated at 37°C in 250 µL PBS 
containing 5 mM reduced glutathione (Sigma) for 24h. While SDH with 0.5 µg Met-
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CCL5 were incubated at 37°C in 250 µL PBS only, for over 4 weeks. At suitable time 
points 250 µL PBS containing 5 mM reduced glutathione was replaced and the 
supernatant was analyzed by DuoSet ELISA kit (R&D Systems) for mouse CXCL12 
(S4V) or human Met-CCL5 according to manufacturer’s instructions. 
 
3.2.11 Mouse Model of Myocardial Infarction and Injection of Hydrogels 
Containing Chemokines  
Eight weeks old male C57BL/6 mice (n = 6-9 per group) were subjected to coronary 
occlusion as described earlier.21,22 Briefly, mice were intubated under general 
anesthesia and positive pressure ventilation was maintained using a rodent respirator. 
Hearts were exposed by left thoracotomy and myocardial infarction (MI) was induced 
by suture occlusion of the left anterior descending artery (LAD) over a silicone tube. 
FDH/ SDH (15µL), alone or loaded with 0.5 µg Met-CCL5 and/or 3µg CXCL12 (S4V), 
were injected into the myocardium of the mice directly after MI. The muscle layer and 
skin incision were closed with a silk suture. The animals were kept in standard 
conditions one day or 4 weeks after MI until further investigation. Heart function of the 
mice was evaluated 1 day before, and 4 weeks after MI. All animal experiments and 
study protocols were approved by local authorities, complying with German animal 
protection laws. 
 
3.3 Results and Discussion 
3.3.1 Synthesis of Linear Poly(glycidol) acetal 
A defined molecular structure as well a narrow polydispersity index (PDI) of 
polymer is very important for using it in biomedical applications. Living anionic 
polymerization allows the synthesis of polymers with PDIs of approximately one 
(Equation 3.1), following Poisson-distribution which is the ratio of weight-average 
molecular weight (  to number-average molecular weight (Mn).  
          Eq.3.1 
Glycidol (2, 3-epoxypropanol-1) is an oxirane monomer containing a hydroxyl group. 
Polyethers obtained from this monomer contain a hydroxyl group in each structural 
repeating unit. In order to obtain linear polymers of glycidol its hydroxyl group has to be 
protected. Living anionic polymerization of monomer proceeds via ring-opening, 
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resulting into polymer with narrow PDI, the degree of polymerization only depends on 
the monomer [M]0 and initiator [I]0 concentration as well as the conversion xp and can 
be calculated by Equation 3.2.  
                Eq.3.2 
While polymerizing unprotected glycidol would lead to equilibrium between three active 
species and in the following steps to a highly branched polymer (Scheme 3.6). 
 
Scheme 3.6: Schematic representation for formation of highly branched polyglycidol 
 
Thus to obtain well defined linear polyglycidol, monomers with protected hydroxyl group 
like ethoxy ethyl glycidyl ether (EEGE), allyl glycidyl ether (AGE) or tert -butyl glycidyl 
ether (t-BuGE) are used. 
 
Scheme 3.7: Structure of (a) unptotcted glycidol and different protected glycidoly (b) 
ethoxy ethyl glycidyl ether (EEGE), (c) allyl glycidyl ether (AGE) (d) tert -butyl glycidyl 
ether (t-BuGE)  
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The polymerization mechanism is illustrated in Scheme 3.8. The reaction is initiated by 
a nucleophillic attack of potassium tert-butoxide on the secondary carbon atom of the 
epoxide, causing ring-opening and formation of an active chain end (Scheme 3.8 (a)). 
 
Scheme 3.8: Polymerization mechanism of living ring-opening anionic polymerization 
of ethoxy ethyl glycidyl ether  
 
This propagates the reaction (Scheme 3.8 (b)). Termination of the polymerization can 
be achieved by deactivation of the active chain ends by a proton donors like water or 
methanol (Scheme 3.8 (c)). In this work as a protection method, the acid-catalysed 
reaction of glycidol with ethyl vinyl ether leading to 2,3-epoxypropyl-1-ethoxy ethyl ether 
(EEGE) was chosen.23 During this reaction, a big excess of vinyl ether was used where 
ethyl vinyl ether acted as a reagent as well as a solvent. The obtained protected 
monomer is stable under anionic polymerization conditions and more importantly, it can 
easily be polymerized via anionic polymerization under conditions close to the living to 
give linear polymer. Under these conditions, polymers with good control of the molar 
mass and narrow molar mass distribution can be obtained.20 
Linear poly(glycidol acetal) polymer with degree of polymerization (DP) 60 was 
prepared. The polymerisation was carried out in a homogenous system, in dry THF as 
medium using potassium t-butylalcoholate (t-BuOK) as initiator. Important is also the 
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fact that the calculated DP values of polymers corresponded well to the targeted ones, 
indicating good control of polymerisation under chosen conditions. The polymer 
structure was confirmed by 1H NMR spectroscopy (Figure 3.1) 
 
Figure 3.1: 1H NMR spectrum of poly(glycidol acetal) 
 
showing the presence of glycidol acetal repeating units. Three groups of signals were 
observed. However, exact calculation of molar masses of synthesized polymers based 
on the peak integration could not be performed using 1H NMR spectroscopy. The 
signals derived from the initiator methyl groups and methyl groups form acetal groups 
overlapped, making calculation impossible. From 1H NMR spectra (Figure 3.2), it only 
can be concluded that upon this conditions monomer is stable and the protective 
groups remain unchanged. To de-protect poly(glycidol acetal) to poly(glycidol) different  
methods are already found and published.20,24 Spassky et al. carried it out by acidic 
hydrolysis in two ways.20 The first method was two step hydrolysis with concentrated 
formic acid to poly(formate), followed by saponification with KOH in dioxane/methanol 
mixture in order to regenerate the hydroxyl groups. The second one was the direct 
hydrolysis by aqueous hydrochloric acid in THF. However, in case of hydrolysis by HCl 
some polymer chain degradation was reported. The other published methods involved 
hydrolysis of acetal groups by oxalic acid in acetone/water mixture or in methanol using 
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AlCl3 as de-protecting agent.
24 In this work de-protection of protected poly(glycidol 
acetal) was performed by hydrolysis in aqueous hydrochloric acid in THF.  
 
 
Figure 3.2: 1H NMR spectrum of poly(glycidol) 
 
3.3.2 Synthesis of Thiolated Polymers 
sP(EO-stat-PO)  is a six arm star shaped polymer with the average molecular weight of 
12000g/mol. The backbone is a statistical copolymer of ethylene oxide and propylene 
oxide in the ratio 80 to 20 and the arms of the stars are terminated by –OH groups. The 
propylene oxide content prevents the crystallization of the ethylene oxide segment. 
For the preparation of thiol functionalized polymers via Steglish esterfication branched 
prepolymers sP(EO-stat-PO) and linear PG were used. The thiol functionalized, 
hydrophilic polymers have been prepared in a two step synthesis. In the first step the –
OH functionalized polymers, either sP(EO-stat-PO) or PG, have been crosslinked with 
disulfide crosslinker 3,3’-dithiopropionic acid (DTPA) followed by the reduction of 
disulfide bonds with tris(2-carboxyethy) phosphine (TCEP) to thiol groups in the second 
step. A general procedure for obtaining thiomers by this approach is presented in 
Scheme 3.9. 
Step 1: Crosslinking of –OH functional polymers with DTPA 
The crosslinking applied in this procedure is due to esterification reaction. Steglich 
esterification was used rather than Fisher esterification as it is a mild reaction which 
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allows the conversion of sterically demanding and acid labile substrates. The 
mechanism of Steglich esterifiction is as follows: 
 
 
 
 
Scheme 3.9: Schematic representation of the –SH functionalised polymer synthesis. 
 
DCC (dicyclohexylcarbodiimide) and the carboxylic acid are able to form an O-
acylisourea intermediate, which offers reactivity similar to the corresponding carboxylic 
acid anhydride (Scheme 3.10).  
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Scheme 3.10: Schematic representation of formation of O-acylisourea intermediate 
 
The alcohol is then added to the activated carboxylic acid to form the stable 
dicyclohexylurea (DHU) and the ester (Scheme 3.11). 
 
Scheme 3.11: Schematic representation of formation of stable dicyclohexylurea (DHU). 
 
But the O-acylurea formed can undergo slow acyl migration to form N-acyl urea as a 
side product. In order to avoid this side reaction 4-N,N'-dimethylaminopyridine (DMAP) 
was used. DMAP, as a stronger nucleophile than the alcohol, reacts with the O-
acylisourea leading to a reactive amide ("active ester"). This intermediate cannot form 
intermolecular side products but reacts rapidly with alcohols. Thus DMAP acts as an 
acyl transfer reagent in this way, and subsequent reaction with the alcohol gives the 
ester (Scheme 3.12 and Scheme 3.13). 
 
Scheme 3.12: Schematic representation of use of DMAP as an acyl transfer reagent. 
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Scheme 3.13: Modified reaction scheme using DMAP as a catalyst for Steglish 
Esterification. 
 
Step 2: Reduction of disulfide bonds 
The water-soluble phosphine TCEP is widely employed as a reductant of disulfide 
bonds in a variety of peptide, protein, and cellular systems. Model studies show that 
reduction of disulfides by phosphines is initiated by rate-limiting formation of a 
thiophosphonium salt. Subsequent, rapid hydrolysis releases the second thiol fragment 
and the phosphine oxide (Scheme 3.14). 
 
 
Scheme 3.14: Reduction of disulfide bonds with TCEP. 
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3.3.3 Characterization of Polymers 
Both FT-IR and Raman spectroscopy are suitable tools to analyze structural and 
chemical properties of substances possessing sulfhydryl groups. The Raman S-H 
stretching band occurs in an interval of the vibrational spectrum (2500-2600 cm-1) 
which is devoid of interference from any other fundamental mode of vibration of the 
macromolecule. Spectral interferences from water molecules and from possible overlap 
of bands are thus less problematic in Raman than in FT-IR spectroscopy.25 Raman 
spectroscopy allows also a direct means of observing the disulfide group since the S-S 
stretching frequency normally appears as a sharp line near 500 cm-l. 
In this study both FT-IR and Raman spectroscopy have been used for the qualitative 
proof of the –SH bond formation in sP(EO-stat-PO) and PG polymers. FT-IR spectral 
analysis of the HS-PG clearly indicates the presence of the strong thiol bands at 2559 
cm-1 and 917 cm-1. In the HS-sP(EO-stat-PO)  system however, it was not possible to 
detect the –SH characteristic band due to the overlap with the band in the 2560 cm-1 
region. In contrast, in the Raman spectroscopy the S-H stretching mode can be clearly 
observed at 2578 cm-1 and at 2574 cm-1 for both HS-sP(EO-stat-PO) and HS-PG, 
respectively (Figure 3.3). This is a clear indication for the thiol group presence. 
 
 
Figure 3.3: Raman spectra of HS-sP(EO-stat-PO) (left) and HS-PG (right) indicating 
the thiol signal ~ 2575 cm-1 and confirming the successful thiolation of the prepolymers. 
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In this work quantitative estimation of free thiol groups in HS-sP(EO-stat-PO) and HS-
PG was determined from 1H-NMR. Exact number of repeating units of the propylene 
oxide and ethylene oxide units in HS-sP(EO-stat-PO) was calculated according to 
Gasteier.26 On calculation repeating propylene oxide units were found to be 36. Thus 
the number of proton from methyl group of propylene oxide comes to be 108 which 
were taken as reference at 1.21ppm. After thiol functionalization via Steglish 
esterification and subsequent reduction, the 4H (H-1/-2) proton shows a multiplet at 
2.78 ppm. Integration of these protons comes out to be 12.11 and on division by 4 
gives a value of 3.02, which indicates that out of 6 arm, 3 arm of the sP(EO-stat-PO) is 
thiol functionalised (Figure 3.4). 
 
Figure 3.4:1H-NMR spectrum of thiol functionalized sP(EO-stat-PO) 
 
The amount of free thiols as measured for HS-sP(EO-stat-PO) from several different 
synthesis was between 2.6 and 3.1 and did not change significantly from batch to 
batch. 
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For the determination of the thiol functionalization in PG comparison of backbone signal 
(H-2/-3/-7/-8/-9) with signals of the one methylene group (H-4) of thiol functionalised 
unit was done (Figure 3.5). Signals at δ = 4.4 - 4.1 ppm belong to H-4. Signals at δ = 
3.9 -3.4 ppm belong to H-2/-3/-7/-8/-9. The degree of functionalization was calculated 
from the ratio of these integrals. Setting the integral of the signals at δ = 4.4-4.1 ppm to 
2, the integral of the signals at δ= 3.9-3.4 ppm acquire a value x specific for the degree 
of functionalization. 
 
Figure 3.5: 1H-NMR spectrum of thiol functionalized PG 
 
If three protons, which belong to the thiopropionate repeating unit backbone, are 
subtracted from x, the integral value equals five protons belonging to the glycidol 
repeating units. From these values, the degree of functionalisation (DOF) can be 
calculated according to Equation 3.3. 
DOF = 1/1+ ((x-3) /5) ×100                  Eq.3.3 
In case of Figure 2.5 DOF = 1/1+ ((18.21-3) /5) ×100, which comes out to be 24.74% 
and corresponds to 15 thiol group in HS-PG 
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3.3.4 Hydrogel Synthesis 
The hydrogels were prepared from HS-sP(EO-stat-PO) as well as from HS-PG either by 
oxidation or Michael addition respectively. Regardless, the preparation procedure all gels 
were transparent and highly elastic. 
One of the most characteristic reactions of the thiol groups is their oxidation to disulfide 
bonds (Scheme 3.15). This reaction can be induced either by oxygen or by a variety of 
other chemical agents.  
 
 
 
Scheme 3.15: Crosslinking mechanism of –SH groups to disulphide by oxidation. 
 
Disulfide bonding is generally assumed to proceed through the deprotonated form of 
thiols. An effective reaction and a quick gelation can be obtained only at high values of 
pH. Oxidation of pendant thiol groups (R-SH) to disulfides (R-SS-R) can be achieved 
either by oxygen/oxidising catalyst (Scheme 3.15, A) or by a thiol-disulfide exchange 
reaction between the thiol (R-SH) and low-molecular weight disulfides (R'-SS-R', 
Scheme 3.15, B). The rate of air oxidation of the thiol group R-SH is determined by a 
one electron transfer from R-S- to oxygen. This reaction rate increases with increasing 
pH, because the concentration of ionized thiol groups increases in an alkaline 
environment.27 During the oxidative gelation the formation of both intra- and inter-
molecular disulfide bonds can be formed. Due to a higher degree of freedom of the 
molecule the intra-molecular reaction is likely to be thermo-dynamically favored. This is 
especially valid for the HS-sP(EO-stat-PO)  system where due to the steric reasons the 
formation of inter- disulfide bonds is slightly improbable. However, from the relatively high 
fraction of thiol groups in linear HS-PG one can expect the formation of inter-molecular 
bonds in this polymer. But the oxidation in air normally takes several hours which in 
many cases is too slow in order to maintain stable miniemulsion for the production of 
nanogels described in the Chapter 4. Therefore in this work hydrogen peroxide is used 
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as an oxidizing agent. H2O2 is water soluble and after gelation, any excess of it can be 
removed easily by dialysis. 
Gelation of HS-sP(EO-stat-PO) as well as HS-PG was initiated by addition of 3 × 10-3 
mmol H2O2 at pH 7.4 on a 40% (w/v) polymer solution. The bulk gelation time of 5 and 3 
min for HS-sP(EO-stat-PO) and HS-PG respectively at pH=7.4 was recorded. The 
crosslinking of the HS-sP(EO-stat-PO) and HS-PG was also performed with low 
molecular weight PEG-diacrylate through a Michael type addition reaction at pH = 7.4 
(Scheme 3.16). 
 
 
Scheme 3.16: Michael type addition reaction between acrylate and thiol group 
 
Thiol to acrylate was taken in the ratio of 1:1 and it was observed that the gelation 
occurred within seconds.  
Raman spectroscopy has been employed in order to prove the formation of disulfide 
bonds in the case of crosslinked hydrogels by oxidation as well as presence of –C-S- 
bond in the case of the hydrogels crosslinked both by oxidation and Michael addition.  
 
Figure 3.6: Raman spectrum showing characteristic peaks of HS-sP(EO-stat-PO) 
hydrogels crosslinked with H2O2 and PEG diacrylate. 
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From Figure 3.6 and 3.7 presenting the Raman spectra of the hydrogels synthesized 
from HS-sP(EO-stat-PO) and HS-PG respectively one can clearly seen that the -SH 
band present in the polymers precursors strongly weakens upon crosslinking. In the case 
of hydrogels synthesized by oxidation two bands characteristic of -S-S- vibrations appear 
at 495 and 504-510 cm-1. In addition, for all hydrogels the stretching vibrations of the C-S 
bonds is present at 671 and 652 cm-1 frequency. 
 
Figure 3.7: Raman spectrum showing characteristic peaks of HS-PG hydrogels 
crosslinked with H2O2 and PEG diacrylate 
 
This confirms the presence of thioether linkages in the hydrogel synthesized by oxidation 
and especially in the gels synthesized by the Michael addition reaction between the thiol 
groups with the diacrylate. 
 
3.3.5 HS-sP(EO-stat-PO) based Hydrogel for Chemokines Delivery. 
3.3.5.1 Functional Analysis of Chemokines in HS-sP(EO-stat-PO) Hydrogels 
Different biodegradable synthetic hydrogels were recently described to ensure the 
immobilization of the chemokines at the desired location as well as a continuous release 
over a predefined period.28,29  
In this work selection of hydrogels for loading two different typed of chemokines 
was based on their degradation kinetics. A rapid degradable hydrogel assures a faster 
short release and action of a chemokine Met-CCL5 which blocks neutrophil infiltration in 
the first hours of MI. A second slower degradable hydrogel serves to ensure a long 
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release and action of another chemokine CXCL12 (S4V) to recruit hematopoietic stem 
cells over several weeks. It is well known that CXCL12 plays a very important role in 
driving chemotaxis of stem cells and progenitor cells to the infarcted myocardium and 
promotes neovascularization and tissue regeneration.30,31 Due to the fast degradation of 
CXCL12 itself mutant CXCL12 resistant to matrix metalloproteinase-2 (MMP-2) and 
Dipeptidyl peptidase IV (DPPIV/CD26) cleavage was formulated in a synthetic, 
biodegradable hydrogel for a controlled long term release. 
 
Figure 3.8: Showing the location of administration, for the two hydrogels in the heart. 
 
The administration of this mixture of chemokine derivatives and synthetic biodegradable 
hydrogels manipulated the inflammatory reaction after MI and sustained the endogenous 
reparatory mechanisms. Therefore, this study describes a promising therapeutic 
strategy, which is a viable alternative to orthologous cell-based therapies, with important 
clinical significance.  
In order to control the local release of the protease-resistant CXCL12 and Met-CCL5, two 
different hydrogels were utilized. HS-sP(EO-stat-PO) was chosen as precursors for both 
type of hydrogels, which were crosslinked in two ways, either by disulphide crosslinking 
or by thioether crosslinking resulting in fast degradable hydrogels or slow degradable 
hydrogels (FDH or SDH) respectively.  
Fast degradable hydrogels are termed so due to fast reduction of disulphide bond in 
cytosolic environment while the slow degradable hydrogels degrade comparatively slowly 
due to slow hydrolysis of ester bonds.32  
The FDH is used for the formulation with Met-CCL5 for a quick release to inhibit 
neutrophil infiltration within the first hour after MI. This fast release of Met-CCL5 from 
FDH was confirmed by incubation in PBS and 5mM glutathione, a tripeptide 
responsible for reduction of disulphide bonds in cytosol,33 which led to complete 
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degradation of the gel after 24 h (Figure 3.9A).The SDH was conceived for the 
formulation with the protease-resistant CXCL12 (S4V) for a gradual release in order to 
recruit hematopoietic stem cells from the circulating blood during a time period of 4 
weeks after MI. To confirm the release rate, the CXCL12 (S4V)-SDH was incubated for 
33 days in PBS for detection of local release over time. After 33 days the SDH was 
entirely degraded due to the hydrolytic cleavage of ester bonds in the backbone and 
release of chemokine was no longer detected (Figure 3.9B). 
 
Figure 3.9: A. Release assay of the Met-CCL5 chemokine from the FDH over 24 hours. 
B. Release assay of the CXCL12 (S4V) chemokine from the SDH over 33 days. 
C. Proliferation assay of hydrogel-treated HUVECs compared with untreated cells. 
D. Cell viability assay of -treated HUVECs compared with untreated cells. 
 
While proliferation and viability of HUVECs were not affected by culturing in the presence 
of the HS-sP(EO-stat-PO) (Figure 3.9C, D) proving it to be biocompatible. 
Due to the fast degradation, CXCL12 quickly disappears after very short action. 
Therefore in this study, a mutant CXCL12, resistant to MMP-2 and DPPIV/CD26 
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cleavage was formulated in a synthetic, biodegradable hydrogel for a controlled long 
term release.  
3.3.5.2 Improvement of Cardiac Function after MI in Mice by Combined Treatment 
with the Protease-Resistant CXCL12 and Met-CCL5 
To investigate a possible beneficial role of a blocked short term neutrophil influx after 
cardiac ischemia combined with a longer term recruitment of hematopoietic cells, the 
chemokine-loaded hydrogels were applied in an experimental model of MI. In this 
strategy effect of combining the Met-CCL5 and protease-resistant CXCL12 was seen, for 
the simultaneous activation of two important mechanisms for preservation of heart 
function: inhibition of neutrophil infiltration and enhanced neovascularization by 
increasing recruitment of hematopoietic stem cells is shown. Met-CCL5 antagonizes 
CCR1 and CCR5 activation and function in response to its natural ligand CCL5, and is 
able to reduce inflammation in models of induced inflammatory and autoimmune 
diseases, but also after MI.34 
 
Figure 3.10: A. Neutrophil infiltration in the myocardium were reduced in Met-CCL5-FDH 
and in Met-CCL5-FDH+CXCL12 (S4V)-FDH, compared with FDH, SDH and 
CXCL12 (S4V)-FDH treated mice 1 day after MI. B. Compared with FDH SDH and Met-
CCL5-FDH treated mice, the CXCL12 (S4V)-SDH and the combination Met-CCL5-
FDH CXCL12 (S4V)-SDH displayed a significantly smaller infarct size after 4 weeks. 
 
At day 1, infiltration of MI-induced neutrophils in the infarcted area was effectively 
reduced in both the Met-CCL5-FDH and the Met-CCL5-FDH+CXCL12 (S4V)-SDH 
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groups, but not in the control group that received only hydrogel or in only CXCL12 (S4V)-
SDH group (Figure 3.10, A). This confirmed the specificity of the administration of the 
CCR1 and CCR5 antagonist Met-CCL5 for the prevention of neutrophil recruitment. After 
4 weeks, the infarcted area was reduced by 50% in the CXCL12 (S4V)-SDH and in the 
combined Met-CCL5-FDH+CXCL12 (S4V)-SDH group, compared to the groups that 
received hydrogel only and Met-CCL5-FDH (Figure 3.10, B).  
Since the infiltration of neutrophils occurs only for a short time period.35 Met-CCL5 was 
combined with a very quickly biodegradable hydrogel, which assures the release of this 
antagonist only for several hours is essential to avoid the blocking of later functions of 
Met-CCL5 e.g. over CCR5, such as recruitment of reparatory monocytes or T regulatory 
cells,36 which is necessary for a proper healing and scar formation. 
 
3.3.5.3 Combined Treatment with the Protease-Resistant CXCL12 and Met-CCL5 
after MI in Mice  
Similarly, neovascularization after MI was also improved in both the CXCL12 (S4V)-SDH 
and Met-CCL5-FDH + CXCL12 (S4V)-SDH groups to a higher extent as the Met-
CCL5-FDH, as quantified by CD31-staining (Figure 3.11, A). This indicates a 
CXCL12 (S4V)-mediated increase of angiogenesis in infarcted myocardium, supporting 
the hypothesis. Interestingly, these findings also suggest that recruitment of 
hematopoietic cells through CXCR4 would serve to reduce infarct size rather than the 
blockade of initial neutrophil infiltration. However, evaluation of the functional parameters 
of the heart revealed a significant improvement of cardiac function in the Met-CCL5-FDH 
+ CXCL12 (S4V)-SDH group that received a combined treatment (Figure 3.11, B). The 
ejection fraction was increased in the group with Met-CCL5-FDH and CXCL12 (S4V)-
SDH in comparison to the control group, but the combined treatment with Met-CCL5-
FDH + CXCL12 (S4V)-SDH show the highest preservation of the heart function 
comparing to all other groups (Figure 3.11, B).  
Remarkably, the combined treatment with Met-CCL5-FDH + CXCL12 (S4V)-SDH was 
also able to improve cardiac output compared with the hydrogel only and single 
chemokine-treated groups (Figure 3.11, C). Thus by the combined treatment with both 
recombinant chemokines formulated in a time-dependent degradable hydrogel, the heart 
function was significantly preserved and remodeling of the ventricle was improved. 
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Figure 3.10: A. The neovascularization of CXCL12 (S4V)-SDH and the combination 
Met-CCL5-FDH CXCL12 (S4V)-SDH treated mice was higher compared with FDH, SDH 
and Met-CCL5-FDH treated mice, 4 weeks after MI. B. Ejection fraction (EF) was 
increased by the combined treatment with Met-CCL5-FDH+CXCL12 (S4V)-SDH 
compared with Met-CCL5-FDH, CXCL12 (S4V)-SDH and control, 4 weeks after MI. C. 
Cardiac output (CO) was increased by the combined treatment with Met-CCL5-
FDH CXCL12 (S4V)-SDH compared with Met-CCL5-FDH and CXCL12 (S4V)-SDH and 
control, 4 weeks after MI. 
 
3.4 Conclusion 
Synthesis of linear PG via anionic polymerization as well as functionalization of 
sP(EO-stat-PO) and PG with thiol groups was acheived. In order to introduce thiol 
functionality, both polymers were crosslinked in the first step with the disulfide 
crosslinker, 3,3’-dithiopropionic acid. Subsequently, the disulfide bonds in the resulting 
hydrogel were reduced by tris(2-carboxyethyl) phosphine (TCEP). In this way thiol 
functional HS-sP(EO-stat-PO) and HS-PG could be obtained The prepolymers formed 
hydrogels by either oxidative or Micheal addition type crosslinking. 
Further HS-sP(EO-stat-PO) prepolymer was used successfully for the synthesis of 
hydrogel for chemokine delivery. This study shows evidence that the combined therapy 
of the protease-resistant CXCL12-SDH and Met-CCL5-FDH in a time dependent manner 
preserves cardiac function, promotes angiogenesis and facilitates wound healing 
processes by recruitment of hematopoietic stem cells from the circulating blood and 
attenuating neutrophil-induced myocardial inflammation. This therapeutic strategy 
constitutes a promising and accessible option to optimize cardiac repair and remodeling 
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after myocardial injury, with significant clinical implications, offering a feasible and viable 
alternative to cell-based therapies. 
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CHAPTER 4 
 
Biocompatable and Degradable Nanogels via 
Oxidation and Addition Reactions of Synthetic 
Thiomers in Inverse Miniemulsion 
 
Part of the work dealing with hemocompatibility studies of nanogel was performed in 
the work group of Prof. Christian Grandfils CEIB, University of Liège, Allee de la 
Chimie, 3, B6c, B-4000 Liege, Belgium. 
Part of this work is published in Journal of Polymer Science Part A: Polymer Chemistry 
2009, 47, 5543. 
 
4.1 Introduction 
Hydrogel nanoparticles, so called nanogels, are hydrophilic cross-linked 
polymeric particles with sub-micrometer size. They combine characteristics of 
hydrogels like biocompatibility, high water content, as well as tunable chemical and 
mechanical properties with the features of nanoparticles such as high surface area and 
overall sizes in the range of cellular compartments. These properties make them 
intriguing candidates for entrapment of hydrophilic bioactive molecules such as DNA or 
proteins to provide a hydrophilic, protective environment and thus prevent 
degradation.1,2 So far, little attention has been paid to the size-dependence on the 
cellular uptake and pharmacokinetics. A prerequisite for this is however, synthetic 
access to well defined particles.  
Several techniques have been used for the preparation of nanogels such as 
precipitation polymerization, photolithography, micromolding, microfluidics and inverse 
emulsion techniques.3 Polymerization in inverse miniemulsion is one way that allows 
preparation of gel particles with controlled size in the submicron range. Yet, syntheses 
of nanogels in inverse emulsions are mostly done by radical polymerization4-7 and only 
little work has been reported on cross-linking of well defined prepolymers.8,9 Such a 
prepolymer condensation concept based on hydrophilic, multi-thiolfunctionalized 
oligomers and polymers will be particularly suitable for incorporating peptides and 
proteins in particles that are stable in extracellular physiological conditions but degrade 
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after uptake by cells within the reductive environment of the cytosol where, for 
example, glutathione, a tripeptide with a free thiol group, readily cleaves disulfides to 
thiols.10 In contrast to radical polymerisation techniques, oxidative coupling of thio-
functional macromers in inverse miniemulsion allows the attachment of cystein-
terminated peptide sequences as the free thiol groups do not interfere with the 
polymerization. As a best example so far, high molecular weight, thiol-functionalized 
hyaluronic acid has been cross-linked in inverse miniemulsion by oxidation.11 However, 
variation of functionality or molecular architecture of the gel precursor could not be 
achieved.  
In this chapter synthesis and characterization of biocompatible and degradable nanogel 
carriers composed of thiol-functionalized polymers based on sP(EO-stat-PO) and PG 
is presented. Nanogel particles are prepared by cross-linking the polymers in inverse 
miniemulsion via oxidation of thiol groups to disulfide bonds. Synthesis and 
characterization of the gel-precursors, preparation of the nanogels and their 
characterization regarding particle size distribution in solution and in the dried state, 
chemical composition, degradation behaviour as well as in vitro biocompatibility and 
hemocompatibility studies are presented and discussed. 
 
4.2 Experimental  
4.2.1 Materials and Methods 
For preparation of nanogels thiol-functionalized sP(EO-stat-PO) and PG were 
synthesized as described in Chapter 3. n-hexane (HPLC) (Sigma), THF (p.A.) (VWR), 
Span 80 (Sorbitan monooleate) (Sigma), Tween 80 (polyoxyethylene (20) sorbitan 
monooleate) (KMF), Hydrogen peroxide 30% (p.a.,VWR), PEG diacrylate (Mn=700 
g/mol Sigma), Glutathione (99%, Aldrich) were used as received. Phosphate buffered 
saline (PBS) from Sigma has been dissolved in water to 0.04 M concentration 
(pH=7.4). Dialysis membrane (MWCO = 3500 Dalton), has been purchased from 
Spectrum Laboratories, Inc. Demineralised water was used throughout the work. 
 
Scanning Force Microscopy (SFM) studies were conducted using a Nanoscope IIIa 
from Digital Instruments operating in the tapping mode. Standard silicon cantilevers 
were used (PPP-NCH from Nanosensors) with a spring constant k ≈ 42 N/m and an 
oscillation frequency fo ≈ 70 kHz. For the SFM measurements samples were cast onto 
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freshly cleaved mica by spin coating at the rotation speed of 2000 rpm. The samples 
were dried in vacuum for 2 h prior to measurements. 
 
Scanning electron microscopy (SEM) was performed with a HITACHI S- 4800 
instrument in a cryo mode with secondary electron image resolution of 1.0 nm at 15 kV, 
2.0 nm at 1 kV and 1.4 nm at 1 kV with beam. The material is fixed on a holder and 
was rapidly frozen with boiling liquid nitrogen. It was then transferred to the high 
vacuum cryo-unit, the Balzers BF type freeze etching chamber. The cryo-chamber 
equipped with a knife can be handled from outside by means of a level to fracture the 
sample for applications in which imaging of the surface of inner structures is aimed. In 
order to remove humidity the sample is sublimated from 5 to 15 min then the entire 
material is further inserted into the observation chamber. 
 
Dynamic Light Scattering (DLS). The particle sizes were measured by photo 
correlation spectroscopy using a Malvern Zetasizer Nano ZS at a fixed scattering angle 
of 173°. Non-invasive back scatter (NIBS) technology takes particle sizing to sensitivity 
in the 0.6 nm to 6 µm range. Disposable poly(styrene) cuvettes were used for 
measurement in water. ‘Expert System’ software was used for data interpretation. The 
presented data is the average value from five measurements. The DLS measurements 
give a z-average size (or cumulant mean) value, which is an intensity mean and the 
polydispersity index (PDI). The cumulant analysis has the following form:  
ln(g(1)(t)) = -
_
t + µ2t
2 + ..... 
where g(1) is the first order correlation function; 
_
 is the average decay rate and first 
cumulant; µ2 is the second cumulant. The value of µ2/
_
2 is known as polydispersity 
index (PDI).  
 
4.2.2 Preparation of Nanogels in Inverse Miniemulsion 
For preparation of the miniemulsion, 5 mL of n-hexane containing 150 mg of a 3:1 
weight ratio of Span 80 and Tween 80 were used as organic phase, while the aqueous 
phase consisted of 220 mg polymer dissolved in 0.5 mL 0.04 M PBS buffer (pH = 7.4). 
The two phases were combined and pre-emulsified by magnetic stirring for 10 min 
followed by miniemulsification by ultrasonication for 60 s with a Branson sonifier (W450 
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Digital at duty cycle of 30% and output control of 90%). During the sonication, the 
reaction vessel was cooled with an ice-bath. Subsequently, 20 µL of 0.1 M H2O2 was 
added and the mixture was sonicated again for 60 s. The reaction was allowed to 
proceed for 15 min at room temperature followed by quenching of the oxidation by 
addition of 4 mL of acidic water (pH = 3). For synthesis of nanogels cross-linked via 
Micheal addition similar procedure as stated above was followed with addition of PEG 
diacrylate 129 mg (for HS-PG nanogels) or 13.0 mg (for HS-sP(EO-stat-PO) 
nanogels). Separation of the nanogels was achieved by centrifugation at 10000 rpm for 
30 min followed by decantation of the supernatant. Nanogels present in the aqueous 
layer were carefully washed twice with hexane (10 mL) and four times with THF (20 
mL) in order to remove the surfactants and unreacted polymer. The remaining organic 
solvents and acid were removed by dialysis. Purified nanogels were stored in millipore 
water at 4 °C for further use. 
 
4.2.3 Degradation of Nanogels 
Reductive degradation of the nanogels to the corresponding thiol-containing sP(EO-
stat-PO) and PG fragments was conducted in the presence of 10 mM glutathione in 
PBS buffer (pH=7.4) at 37 °C (mass ratio glutathione/nanogel = 0.4). After 6 h, the 
solution was dialysed, freeze-dried followed by analysis with Raman-spectroscopy. A 
part of the solid was dissolved in water, spin casted onto mica and the resulting 
polymer film was analysed by SFM. 
 
4.2.4 Cytotoxicity of Nanogels 
Standard indirect cytotoxicity tests were carried out based on the recommendation of 
the International Standardization Organization (ISO) described in DIN EN ISO 10993-5. 
For cytotoxicity testing L929 mouse connective tissue fibroblasts were purchased from 
DSMZ GmbH (Germany). L929 cells were seeded on tissue culture polystyrene (TCPS) 
and were maintained in RPMI supplemented with L-glutamine, 10 % fetal calf serum 
and 1% penicillin-streptomycin (PAA, Germany) at 37°C and humidified atmosphere 
containing 5% CO2. All experiments were conducted on subconfluent cell layers. To 
detect cytotoxic effects, the cells were incubated with 0.5 mg/mL concentration of the 
nanogel particles. The LIVE/DEAD® Viability/Cytotoxicity Assay Kit from Molecular 
Probes (MoBiTec GmbH, Germany) was applied 24 and 72 h after addition of the 
nanogel particles to the cultivated L929 fibroblasts. This test provides a two-color 
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fluorescence cell viability assay that is based on the simultaneous determination of live 
(green colored) and dead (red colored) cells with two probes that measure recognized 
parameters of cell viability – intracellular esterase activity and plasma membrane 
integrity. 
 
4.2.5 Hemocompatibility Tests were performed according to 1SO 10993-4 adopting 
the general conditions of interaction of nanoparticles with blood). The tests are 
summarised below. 
The hemocompatibility of the nanogels has been assessed analysing the following 
standard parameters  
1. Microscopic pictures of the whole blood after material exposure (smear) 
2. Haemolysis test according to ASTM (Standard practice for assessment of 
haemolytic properties of materials, American Society for Testing and Materials 
Designation: ASTM:  F 756-00). 
3. Platelets and Red blood cell counting. 
4. Analysis of the activation of the coagulation cascade either by the intrinsic (TCA 
test) or the extrinsic (Quick) pathways. 
5. Complement activation by determination of the C3a concentration (ELISA kit). 
 
4.2.5.1 Blood Sample Collection 
Human blood was obtained from The Red Cross Transfusion at Central Hospital of the 
University of Liège. Blood was collected from healthy donors in 4.5 mL tubes containing 
3.2% sodium citrate (anticoagulant). Experiments were performed within 2 hours after 
collection. This study received the approval of the Ethical Committee of the Medical 
Faculty of Liège. 
 
4.2.5.2 Sample Preparation 
Briefly, in micro Eppendorf tubes (200 µL) one volume of nanogel solution (10 mg/mL) 
was diluted in nine volumes of whole blood. In all the experiments a rapid 
homogenization of the nanoparticle suspension with the whole blood was performed in 
order to avoid any high local concentration of NP’s. Samples were incubated for 15 
minutes at 37°C under horizontal roller mixing (35 rpm). For all the tests, pyrogen free 
water which was used to disperse the nanogel was also measured as a control. 
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4.2.5.3 Realization of Blood Smears for Control of RBC’s morphology 
Just after blood incubation, 5 µL of the blood / NP mixtures were withdrawn and spread 
immediately on microscopy glass slide. Blood cells were observed with Olympus Provis 
microscope at 50x magnification in transmission mode. At least two representative 
pictures were taken per sample. 
 
4.2.5.4 Hemolysis test 
Hemolysis test was adapted from Standard Practice for Assessment of Hemolytic 
Properties of Materials (ASTM designation: F 756-00).12 NP and blood were prepared 
and incubated as described above. After incubation samples were centrifuged for 5 
minutes at 600 g at room temperature (RT). Supernatants were collected and mixed 
with cyanmethemoglobin reagent. Hemoglobin released was measured at 540 nm in a 
microplate reader (Anthos HT III, type 12600). A calibration curve was established with 
bovine hemoglobin standard over a range of hemoglobin concentrations from 0.025 
μg/mL to 3700 μg/mL. Saponine (0.8 mg/mL) and PBS were used as positive and 
negative control respectively. Total hemoglobin released from whole blood diluted in 
cyanmethemoglobin reagent was determined as 100% hemoglobin release. Hemolysis 
was expressed as the percentage of hemoglobin released (% rHb) to total content. 
Tests were done in triplicate. 
 
4.2.5.5 Counting of Platelets and Red blood cells (Emerald) 
Red blood cells (RBC) and platelets count was determined with a Coulter Multisizer IIS 
after blood dilution in Isoton II. For RBC’s analysis the whole blood was diluted (20x) in 
isotonic medium. Platelets were analysed starting from a platelet rich fraction obtained 
by centrifugation blood samples diluted (24x) in isotonic solution performed at 850g for 
90s at RT. 1 mL aliquots of the supernatants were added to 40 mL isotonic solution. 
Counting was performed on a Coulter Multisizer II equipped with an orifice tube of 70 
µm. RBC’s were counted between 3.7 and 8 µm and platelets between 1.0 and 3.7 µm. 
Samples incubated with PBS (pH 7.4) were used as negative control. Tests were done 
in duplicate. 
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4.2.5.6 Evaluation of Blood Coagulation: Intrinsic and Extrinsic pathways  
TCA assays and Quick test were performed on a Dade Behring instrument (Behring 
Coagulation Timer, or BCT) with commercial reagents (a C.K. PREST kit (Roche 
Diagnostic) for TCA and Tromborel S (Dade Behring/Siemens for Quick test). 
Whole blood and NP suspensions were mixed and incubated as described above. 
Samples were centrifuged during 5 minutes at 2000 g (RT). After supernatant collection 
prothrombin time (PT) and activated partial thromboplastin time (APTT) were measured 
directly with a Behring Coagulation Timer analyzer (BCT) (Dade Behring). Kaolin (0.5 
mg/mL final blood concentration) was used as a positive control in TCA and PBS as 
negative control. Measurements were conducted in duplicate.  
 
4.2.5.7 Complement Activation  
After incubation of NP with blood, EDTA (1 mM final) was added in order to stop any 
complement activation. Zymozan (final blood concentration: 2 mg/mL) was used as 
positive control, and PBS, as negative control. Non-incubated blood was added as 
additional negative control. Samples were centrifuged for 5 minutes at 2000 g at RT. 
Supernatants were stored at –80°C until the analysis. Complement activation was 
estimated adopting the Human C3a ELISA kit for quantification of Human C3a-desArg 
(Beckton Dickinson). Absorbance was measured at 450 nm with a microplate reader 
(Anthos HT III, type 12600). Concentration of C3a was expressed in ng/mL and as 
percentage of activation. Measurements were conducted in duplicate.  
 
4.3 Results and Discussion 
Linear poly(glycidol) (Mn = 4500 g/mol, PG) and six arm, star shaped polymers 
with copolymerized ethylene oxide and propylene oxide in the ratio 4 to 1 (Mn = 12000 
g/mol, sP(EO-stat-PO)) were chosen as precursors for the nanogels. Both polymers 
are hydrophilic and biocompatible, and the molecular weights are well below 30000 
g/mol, which are set as limit that allows renal clearance for linear PEO.13  
It is known that inverse emulsions are generally less stable than regular oil-in-water 
emulsions due to lack of electrostatic stabilization.8 Based upon numerous experiments 
with different surfactants and co-surfactants which could form stable emulsions, FDA 
approved Span 80 and mixture of Span 80 and Tween 80 surfactants were selected for 
the particle synthesis since they showed most efficient stabilization of the miniemulsion 
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droplets with the given experimental setup and procedure. Besides checking for 
different surfactants, optimization of bulk cross-linking kinetics of HS-sP(EO-stat-PO) 
and HS-PG with H2O2 and PEG-diacrylate was also done. Scheme 4.1 schematically 
shows the synthesis of nanogels via inverse miniemulsion. 
 
Scheme 4.1: Schematic representation of cross linking in inverse miniemulsion 
 
Nanogels were obtained both by using only Span 80 and a mixture of Span 80 and 
Tween 80 (3:1 ratio) as surfactants. However, the SFM and DLS analysis revealed that 
when only Span 80 was used as a surfactant poorly defined particles with high 
polydispersed were obtained (Figure 4.1 left). In contrast, when the mixture of Span 
80/Tween 80 was used as surfactant well-defined, and relatively monodisperse 
particles were formed (Figure 4.1 right). This can be explained as for maximum 
stability, the interfacial film resulting from the absorbed surfactant should be 
condensed, with strong lateral intermolecular forces and should exhibit high film 
elasticity. Since highly purified surfactants generally produce interfacial films that are 
not closed packed and hence not mechanically strong, good emulsifying agents are 
usually a mixture of two or more surfactants rather than an individual surfactant.14 
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Figure 4.1: SFM topography images of nanogels prepared in the inverse miniemulsion 
with Span 80 only (left) and mixture of Span 80/Tween 80 (right). 
 
For surface activity, all surfactants must have a hydrophobic and hydrophilic portion 
and the ratio of hydrophobic to the hydrophilic portion is what is called as its balance 
i.e. “HLB” which stands for HYDROPHILE/LIPOPHILE/BALANCE. It was invented for 
use with NONIONIC surfactants in particular. The hydrophilic portion is usually a 
polyhydric alcohol or ethylene oxide, while the lipophilic group is usually a fatty acid or 
a fatty alcohol in most cases. HLB of a surfactant is thus an indication of the solubility 
of the surfactant, the lower the HLB value, the more lipophilic or oil soluble the 
surfactant, the higher the HLB value the more water soluble or hydrophilic the  
surfactant is. The hydrophilic-lipophilic balance of a surfactant is thus a measure of the 
degree to which it is hydrophilic or lipophilic. Generally, HLB values can be used as 
rough guide for surfactant selection and to predict the surfactant properties of a 
molecule. For W/O emulsions, HLB values from 4 to 7 are best suited, while HLB 
values in the range of 8-16 are considered for O/W systems. Therefore the correct 
selection of surfactants and thus HLB is important so as to ensure colloidal stability of 
aqueous droplets and the resulting polymeric particles.15 Moreover Poly(ethylene 
glycol) part of Tween 80 shows strong interaction with aqueous phase providing better 
interfacial tension and hence barrier to coalescence,14 and hence co-surfactant 
systems containing Span 80 (sorbitan monooleate) with a low HLB (4.3) and Tween 80 
(polyethyleneglycol-sorbitan monooleate) (Scheme 4.2) with a higher HLB (15) were 
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thus used to keep the HLB value in the range for W/O emulsion and optimize the 
emulsion stability. 
 
 
Scheme 4.2: Schematic representation of the surfactant Span 80 and Tween 80. 
 
Using this surfactant system first, preparation of disulfide crosslinked particles from HS-
sP(EO-stat-PO) polymers by oxidation in inverse miniemulsion is discussed. Generally, 
disulfide formation proceeds through the deprotonated form of thiol groups. Thus, in 
order to maintain slightly basic reaction conditions PBS buffer (pH=7.4) is used as a 
dispersed phase. Furthermore, the ionic strength of PBS serves as osmotic agent in 
the droplets to stabilize them against Ostwald ripening. Bulk experiments with HS-
sP(EO-stat-PO) showed that simple oxygen mediated gelation takes more than six 
hours at physiological pH = 7.4, thus too long with respect to inverse miniemulsion 
stability. Upon addition of H2O2 as an oxidation promoter, the bulk cross-linking reaction 
could be shortened to 5 min. Therefore it can be concluded that presence of H2O2 is 
indispensable for the formation of disulfide cross-linked nanogels in the inverse 
miniemulsion. Cryo-scanning electron microscopy (cryo-FESEM) and dynamic light 
scattering (DLS) were applied to characterize the nanogel particle size in water, and 
thus in the swollen state, and scanning force microscopy (SFM) has been used as a 
characterization technique for dry particles. Figure 4.2 shows the cryo-FESEM and 
DLS analysis of HS-sP(EO-stat-PO) nanogels. Particle size analysis with DLS gives 
the z-average particle diameter of 380 nm with a PDI of 0.24. Cryo-SEM images clearly 
show that the particles have a well-defined spherical shape, as expected for particles 
synthesized by miniemulsion techniques, with particle diameters d in the range of 230 
nm < d < 350 nm. Taking into account the freezing-step that may lead to partial volume 
loss of the nanogels during cryo-FESEM, these two techniques correlate well with 
respect to size analysis of the nanogels in the hydrated state.  
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Figure 4.2: Characterization of HS-sP(EO-stat-PO) nanogels prepared by oxidative 
crosslinking in water (swollen state): by cryo-FESEM (left) and by DLS (right). 
 
Size determination of such disulfide cross-linked HS-sP(EO-stat-PO) nanogels in the 
dry state has been achieved by scanning force microscopy. Samples were prepared by 
spin-coating from aqueous solution onto mica followed by drying in vacuum. By the 
spin-coating process a dense monolayer of single particles is formed initially. Upon 
drying, the nanogels decrease their volume and a regular pattern of separated, single 
nanogel particles results. From the SFM topography image showing isolated nanogels 
(Figure 4.3) an average diameter dav = 110 ± 10 nm and an average height hav = 28 ± 
2 nm could be determined as adsorbed on mica. The large anisotropy demonstrates 
that on mica, the soft and deformable nanogels adopt a flattened, oblate spheroidal 
shape. This flattening can be contributed to a strong affinity of the hydrophilic particles 
towards the polar mica surface in air as well as to indentation by the SFM tip. 
Regardless of the reason for flattening, the volume (V) of the adsorbed particles can be 
calculated form the formula for spheroids: V = 4/3  abhav (where a = b = average 
diameter (dav) = 110 ± 10 nm; average height hav = 28 ± 2 nm). With the equation for a 
perfect sphere V = 4/3 R3, the radius R and thus, also the dav of perfectly spherical 
nanogels in the dry state could be calculated to be dav = 70 ± 5 nm. Hence, by 
comparing this value with the size in aqueous environment determined from cryo-
FESEM and DLS, a strong swelling ability of the nanogels is obvious and the swelling 
ratio can be estimated in between 3.5 and 5 (Figure 4.3). 
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Figure 4.3: Left: SFM topography image of the HS-sP(EO-stat-PO) nanogels prepared 
by oxidation crosslinking. Scan size is 2  2 µm and z-range is 40 nm. Right: 
Schematical representation of the nanogel adsorbed on to mica surface and a nanogel 
adopting ideal spherical shape.  
 
Figure 4.4: Characterization of HS-sP(EO-stat-PO) nanogels in water (swollen state) 
prepared via Michael addition reaction: by cryo-FESEM (left) and by DLS (right). 
 
Figure 4.4 presents the cryo-SEM and DLS of the HS-sP(EO-stat-PO) nanogels 
prepared by the crosslinking via Michael addition. Similar to the disulphide crosslinked 
particles nanogels prepared via Michael adddition have spherical shape. The size of 
the particles determined from cryo-FESEM image analysis is 250 nm < dav < 400 nm 
 69 
 
and from DLS dav = 220 nm. The nanogels however have broader size distribution in 
comparison to the particles shown in Figure 4.2. 
It is known that PEO based polymers show a tendency to form aggregates in water that 
may be easily confused with real cross-linked particles in the DLS analysis.16 Also the 
regular pattern formation on mica is not an unequivocal proof for the formation of 
nanogels since in some cases, dewetting of polymer films may result in similar 
patterns.17 Thus optimization of  spin-coating parameter was done and areas of the 
sample where the transition between nanogel aggregates and the monolayer occurs 
were analysed. The clear detection of individual nanogels in the larger aggregates that 
were formed during the spin-coating process undoubtedly proves the successful cross-
linking of the prepolymers to nanogel particles (Figure 4.5). 
 
Figure 4.5: SFM topography image depicting the transition between the aggregated 
and isolated HS-sP(EO-stat-PO) nanogels. The formation of aggregates is due to the 
spin coating process and does not reflect the situation in the water. Scan size is 4  4 
µm and z-range is 150 nm. 
 
Generally, particles prepared by oxidation of HS-PG showed very similar behaviour to 
HS-sP(EO-stat-PO) nanogels regarding their dispersion stability. However, in water 
these nanogels possess broader size distributions with a z-average particle diameter of 
330 nm and PDI = 0.54 as measured by the DLS and particle diameters d in the range 
of 100 nm < d < 350 nm determined by cryo-FESEM. For nanogels prepared by 
Michael addition particle diameters d was in the range of 250 nm < d < 550 nm (Figure 
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4.6, left) by cryo-FESEM while with DLS they showed a diameter of 450 nm and PDI = 
0.65. 
 
Figure 4.6: Characterization of HS-PG nanogels in water (swollen state): by cryo-
FESEM and DLS technique for nanogels prepared by oxidative crosslinking (left) and 
by Micheal addition (right). 
 
The SFM of the dry HS-PG nanogels prepared both by oxidation crosslinking as well as 
by Michael addition is presented in Figure 4.7. It can be seen that in the size 
distribution of the particles crosslinked via oxidation is large in comparison with the 
nanogels crosslinked with PEG-diacrylate. SFM measurements of nanogels on mica 
performed in the dry state confirm the DLS results and show polydisperse disulfide 
crosslinked HS-PG particles (Figure 4.7). 
 
Figure 4.7: SFM characterization of dry SH-PG nanogels crosslinked by oxidation (left) 
and via Michael addition (right).Scan size is 2  2 µm and z-range is 100 nm. 
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In order to prove the degradability the disulfide cross-linked nanogels were incubated 
with a glutathione (GSH) solution. Figure 4.8a illustrates the 2000 - 3500 cm-1 Raman 
spectra range of HS-sP(EO-stat-PO) nanogels before and after incubation with 10 mM 
GSH for 6 h. The noteworthy feature is the band at about 2580 cm-1 which corresponds 
to stretching modes of thiol groups in the reduced particles. This band is not detectable 
in the crosslinked nanogels and appears upon incubation with GSH. In addition, spin-
coating the nanogel-solution after reduction onto mica resulted in a dewetted polymer 
film where no nanogels could be detected (Figure 4.8b). These results evidence that 
the nanogel disulfide cross-linkages can be cleaved with GSH what confirms 
degradability of the particles under cytosolic conditions.  
 
 
Figure 4.8: Characterization of reduced SH-sP(EO-stat-PO) nanogels: (a) by Raman 
spectroscopy of reduced nanogels (upper spectra) and nanogels before the reduction 
(lower spectra); (b) SFM topography image. Scan size is 10  10 µm and z-range is 20 
nm. 
 
4.3.1 Cytocompatibility 
A live/dead cell viability assay was used to investigate the cytotoxicity of all prepared 
nanogels. After 24 and 72 h incubation of L929 cells with nanogels (c = 0.5 mg/mL), 
differential interference contrast (DIC) microscopy and fluorescence microscopy were 
used to assess cell morphology and visualize live and dead cells.  
Live cells with intact membranes are stained with green fluorescence, while dead cells 
were stained with red fluorescence. Figure 4.9 shows fluorescence images of cells 
incubated with HS-sP(EO-stat-PO) nanogels after live/dead staining. 
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Figure 4.9: Fluorescent image of live (green) and dead (red) L929 cells after 72 h 
incubation with nanogels (c = 0.5 mg/mL). Counting of live and dead cells indicated 94 
± 2% viability 
 
Careful counting of live and dead cells indicated 94 ± 2% viability of L929 cells in the 
presence of HS-sP(EO-stat-PO) nanogels, as compared to 96 ± 2% cell viability in the 
absence of nanogels as a control experiment. Comparable results have been achieved 
with HS-PG nanogels. This clearly shows the cytocompatibility of nanogels prepared 
from HS-sP(EO-stat-PO) and HS-PG.  
 
4.3.2 Hemocompatibility 
Estimation of hemocompatiblity of the nanoparticles is required to elicit several 
toxicological reactions, in particular embolisation, hemolysis, cellular activation, and 
several well-known biological cascades such as coagulation, complement activation, 
kinin/kininogen, and fibrinolysis. When using nanoparticles as carriers the first barrier 
that they meet is the blood itself and the Reticulo-Endothelial System (RES) which is 
directly connected to the liver/spleen. The efficiency of this clearance system at 
eliminating foreign bodies from the blood circulation is so effective that the blood life-
time of nanoparticles typically does not exceed some part of minutes. This efficiency in 
elimination has been demonstrated as the result of non-specific18 or immune-specific 
immunogenic response.19 Therefore, to verify the hemocompatibility of nanogels both 
for toxicological reasons and efficiency of targeting is required. The nanoscale of 
nanogels amplifies the total surface exposed to the human body, as compared to the 
same amount of bulk material. As a rough calculation 10 mg of spherical nanogels with 
a mean diameter of 100 nm and of a density of 1 will develop a total area of 0.6 m2. In 
regards to that, when the nanogels are diluted with 1 mL of human blood, they will be 
 73 
 
exposed to 4.5 billion of RBC’s, 400 million of platelets, ~ 5 million of white blood cells 
and about 70 mg of plasma proteins. Therefore nanogels may significantly interact with 
humoral and cellular blood components and could significantly modify the well-known 
biological cascades involved in blood reactivity. It is also important to stress the need to 
evaluate the hemo-reactivity of nanogels tailored for external applications like oral and 
nasal administration. Indeed, in the present status of knowledge of the final outcome / 
biodistribution of these nanoparticles, it cannot be excluded that the particles could 
finally be transferred within the blood circulation. It has, for example already been 
reported that the nasal epithelium displays a relatively high permeability to drugs due to 
the presence of a dense blood vessel network.20 Recently, several studies have 
indicated that hydrophilic or relatively large molecules such as proteins, viruses or 
dextrans with a molecular weight up to 20 kDa can be directly transported from the 
nasal cavity to the Cerebro Spinal Fluid (CSF) using neuronal anterograde and 
retrograde transport in a molecular weight dependent manner.21, 22 Thus a drug 
administered by the nasal route may enter either the blood of the general circulation or 
into CSF via choroids plexus blood-brain. Thus for potential use of nanoparticles as 
drug carriers, screening them for hemocompatibility becomes a requisite criterion. 
In order to detail the hemoreactivity of disulphide crosslinked sP(EO-stat-PO)  and PG 
nanogels following panel of tests as given below were performed adopting the ISO 
10993-4. It is worthwhile to mention that the hemocompatibility assessment were 
performed only when  following key criteria like chemical purity, size (at least below 1 
µm), batch reproducibility, NP in vitro stability, in vitro safety verified on at least one 
animal cell type, were satisfied. 
 
4.3.2.1. Realization of Blood Smears for Control of the RBC’s Morphology  
In this study the interaction of nanogels on the morphology of red blood cells (RBC) 
was investigated. The microscopic analyses of RBC incubated with nanogels showed 
no change in morphology for the concentrations evaluated.  
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Figure 4.10: Microscopic pictures of the whole blood smear after exposure to a.) 
sP(EO-stat-PO) nanogel (1/20 dilution), b) sP(EO-stat-PO) nanogel (1/200 dilution), c). 
PG nanogel (1/20 dilution), d.) PG nanogel (1/200 dilution), as a control e.) PBS buffer 
non-incubated and f.) PBS buffer incubated was used. Maginfication 50x, scale 100μm. 
 
On visualising the smear after its interaction with nanogels, no significant change or 
alternation in the morphology of RBS’s was observed. There was small patch like area 
seen when higher concentration of PG nanogels were used, which could be attributed 
to change in wetting properties of the glass substrate when in contact with the 
nanogels. As a consequence adhesion of the blood cells alters and this alteration 
occurs in “a patch way” producing macro-irregularities in the deposition of the blood 
cells. 
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4.3.2.2 Hemolysis Test  
This assay is based on colorimetric detection of cyanmethemoglobin in solution. The 
cyanmethemoglobin reagent which is used in this assay is a mixture of potassium 
ferricyanide, potassium cyanide and sodium bicarbonate. Nanogels were incubated in 
blood, and hemoglobin released by damaged cells due to nanogels interaction was 
measured. Ferrous ions from the released hemoglobin get oxidized to methemoglobin 
in by ferricyanide in presence of bicarbonate and subsequent step cyanide converts the 
methemoglobin to cyanmethemoglobin. The undamaged erythrocytes from the sample 
were removed by centrifugation and the amount of cyanmethemoglobin in the 
supernatant was measured spectrophotometrically via the absorbance at 540 nm 
(Figure 4.11). 
 
 
Figure 4.11: Multiplate of the haemolytic test and calibration curve of the 
cyanmethemoglobin test. 
 
This measured absorbance was compared to the standard curve in order to determine 
the concentration of hemoglobin in the supernatant and this hemoglobin concentration 
was compared to the value obtained from the supernatant of the blood sample 
untreated with nanogels to obtain the percentage of particle induced hemolysis referred 
to as percentage hemolysis. 
The results highlighted in Table 4.1 show that both type of nanogels were not 
haemolytic (< 2 %) according to ASTM standard (F 756-00) for the concentrations 
measured. 
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Table 4.1 Counting of Platelets and red blood cell after interaction of nanogels to blood 
 
4.3.2.3 Platelet and Red Blood Cell Counting 
The counts of Platelet and RBC in blood were measured after there interaction with 
nanogels (Table 4.2). 
 
Table 4.2 Counting of Platelets and red blood cell after interaction of nanogels to blood 
Sample ID Mean ± SD Mean ± SD 
Platelets, N/µL 
Ctrl n/inc Ctrl inc 
222000 6557 210667 22502 
1/20 1/200 
sP(EO-stat-PO) 
nanogel 214000 9849 211667 10408 
PG nanogel 271667 5132 217667 6506 
water 195667 19732 190000 26153 
RBC’s, N/µL 
Ctrl n/inc Ctrl inc 
4063333 57735 4110000 160000 
1/20 1/200 
sP(EO-stat-PO) 
nanogel 4083333 210079 4116667 160416 
PG nanogel 3876667 51316 3946667 73711 
water 4286667 411866 3976667 55076 
* Ctrl n/inc : blood control non incubated ** Ctrl inc: blood control incubated 
N/µL = number of cells counted per µL ; SD : Standard Deviation 
 
No significant changes were observed in platelet and RBC’s counting for the 
concentrations of nanogels evaluated.  
 
 
Sample ID % Hb ± SD 
C+ 14.91 0.62 
C- 1.34 0.10 
Plasma 0.60 0.03 
 
Mean ± SD Mean ± SD 
1/20 1/200 
sP(EO-stat-PO)nanogels 1.05 0.11 0.84 0.05 
PG nanogels 1.19 0.11 1.11 0.05 
Water 1.19 0.11 1.11 0.05 
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4.3.2.4. Coagulation Cascade Activation through Intrinsic and Extrinsic Pathways 
4.3.2.4.1 TCA I normal: This analysis of the coagulation through the intrinsic pathway 
is realized in standard conditions of operation in clinical biology, i.e. with the addition of 
kaolin, as activator of this biological cascade. It allows to verify if the factors associated 
with this cascade are adsorbed or denaturated by the foreign material (i.e. the NP). A 
reduction of the percentage corresponds to an inactivation of this coagulation pathway.  
 
Table 4.3 Hemostasis control test for nanogels 
Sample ID TCA I  normal (%) Quick (%) 
Positive Ctrl+Kaolin 40.6 >130 
 1/20 1/200 1/20 1/200 
sP(EO-stat-PO) nanogel >100 >100 103.3 100 
PG nanogel >100 >100 105.0 100 
water >100 >100 103.3 98.4 
Ctrl n/inc  >100 >100 103.3 101.6 
* Ctrl n/inc : blood control non incubated 
 
In order to activate this pathway, phospholipid suspension, an activator (kaolin), and 
calcium (to reverse the anticoagulant effect of citrate) were mixed into the plasma 
sample and the time of clot formation was measured. 
 
4.3.2.4.2 Quick Test: The Quick test was performed to explore the extrinsic 
coagulation system. Calcium thromboplastin and excess calcium were added to 
citrated plasma to induce coagulation and the time of fibrin clot formation was 
measured. This analysis of the coagulation through the extrinsic pathway is realized in 
standard conditions of operation in clinical biology, with the addition of thromboplastin, 
as activator of this biological cascade. It allows to verify if the factors associated with 
this cascade are adsorbed or denaturated by the foreign material (i.e. the NP). A 
reduction of the percentage corresponds to an inactivation of this coagulation pathway. 
As the results in Table 4.3 shows neither extrinsic, nor intrinsic pathways of the 
coagulation are affected by the presence of the nanogels at the concentration 
considered.  
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4.3.2.5 Compliment Activation 
Complement system represents a major mechanism of our immune response. It 
depends upon a biochemical cascades that recognizes foreign antigens. It occurs via 
three different pathways: the classical pathway, the alternative pathway, and the 
mannose-binding lectin pathway.23 Although the triggers and the initial steps in the 
activation of each of these pathways differ, they all converge at the formation of C3 
convertase. C3 convertase cleaves C3; this is the most important step in the activation 
pathway. Large numbers of opsonizing proteins, primarily C3a and C3b are generated 
on C3 hydrolysis, which coat the pathogens surfaces to facilitate their uptake and 
destruction by phagocytic cells.24  
 
Figure 4.12: Multiplate of Compliment activation test and calibration curve for C3a 
assay 
Table 4.6 Compliment Activation assay for nanogels 
Sample ID 
C3a  
(ng/mL) 
± SD  
(ng/mL) 
C3a  
 (ng/mL) 
± SD 
(ng/mL) 
Ctrl Non-Inc* 2666.3 120.1 - - 
Ctrl Inc** 2727.9 259.3 - - 
Ctrl + 6438.1 663.0 - - 
 1/20 1/200 
sP(EO-stat-PO) nanogel 3075.0 212.2 4087.5 113.5 
PG nanogel 4123.1 132.3 3826.2 110.8 
water 3776.7 193.3 3938.0 15.8 
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Nanoparticles can be cleared from the blood circulation as a consequence of 
complement activation in particular via a pathway which arises from the proteolytical 
cleavage of C3 into anaphylatoxic peptide C3a. Due to the large surface exposed, 
nanoparticles in suspensions within the blood could enhance the activation of the 
complement.  
The assay is based on the detection of C3a, when nanoparticle comes in contact with 
blood. C3a is a small polypeptide consisting of 74 amino acids and in itself is very 
short-lived. In serum, it is cleaved rapidly into the more stable C3a-desArg (also called 
acylation stimulating protein, ASP). Therefore, measurement of C3a-desArg allows 
reliable conclusion about the level of complement activation in the samples. For 
convenience, both forms will be referred as C3a. From Table 4.6 it could be seen that 
no significant activation of the complement was observed in the presence of the 
nanogels. 
 
4.4 Conclusion 
Formation of nanogels by cross-linking of thiol-functional hydrophilic 
prepolymers in inverse miniemulsion was demonstrated and unequivocally proven by a 
combination of DLS, cryo-SEM and SFM characterization. Oxidative coupling resulted 
in particles that are stable in PBS buffer at pH 7.4 but decompose in reductive 
conditions. Cell viability test according to ISO 10993-5, showed that the nanogels were 
non cytotoxic towards L929 fibroblasts. Hemocompatibility studies showed that the 
nanogels were hemocompatible according to ISO 10993-4 adopting general conditions 
of interaction of nanoparticles with blood. Biocompatibility, intracellular degradability, 
fully synthetic polymeric building blocks with molecular weights that allow renal 
clearance and the possibility to tailor the synthetic precursors regarding structure and 
functionality make this system a versatile platform for drug delivery. 
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CHAPTER 5 
 
Mild Oxidation of Thiofunctional Polymers to 
Cytocompatible and Stimuli-Sensitive Hydrogels 
and Nanogels 
 
Part of this work is published in Macromolecule Bioscience DOI: 
10.1002/mabi.201200389  
 
5.1 Introduction 
Aside of functionalization with bioactive ligands, nanoparticle size control is one 
key aspect in nanotechnology, as many in-vivo functions and effects of Nanoparticles 
depend on their size including internalization pathways, complement activation, 
immunogenicity, intracellular trafficking, circulation times, targeting and clearance.1 
Rejman et al. demonstrated that nanoparticles with a diameter < 200 nm are 
internalized via clathrin-coated pits while the internalization of 500nm sized particles 
were caveolae mediated. In addition, the larger particles were not delivered to the 
lysosomes, which could be one of the reasons why larger nanoparticles result in higher 
transfection efficiencies even with smaller ones being internalized better.2 Porter et al. 
found that PEGylated nanoparticles smaller than 150 nm in diameter accumulated in 
the bone marrow of rabbits whereas larger particles were mostly sequestered by the 
liver and spleen and only a small fraction reached the bone marrow.3 In recent studies 
it was also illustrated that nanoparticles with size around 100 nm had a greater uptake 
than microparticles of 1 μm and much greater uptakes than 10 μm microparticles. A 
similar study conducted in rat’s in situ intestinal loop model, exhibited widespread 
penetration of nanoparticles in submucosal layer, while microparticles were localized 
mainly in the epithelial lining.4, 5  
These few examples underline the importance of the precise case-sensitive size 
selection and size control of nanoparticles for a demanded application. Drug release at 
the site is also influenced by particle size. Faster discharge of drug is accomplished by 
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use of smaller particles with larger surface area to volume ratio as they lead to 
conjunction of the drug near the particle surface. On the contrary, drug release is 
slower with particles with larger core size, even though they encapsulate higher 
amounts of the drug.6 While smaller particles show advantage with respect to drug 
discharge they also run a higher risk of aggregation during storage and transportation. 
Thus to develop nanoparticles with smallest possible size and maximum stability at the 
same time is a challenging task. 
Therefore nanoparticle size control is the key to optimize nanoparticle delivery vehicles 
for controlled release and thereby making them applicable in various clinical fields. Also 
the influence of size on nanoparticle bio-distribution has been established as organ 
specific and non-linear.7 This is in part attributed to organ-specific physical and 
physiological barriers that systematically administered nanoparticles come across.8 
Therefore the significance of tuning nanoparticle size for each distinct in vivo 
application is emphasized by non-linear influence of nanoparticle size on bio-
distribution, which varies from organ to organ. 
As discussed earlier disulfide cross-links can be introduced either by using reactive 
disulfide cross-linkers9 or by oxidation of thiol functional precursors.10 The latter method 
allows covalent coupling of cysteine-terminated drugs (for example peptides) to the 
particle matrix through disulfide bonds during or after particle preparation. Thus, in the 
extracellular milieu, the bioactive molecules are protected against degradation and will 
be released upon entering the targeted cell. Oxidation of thiol bearing matrix molecules 
can be performed upon exposure to air.11 This process is, however, relatively slow and 
not useful for most nanogel preparation techniques. Thus, oxidizing catalysts such as 
diamide, peroxides, and sodium tetrathionate, or a catalyst based on Fenton chemistry, 
are often applied in order to shorten the oxidation time.12 Those catalysts possess 
strong oxidation potential which is favorable for fast gelation but on the other side also 
results in oxidation of thiols to higher oxidation numbers and restricts the possibility to 
embed oxidation sensitive molecules into the hydrogels. 
In Chapter 4 formation of redox-sensitive and biodegradable nanogels with 
hydrodynamic diameter of 350 ± 50 nm using hydrophilic thiol-functionalized 
prepolymers based on star shaped poly(ethylene oxide-stat-propylene oxide) (sP(EO-
stat-PO)) and linear poly(glycidol) (PG) was reported. Nanogels were prepared by 
oxidative cross-linking of thiol groups to disulfide bonds in inverse miniemulsion using 
hydrogen peroxide.13 While this proof-of concept study has shown that this preparation 
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route is feasible, only poor control over nanogel size could be achieved. More 
importantly, the use of hydrogen peroxide as oxidation catalyst is unfavourable for the 
embedding of peptides and proteins, as under certain conditions, disulphides are not 
the sole reaction products.14 
In this chapter a comparative investigation of alloxan, a mild oxidation catalyst, and 
hydrogen peroxide as oxidation catalyst for the formation of disulphide crosslinked 
hydrogels and nanogels is made. Further formulation strategies to control the size of 
the disulphide crosslinked PG nanogel prepared via inverse miniemulsion for both 
catalyst systems is presented  and the  differences are discussed. Finally, 
investigations on nanogel stability and degradation behaviour in presence of GSH as 
well as in vitro cytocompatibility are shown.  
 
5.2 Experimental  
5.2.1 Materials and Methods 
Thiol functionalized linear poly(glycidol) (HS-PG) (Mn = 6100 g/mol, Mw /Mn = 1.17, 15 
thiol groups) was prepared as described in literature.13 n-hexane ( ≥ 95%, Sigma), THF 
(99%, VWR), hydrogen peroxide (30%, VWR), Span 80 (Sigma), and Tween 80 
(Sigma-Aldrich), Brij 30 (Sigma), Laureth-3 (Fluka), Span 60 (Sigma), 2-
hydroxyacrylate (96%, Sigma), glutathione (GSH) (99%, Sigma), alloxan monohydrate 
(Sigma) and Alexa Fluor 488 maleimide dye (720.88 g/mol) (Invitrogen), WST reagent 
(Roche Diagnostics) Accutase (PAA), Isoton III (Beckmann Coulter) were used as 
received. DMEM, 10 % Fetal Calf Serum (FCS), 1 % penicillin/streptomycin and 1 % 
HEPES buffer were purchased from Invitrogen. Phosphate buffer saline (PBS) from 
Sigma has been dissolved in water to 0.04 M concentration (pH = 7.4). Minisart syringe 
filters (5 µm) were purchased from Sartorius and dialysis membrane (MWCO = 3500 
Da) was purchased from Spectrum Laboratories, Inc. 
 
UV/Vis- Spectrophotometry UV/Vis transmission spectra were determined using a 
Varian Cary 100 Bio-UV-Visible split-beam spectrophotometer running with Cary 
WinUV scan application with a capacity of measuring 6 samples at a time. Samples 
were scanned at 500 nm. A high-intensity Xe flash lamp was used as the source for UV 
light, which permits taking 80 data per second.  
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Fluorescence Microscopy Zeiss Axioplan 2 upright digital imaging microscope was 
used for fluorescent imaging. It was equipped with a high resolution digital camera 
(Zeiss Axiocam HRc) and image processing software (AxioVision Release 4.7) with 
100 W tungsten and mercury light sources. Axiovision software controls the stage, filter 
sets, and AxioCam camera provides Z-stack and multi-channel digital image capture 
capabilities with a resolution of 1300 × 1030 (native) up to 3900 × 3090 pixels. 
Microscope objectives available were 10X, 20X and 50X.  
 
5.2.2 Bulk gelation kinetics  
In order to determine the kinetics of bulk hydrogel formation 50 mg of HS-PG (8.20 × 
10-3 mmol) was dissolved in 125 µL PBS buffer at pH 6.0 and 7.4 or borate buffer at pH 
8.0. The solutions were homogeneously mixed followed by the addition of the oxidation 
catalyst. The amounts of the added catalyst are listed in Table 5.2. Gelation time was 
qualitatively determined by the vial inversion method. 
 
5.2.3 HS-PG Labelling with Alexa Fluor 488 
Fluorescently labelled HS-PG was synthesized by the Michael addition type reaction 
between maleimide group present in the Alexa Fluor dye and the thiol functionalities of 
HS-PG. In this reaction 1 g of HS-PG (1.64 × 10-1 mmol) was dissolved in 5 mL of PBS 
buffer at pH = 7 followed by the addition of 0.3545 g Alexa Fluor maleimide (4.91 × 10-1 
mmol). The mixture was stirred in dark for 12 h under argon atmosphere followed by 
dialysis and lyophilisation. 
 
5.2.4 Nanogel Preparation 
Nanogels were prepared via inverse miniemulsion method. For the preparation of the 
miniemulsion, surfactant (37.5 mg of 3:1 weight ratio of Span 80 and Tween 80, if not 
stated otherwise) dissolved in 1.25 mL of n-hexane was used as organic phase. The 
aqueous phase consisted of 50 mg (8.20 × 10-3 mmol) of HS-PG dissolved in 125 µL of 
0.04 M PBS buffer (pH = 7.4). The organic and the aqueous phases were pre-
emulsified by magnetic stirring for 10min. After stirring the system was ultrasonicated 
using a Branson sonifier W450 with a ¼  horn at duty cycle of 30% and output control 
of 90% under ice cooling. Glass vials of 18 mm in diameter were used for all nanogel 
synthesis. It was found that the geometry of the vessel and location of sonication probe 
in the vessel was very important for the efficiency of sonication. Thus, each run used 
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the same type of vessel with the horn immersed to the same depth each time. Cross-
linking was initiated by subsequent addition of H2O2 or alloxan catalyst followed by a 
further sonication step. If not stated otherwise, 30 µL of 0.1 M H2O2 or 0.1 M alloxan (3 
× 10-3 mmol) was used. The sonication times before and after the addition of catalyst 
are specified in the following sections. The reaction was allowed to proceed for 20 min 
at room temperature with constant stirring followed by quenching of free thiol groups by 
2-hydroxy acrylate at pH = 7.4. Any further oxidation was stopped by addition of 1.5 mL 
of acidic water (pH = 3). Separation of the nanogels was achieved by centrifugation at 
10000 rpm for 30 min followed by decantation of the supernatant. Nanogels present in 
the aqueous layer were carefully washed with n-hexane (2 × 1.5 mL) and THF (4 × 2.5 
mL) in order to remove the surfactants and unreacted polymer. The remaining organic 
solvents and acid were removed by dialysis. Purified nanogels were stored in Millipore 
water at 4 °C for further use. This standard procedure for the synthesis of nanogels 
could be easily scaled for higher or lower amounts as long as the ratio of the reactants 
used is maintained. 
 
5.2.5 Influence of Preparation Parameters 
Sonication Time. To assess the effect of sonication time variation before and after 
addition of the catalyst, in two sets of experiments were performed where either one of 
the two times was kept constant at 60s, while to other was varied between 60s and 
1500s. For clarity of sample nomenclature, nanogels prepared with sonication time of 
60s before and 120s after addition of the catalyst are named as 60s/120 s. The 
following combination of parameters was examined for both catalysts: 60s/60s, 
120s/60s, 180s/60s, 240s/60s, 300s/60s, 360s/60s 420s/60s, 600s/60s, 1500s/60s, 
60s/120s, 60s/180s, 60s/240s, 60s/300s, 60s/360s, 60s/420s, 60s/600s, 60s/1500s. 
 
Influence of Hydrophilic-Lipophilic Balance (HLB) of the Surfactant  
The HLB value was tuned by the variation of the ratio of the surfactants Span 80 and 
Tween 80 (Table 5.1). The dependence on nanogel diameter was investigated for four 
HLB values: 5, 6, 7 and 8. The experiments were performed at three different 
sonication times: 60s/60s, 300s/60s, 360s/60s. 
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Table 5.1 Span 80/Tween 80 composition at different HLB values 
HLB 
Span 80 
[mg] 
Tween 80 
[mg] 
5 35.05 2.45 
6 31.54 5.96 
7 28.04 9.46 
8 24.53 12.97 
 
Influence of Type of Surfactant at HLB 7 
The dependence on nanogel diameter was investigated for four HLB values: 5, 6, 7 and 
8. As HLB 7 was found to be most suited value, different combination of surfactants 
and co-surfactants were further investigated at this HLB value for the nanogel 
preparation by inverse miniemulsion at three different sonication times: 60s/60s, 
300s/60s, 360s/60s.  
Table 5.2 Different surfactant composition at HLB 7 
HLB Surfactant 1 Surfactant 2 
7 Span 60 (29.12 mg) Tween 80 (8.38 mg) 
7 Span 80 (15.94 mg) Brij 30 (31.56 mg) 
7 Span 80 (17.25 mg) Laureth 3 (20.25 mg) 
7 Span 80 (24.53 mg) Tween 80 (12.97 mg) 
 
Influence of Polymer Concentration. To determine the effect of polymer 
concentration on the size of nanogels, nanogels were prepared as described with 
varying polymer concentrations of 40, 28 and 12 w/v % with respect to the aqueous 
phase (PBS buffer) at sonication time of 60s/60s, 300s/60s and 360s/60s. 
 
5.2.6 Nanogel Dispersion Stability in PBS at 37 °C and Reductive Degradation. 
Stability of the nanogel dispersions at 37 °C in PBS buffer, with respect to aggregation 
and particle diameter was checked for standard alloxan and H2O2 crosslinked nanogels 
at 0 h, 0.25 h, 1 h, 6 h, 12 h, 24 h and 60 h by DLS and cryo-FESEM measurements. 
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Degradation of unlabelled as well as Alexa Flour 488 labelled nanogels was performed 
in 10 mM GSH solution in PBS (pH = 7.4) at 37 °C. Fluorescence microscopy images 
of particle dispersions before and after reduction were taken to check whether the 
fluorescence is localized in the nanogels before reduction and homogeneously 
distributed in the solution after reduction. Assessment of reduction kinetics in the 
presence of 1, 5 and 10 mM GSH was followed by measuring the solution 
transmittance by means of UV-Vis spectrometry in PBS buffer at 37 °C with different 
ratios of GSH to nanogels. For the concentration 1 mM GSH, degradation kinetics were 
also evaluated by multiple GSH addition. In this experiment, 0.768 mg GSH was added 
into 2.5 mL nanogel solutions every 200 min so that at the beginning of each step the 
GSH total concentration was 1 mM. 
 
5.2.7 Cytocompatibility 
L929 mouse fibroblasts were seeded in a 48 well tissue culture plate (20000 cells per 
well in 500µL DMEM containing 10% FCS, 1% penicillin/streptomycin and 1% HEPES 
buffer) a total of 24 wells were seeded. The cells were incubated for 24h at 37°C in a 
5% CO2 humidified atmosphere. The nanogel sample was dialysed against DMEM 
without additives for 24 h. Afterwards the FCS, penicillin/streptomycin, and HEPES 
were added in the adequate quantity. The culture medium was aspirated from the cells 
and 500 µL of the dialysed nanogels were added to two wells each. 1mL of the 
remaining microgel solution was diluted in DMEM at a ratio of 1:1 and 500 µL of this 
solution was added to three wells each, the remaining 500 µL were diluted 1:2 and 
dispensed to three wells each. The cells were incubated for 48h at 37 C in a 5% CO2 
humidified atmosphere.  
Cytocompatibility of the nanogels with concentrations of 10mg/mL, 5mg/mL and 
1.7mg/mL was evaluated by means of visual examination of cell morphology in a light 
microscope, cell counting and determination of cell activity using the WST reagent 
according to DIN EN ISO 10993-5 was performed. In detail, after incubating the cells 
with the WST reagent at a ratio of 1:10 in supplemented DMEM for 30min at 37°C, the 
adsorption of the supernatant was quantified in a Tecan spectra fluor plus photometer 
(Tecan, Crailsheim, Germany). The cells were rinsed twice with PBS and were 
detached from the surface by incubation with Accutase and diluted 1:100 in 10 mL 
Isoton III. Cells were counted using a CASY 1 TTC cell analyzer (Schärfe System, 
Reutlingen, Germany). Cell number was calculated automatically by the Casy-stat 
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software (Schärfe System). The average and standard deviation were calculated using 
Microsoft Excel. 
 
5.3 Results and Discussion 
This study was conducted with two major goals, the first being identification of 
preparation conditions for redox-sensitive nanogels from thiofunctional prepolymers 
with precise control over particle size in the range of 150 to 500 nm, the second, being 
the establishment of an alternative and milder oxidation catalyst than the often used, 
hydrogen peroxide, so as to enable the encapsulation of oxidation sensitive drugs 
within the hydrogels and nanogels.  
Hydrogen peroxide can oxidize thiols to higher oxidation states. Diverse studies 
describe the products of thiol oxidation with hydrogen peroxide; however there is no 
consensus concerning the reaction products obtained at different reaction conditions as 
well as the possible mechanisms. Based on the experiments performed with small 
molecular thiol containing compounds, several groups proposed a two-step nucleophilic 
reaction mechanism involving the rate-determining nucleophilic attack of the thiolate 
anion on the unionized H2O2 to generate cysteine sulfenic acid (CSOH) as an 
intermediate in a first step. In the case of peroxide excess, this intermediate can 
undergo a condensation reaction to thiosulfinate or it can further react with H2O2 
forming sulfinic acid (RSO2H) and sulfonic acid (RSO3H) in a subsequent step.
 This 
reaction strongly depends on the molar ratio between peroxide and thiol. At molar 
ratios of H2O2: HS ≤ 1, disulfides are the sole reaction product.
14 However, local 
concentration differences could result in unfavorable side reactions even if the overall 
stoichiometry is correct, and the high global concentration of hydrogen peroxide 
generates a strong oxidizing environment.  
Alloxan (2, 4, 5, 6-tetraoxypyrimidine) was chosen as an alternative to the direct use of 
hydrogen peroxide as it provides a slow, homogeneous and molecularly stoichiometric 
in-situ generation of hydrogen peroxide.15 Thiols reduce alloxan to dialuric acid, in a 
exact molar stoichiometry of 1:1. Dialuric acid readily auto-oxidizes back to alloxan by 
consumption of oxygen. In this process the oxygen is reduced and H2O2 is generated 
which converts the thiols to disulfides. This redox cycling of alloxan is considered to be 
a slow process with the presence of thiols as driving force of the reaction.16 Thus it is a 
step by step in-situ generation and consumption of peroxide at low concentration with 
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direct formation of disulfide contrary to the use of H2O2 as oxidation catalyst where 
much higher concentrations have to be applied and a stronger oxidizing environment is 
generated. 
As a nanogel precursor, linear poly(glycidol) (PG) with a molecular weight of Mw  = 4500 
g/mol was used. Linear PG is a hydrophilic polyether with structural analogy to 
poly(ethylene oxide) (PEG) and additional hydroxymethylene groups attached to each 
repeating unit. It is a biocompatible polymer17 and the molecular weight chosen here is 
well below the limit for renal clearance of linear PEG (30,000 g/mol).18 
Thiofunctionalization of linear PG has been achieved through carbodiimide mediated 
Steglich esterification between the free hydroxyl groups of the polymers and 3, 3’-
dithiodipropionic acid. This reaction yielded hydrogels that were subsequently reduced 
by cleaving the disulfide cross-linkages to thiol groups. NMR analysis showed that the 
thiofunctional PG (HS-PG) contains an average of 15 thiol groups per chain with an 
overall molecular weight of Mw  = 6100 g/mol. 
 
5.3.1 Bulk Gelation Kinetics 
Gelation kinetics of bulk hydrogels as a function of pH and time were investigated at 
first to identify parameter ranges suitable for nanogel preparation. This was particularly 
important in the case of alloxan as there was no experience with this system in the 
setup. Generally, the formation of disulfide linkages proceeds through the deprotonated 
form of thiol groups, so that the reaction only occurs at neutral or basic pH, hence 
control over the pH value is of critical importance. Thus, in order to maintain slightly 
basic reaction conditions and to keep the pH value constant, the oxidation reactions 
were performed in buffer solutions. Bulk experiments showed that simple oxygen 
mediated gelation took more than 6 h in air at physiological pH (PBS buffer, pH = 7.4). 
This is too long with respect to inverse miniemulsion stability, so that the use of an 
oxidation catalyst is indispensable for nanogel formation. Therefore, as described 
above, hydrogen peroxide and alloxan were used as oxidation catalysts. Both 
substances are water soluble and any remaining excess can be removed easily by 
dialysis after gelation. Regardless of the catalyst, the obtained gels were transparent 
and highly elastic. As expected, for both catalysts the gelation kinetics increases with 
increasing pH value due to the higher concentration of thiolate anions (Table 5.3). 
However, at the same pH the gelation time differs dramatically when comparing the two 
catalysts. The hydrogel formation using peroxide was 15, 19 and 17 times faster for pH 
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6.0, 7.4 and 8.0, respectively, in comparison to the gel formation with alloxan. This 
observation can be explained by the slow redoxcycle of alloxan and the in-situ 
generation of low amounts of peroxide as compared to the fast oxidation of thiols in the 
presence of higher concentration of peroxide that is directly added for gelation. 
 
Table 5.3. Bulk gelation kinetics at different pH with H2O2 and alloxan 
Oxidation catalyst 
[3 × 10-3 mmol] 
Gelation time [min] 
pH = 6.0 pH = 7.4 pH = 8.0 
H2O2 8 3 1 
Alloxan 125 59 17 
 
Also the influence of the amount of catalyst was investigated at different pH values. 
Table 5.4 presents the representative data for the set of experiments performed at 
pH=7.4 and pH=8.0 for hydrogen peroxide and alloxan, respectively. For alloxan, pH = 
8 was chosen so that the reaction is fast, whereas pH = 7.4 was chosen for peroxide so 
that the reaction was slow enough to allow determination of the gelation time.  
 
Table 5.4. Dependency of catalyst concentration on bulk gelation kinetics. 
Amount of 
Catalyst [mmol] 
HS / catalyst ratio 
Gelation time [min] 
H2O2 (pH = 7.4) Alloxan (pH = 8.0) 
1 × 10-3 123 5 32 
3 × 10-3 41 3 17 
5 × 10-3 25 2 16 
7 × 10-3 18 1 15 
9 × 10-3 14 0.7 10 
1.1 × 10-2 12 0.7 10 
1.5 × 10-2 8 0.7 precipitation 
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It is remarkable that even at the lowest amount of catalyst, where the ratio between SH 
groups and catalyst was ~120:1, stable and elastic hydrogels were obtained. Up to the 
value of 7 × 10-3 mmol of added catalyst the reaction kinetics are proportional to the 
amount of H2O2 or alloxan added, however for all catalyst concentrations the reaction is 
slower in the case of alloxan. For the amounts ≥ 9 × 10-3 mmol the gelation time stays 
constant in both cases. For alloxan, precipitation occurred at 1.5 × 10-2 mmol. This can 
be attributed to the plateau in cross-linking kinetics in the case of alloxan to its solubility 
in the reaction mixture, which results in a constant maximum alloxan concentration of 
around 10-2 mmol. In the case of peroxide, accelerated cross-linking upon addition of 
higher catalyst amount results in rapid and little controlled network formation. At a 
cross-linking time of 0.7 min, a maximum in the kinetics for the given polymer 
concentration is reached, so that higher peroxide concentration does not result in faster 
gelation. 
 
Figure 5.1: Normalized Raman spectra of hydrogels prepared with three different 
concentrations of (a) H2O2 and (b) alloxan. Inset depicts the S-S stretching frequency 
appearing as a sharp band near 500 cm-l. As control non cross-linked HS-PG 
prepolymer as well as alloxan were measured. 
 
In order to determine and compare the reaction products in the hydrogels prepared with 
peroxide as well as alloxan, Raman spectroscopy was performed for the different 
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hydrogels (Figure 5.1). Raman spectroscopy is a qualitative tool which gives a clear 
evidence of the disulfide group since the S-S stretching frequency appears as a sharp 
band near 500 cm-l.19 
For the hydrogels prepared with peroxide, increasing the catalyst amount results in a 
reduction of the S-S band intensity even though in all experiments, the ratio between 
peroxide and thiol groups was H2O2 / HS < 1. This effect supports the hypothesis that a 
more rapid network formation results in a higher number of free thiol groups that are, 
due to steric constraints, not able to take part in further network formation. Most 
probably, the higher amount of free peroxide with increasing amount of added catalyst 
and the higher amount of remaining free thiols results in formation of oxidation products 
other than disulfides such as sulfinic and sulfonic acid as reported before by others.14 
These, however, could not be directly detected here due to the overlap of their 
characteristic bands between 1090 - 990 cm-1 and 1070 - 1040 cm-1 respectively, with 
the polymer backbone. 
Gels prepared with increasing amount of alloxan did not show any remarkable change 
in disulfide intensity. This can be attributed to the slower mechanism of thiol oxidation 
by alloxan in combination with the observed solubility effects. At the fastest gelation 
time of 10 min, the flexibility of the polymer chains is sufficiently high during cross-
linking to result in a constant cross-linking density and thus disulfide content at all 
alloxan concentrations.  
 
5.3.2 Nanogel Preparation  
Based on the data from bulk gelation kinetics, disulfide cross-linked HS-PG nanogels 
were prepared by inverse miniemulsion. One of the crucial steps in creating a stable 
miniemulsion with well-defined small droplets is the homogenization. Sonication is a 
widely used homogenization method in a lab-scale batch process in which through 
constant fusion and fission processes induced by high shear, both the size and 
polydispersity decrease until the miniemulsion reaches a steady state. The non-ionic 
surfactants used for stabilizing inverse miniemulsions allow droplets preparation in the 
size range from 100 to 800 nm. The stability of these droplets is limited, however, due 
to coalescence and Ostwald ripening. Suppression of these two processes is required 
for the formation of a stable miniemulsion.20 While coalescence can be controlled by 
choosing the appropriate surfactant or surfactant mixture, Ostwald ripening can be 
controlled by the addition of hydrophilic agents into the dispersed phase.21 In this 
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system the aqueous phase was composed of PBS buffer which did not only serve as 
stabilizing agent preventing the Ostwald ripening, but also provided a basic medium for 
the deprotonation of thiols as first and rate limiting step for oxidation to disulfides. A 
PBS concentration of 0.04 M yielded most well defined particles. At lower PBS 
concentrations the stability of the miniemulsion was not sufficient for the cross-linking 
reaction so that polydisperse particles were produced, while higher concentrations 
caused poor polymer solubility. In all experiments the water to oil ratio was kept 
constant at 1:10.  
With these core settings, the dependence of different parameters on particle size and 
size distribution including sonication time, surfactant and surfactant combination, 
catalyst and polymer concentration have been assessed through systematic variation 
of concentrations and ratios. As standard surfactant mixture, Span 80 / Tween 80 = 3 / 
1 (weight ratio) were used for initial examination of the influence of sonication time, 
while a detailed study of different surfactant combinations were performed 
subsequently.  
 
5.3.2.1 Sonication Time before Catalyst Addition 
It was observed that variation of the sonication time before catalyst addition strongly 
affects size and size distribution of the nanogels. Table 5.5 presents and compares the 
diameter z-average as well as polydispersity index (PDI) values obtained from dynamic 
light scattering (DLS) analysis for sonication times ranging from 60 to 1500 s before 
catalyst addition with a constant sonication of 60 s after catalyst addition. In the case of 
peroxide as oxidation catalyst, up to 240 s only marginal changes in the average 
nanogel size were observed. Increase of the sonication time to 300 s results in a 
drastic z-average decrease and to considerable lower PDI values in comparison to the 
values obtained with shorter sonication times. Also, at 300 s, nanogels smaller than at 
sonication times below 360 s with a relatively low PDI of 0.245 were obtained, while 
further increase of the sonication time leads to a strong increase in nanogel size and 
PDI up to micrometer range for 600 s followed by precipitation of larger aggregates at 
even longer sonication times. 
In contrast, the diameter of the nanogels prepared with the alloxan changes only 
slightly as a function of sonication time. The z-average remains at ~ 270 nm for 
sonication times up to the 240 s. Similarly to nanogels prepared with peroxide, the 
particle diameter as well as PDI decreases at a sonication time of 300 s to the smallest 
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particles (diameter 200 nm) with lowest PDI (0.174). Further increase of the sonication 
time results in a slight increase of the particle size as well as the PDI. However, in 
contrast to the particles prepared by peroxide, no formation of micrometer sized 
particles or aggregation was observed. 
 
Table 5.5. Influence of sonication time before addition of catalyst on nanogel size 
Sonication time 
before addition 
of catalyst [s] 
H2O2 Alloxan 
Z-average PDI Z-average PDI 
60 350±13 0.410±0.010 260±10 0.151±0.002 
120 350±10 0.231±0.008 270±10 0.210±0.002 
180 350±09 0.320±0.012 270±10 0.210±0.001 
240 400±15 0.420±0.021 270±13 0.340±0.005 
300 150±11 0.175±0.013 200±12 0.174±0.010 
360 250±11 0.245±0.021 250±10 0.230±0.006 
420 450±10 0.350±0.012 250±12 0.310±0.007 
600 1050±17 1.000±0.012 330±12 0.330±0.006 
1500 -a) -a) 350±10 0.350±0.008 
a) Precipitation of large aggregates 
 
The formation of  large particles and the precipitation with longer sonication times in the 
case of peroxide can be thus attributed to instabilities in the miniemulsion caused by 
long sonication times. Due to the strong oxidation potential of peroxide and the high 
specific surface of the particles in comparison to bulk gels, the cross-linking times are 
much shorter so that the larger aggregates are immediately fixed through rapid cross-
linking by addition of peroxide. For alloxan, the cross-linking is still sufficiently slow to 
allow homogenization of the dispersion with the second sonication step. This 
significantly reduces the effects of the first sonication step before addition of the 
catalyst on nanogel size and PDI.  
 95 
 
Cryo-FESEM images were taken of nanogel samples prepared with 60s/60s, 300s/60s 
and 360s/60s sonication time for direct visualization of the nanogels in the quasi -
swollen state. Nanogel size was determined for 300 nanogel particles for each sample 
with the help of Quartz PCI software and a Gaussian curve was drawn and average 
nanogel size was determined. In all cases, cryo-FESEM images of the samples show 
that the particles have well-defined spherical shapes, as expected for particles 
synthesized by miniemulsion techniques (Figure 5.2 and 5.3) 
 
Figure 5.2: Cryo-FESEM images, particle size Gaussian curve from size distribution 
histograms show the difference in nanogel diameter at sonication time of 60s/ 60s , 
300s/60s, 360s/60s prepared by oxidation with H2O2. Scale bar in the cryo-FESEM 
images corresponds to 1 µm. 
 
Figure 5.3:  Cryo-FESEM images, particle size Gaussian curve from size distribution 
histograms show the difference in nanogel diameter at sonication time of 60s/ 60s, 
300s/60s, 360s/60s prepared by oxidation with alloxan. Scale bar in the cryo-FESEM 
images corresponds to 1 µm. 
 
The size evaluation by DLS measurement was in very good accordance with cryo-
FESEM and the particle size trends with changing sonication time before addition of the 
catalyst were confirmed, showing that both methods correlate well to each other with 
respect to size analysis of the nanogels in the hydrated state. These results show that 
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by proper choice of the sonication time before catalyst addition, size of the nanogels 
can be tailored in the range between 150 and 450 nm. 
 
5.3.2.2 Sonication Time after Catalyst Addition 
While a variation of sonication time before addition of the catalyst showed strong 
influence on particle size, variation of sonication time after catalyst addition did not 
show significant effect on particle size. In a first series of experiments, the sonication 
time before the addition of catalyst was kept constant at 60 s and the sonication time 
after the catalyst addition was varied from 60 s up to 1200 s. Table 5.6 presents and 
compares the diameter z-average as well as polydispersity index (PDI) values obtained 
from dynamic light scattering (DLS) analysis. 
 
Table 5.6. Influence of sonication time after addition of catalyst on nanogel size 
Sonication time 
after addition 
of catalyst [s] 
H2O2 Alloxan 
Z-average PDI Z-average PDI 
60 350±13 0.410±0.010 260±12 0.151±0.001 
120 400±20 0.334±0.012 260±15 0.220±0.020 
180 400±15 0.392±0.012 260±10 0.220±0.013 
240 400±22 0.318±0.014 300±15 0.250±0.001 
300 420±20 0.301±0.002 300±14 0.248±0.018 
360 420±16 0.344±0.004 300±15 0.290±0.017 
420 500±23 0.375±0.006 220±15 0.208±0.003 
600 -b -b 220±17 0.250±0.004 
1000 -b -b 300±11 0.250±0.003 
1200 -b -b 1060±20 0.551±0.005 
b) Precipitation of large aggregates 
 
In the case of the peroxide, the diameter z-average increased gradually up to the value 
of 500 nm for 420 s. Further increase of the sonication time led to the formation of 
visible large aggregates. When alloxan is used as a catalyst the diameter of particles 
first increases slightly up to 300 nm at sonication time of 360 s, then it decreases to 
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220 nm at 420 s and 600 s, followed by a dramatic z-average increase to 1060 nm for 
the sonication time of 1200 s. 
These results suggest that long sonication times lead to destabilization of the emulsion 
which favours particle aggregation. In addition, despite of ice cooling, longer sonication 
can cause a certain bulk thermal heating caused by longer shear times. Since in the 
system there is still a small fraction of highly reactive peroxide present longer 
sonication time could lead to formation of free radicals. These can further interact with 
the polymer network and support inter-particle aggregation. As the amount of peroxide 
is much lower in the case of alloxan, this mechanism is not of major importance for the 
nanogels prepared with alloxan, so that much longer sonication times can be used for 
the generation of nanogels. 
From the obtained results it can be concluded that after cross-linking nanogel size was 
relatively unaffected by sonication time. For the nanogels prepared with the peroxide, 
the slight change of the z-average is proportional to the sonication time while for 
alloxan nanogels the change is rather random. Only at long sonication times, 
regardless of the catalyst used, over sonication led to the formation of large 
aggregates. Based on these results all further experiments were performed by the 
sonication for 60 s after the catalyst addition 
 
5.3.2.3 Influence of the Surfactants and the Hydrophilic-Lipophilic Balance (HLB) 
The choice of appropriate surfactant and surfactant combination is a key to reducing 
the rate of the coalescence of the dispersed droplets and thus increasing the 
miniemulsion stability. Generally, the application of one component surfactant system 
results in poorly packed interfacial films leading to low emulsion stability. Often, a 
combination of surfactants is used with one water-soluble and one oil-soluble 
surfactant. Correlation between the chemical structure of the surfactant and its ability to 
form stable interfacial film is trivial and is unique for each miniemulsion system.22 A 
frequently used indicative approach for predicting the surfactant emulsification 
behaviour is a so called HLB method which shows the relationship between hydrophilic 
and hydrophobic fraction of the molecule as discussed in Chapter 4. 
Particle size dependence at different HLB’s in the range of 5 to 8 was investigated with 
three different sonication time parameters 60s/60s, 300s/60s and 360s/60s (Table 5.7). 
A desired HLB value was obtained by changing the weight ratio of two surfactants 
 98 
 
according to Equation 5.1. The weight ratios of emulsifiers to reaction ingredients was 
always kept constant at 5 wt. %.  
HLB = [4.3 × x] + [15.0 × (1-x)]                                                                    Eq.5.1 
Where x is the weight fraction of Span 80. Values of 4.3 and 15 denote the HLB of 
Span 80 and Tween 80, respectively.  
 
Table 5.7 Influence of HLB in Span80/Tween 80 blend on nanogel size 
Sonication 
time before 
catalyst 
addition [s] 
HLB 
H2O2 Alloxan 
Z-average 
[nm] 
PDI 
Z-average 
[nm] 
PDI 
60 5 350±12 0.230±0.010 350±12 0.201±0.004 
60 6 450±15 0.439±0.012 300±15 0.210±0.002 
60 7 350±13 0.410±0.010 260±10 0.151±0.002 
60 8 650±18 0.446±0.006 380±21 0.251±0.004 
300 5 300±20 0.199±0.007 210±15 0.230±0.010 
300 6 300±13 0.262±0.006 200±17 0.200±0.008 
300 7 150±11 0.175±0.013 200±12 0.174±0.010 
300 8 350±13 0.387±0.010 300±18 0.190±0.007 
360 5 300±11 0.230±0.012 280±13 0.250±0.010 
360 6 275±21 0.310±0.008 280±14 0.210±0.010 
360 7 250±11 0.245±0.021 250±10 0.230±0.006 
360 8 400±14 0.275±0.014 300±11 0.245±0.009 
 
From the results presented in Table 5.7 one can see that in almost all cases, at each 
sonication time applied and regardless of the catalyst used the nanogel diameter 
changes only slightly for HLB 5 and 6 followed by size and PDI decrease at HLB = 7. 
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Subsequently, at HLB = 8 size as well as size distribution increase is observed. 
According to the Bancroft rule the phase in which the surfactant is most soluble forms 
the continuous phase. In case of HLB = 8 the surfactant serves rather as wetting agent 
than as a emulsifier since, showing more solubility in the aqueous phase, the interfacial 
gradient cannot develop and the droplets start to coalesce yielding broader distribution 
of nanogel size. Summarizing, regardless of the oxidation agent and sonication time 
applied, nanogels with the lowest z-average diameter and PDI were obtained at HLB = 
7. 
Based on the results presented in the previous section, the influence of different 
combinations of commercially available nonionic surfactants and co-surfactants at 
constant HLB = 7 was investigated. As oil soluble surfactants, Span 80 as well as Span 
60 (HLB = 4.7) were used. Next to Tween 80 both Brij 30 (Laureth 4) (HLB = 9.7) as 
well as Laureth 3 (HLB = 8.0) were applied as water soluble co-surfactants. As seen 
from Table 5.8, nanogels prepared with surfactant/co-surfactant combination of Span 
60 / Tween 80 and Span 80 / Tween 80 showed narrow PDI with small particle size at 
sonication time of 300s/60s whereas nanogels prepared with other surfactant 
combinations at this sonication time exhibited broader size distribution.  
This difference, especially profound in the case of Span80/Brij 30 system, is not 
immense; however, it demonstrates that a careful selection of the appropriate 
emulsifying system has an impact on the size and polydispersity of the particles. A 
possible explanation for this behavior is a lower HLB of the co-surfactants Brij 30 and 
Laureth3, making the interfacial film not closely-packed and thus mechanically weak 
and less stable in comparison to a better water soluble Tween 80. Comparable results 
obtained with Span 60 and Span 80 is due to similarity in their molecular structure with 
only difference in the presence of a one double bond in a hydrophobic tail leading to a 
slightly better solubility of Span 80 in the oil phase. The yield of nanogels in all cases 
was between 85-90% with respect to the amount of polymer used was calculated by 
the dry mass of the nanogels after dialysis.  
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Table 5.8 Influence of type of surfactant at HLB 7 on nanogel size 
  H2O2 Alloxan 
Surfactants 
Sonication 
[s] 
Z-average 
[nm] 
PDI 
Z-
average 
[nm] 
PDI 
Span 60 : Tween 80 60/60 300±15 0.308±0.008 300±12 0.268±0.001 
 180/60 200±20 0.267±0.010 275±14 0.275±0.005 
 300/60 200±21 0.211±0.010 250±20 0.242±0.004 
 360/60 250±23 0.240±0.011 275±12 0.215±0.005 
Span 80 : Brij 30 60/60 450±12 0.433±0.012 375±14 0.310±0.006 
 180/60 400±18 0.365±0.012 350±16 0.250±0.010 
 300/60 350±13 0.417±0.011 300±19 0.301±0.006 
 360/60 375±16 0.350±0.010 300±20 0.285±0.010 
Span 80 : Laureth 3 60/60 250±17 0.232±0.008 200±21 0.250±0.010 
 180/60 250±15 0.318±0.002 250±15 0.351±0.007 
 300/60 200±15 0.390±0.003 250±18 0.210±0.006 
 360/60 250±16 0.351±0.006 270±20 0.250±0.010 
Span80 : Tween 80 60/60 350±13 0.410±0.010 260±10 0.151±0.002 
 180/60 350±09 0.320±0.012 270±10 0.210±0.001 
 300/60 150±11 0.175±0.013 200±12 0.174±0.010 
 360/60 250±11 0.245±0.021 250±10 0.230±0.006 
 
 
 
 101 
 
5.3.2.4 Influence of the Catalyst Amount 
With decreasing amount of the oxidation catalyst one would expect an increase in 
nanogel size due to pronounced swelling as a result of low cross-linking in comparison 
to a high amount of catalyst employed where the nanogel size is expected to shrink as 
a result of high cross-linking density. However, remarkable changes in the nanogel size 
were not observed showing that cross-linking was very efficient with respect to the 
amount of catalyst used (Table 5.9).  
 
Table 5.9. Influence on nanogel size with varying catalyst amount 
Amount of Catalyst  
[mmol] 
H2O2 Alloxan 
Z-average PDI Z-average PDI 
1 × 10-3 300±13 0.216±0.010 270±12 0.176±0.001 
3 × 10-3 350±21 0.410±0.010 260±12 0.151±0.005 
5 × 10-3 250±20 0.406±0.011 250±13 0.210±0.004 
7 × 10-3 250±22 0.495±0.008 250±12 0.340±0.007 
9 × 10-3 250±21 0.372±0.009 250±11 0.215±0.010 
1.1 × 10-2 275±19 0.401±0.010 240±10 0.210±0.010 
 
This is in accordance to the results obtained with the bulk hydrogels. In addition, higher 
cross-linking density of the nanogels is not possible most likely due to the constrained 
confinement of polymer chains in the small miniemulsion droplets, even when a very 
high shear force produced by sonication allows the catalyst to be homogeneously 
distributed within the aqueous droplet. 
 
5.3.2.5 Influence of Polymer Amount 
In all experiments described so far the prepolymer concentration was 40 w/v %. In this 
section, the influence of the amount of prepolymer on the particle size at two additional 
concentrations: 28 and 12 w/v % and at different sonication times is shown. From the 
data presented in Table 5.10 it can be clearly seen that a decrease in polymer 
concentration leads to an increase of nanogel size.  
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Table 5.10 Influence of polymer amount 
Sonication 
time [s] 
Polymer 
concentration 
[w/v %] 
H2O2 Alloxan 
Z-
average 
[nm] 
PDI 
Z-
average 
[nm] 
PDI 
60/60 40 350±13 0.410±0.010 260±10 0.151±0.002 
60/60 28 450±13 0.400±0.009 300±13 0.175±0.002 
60/60 12 480±14 0.375±0.006 350±12 0.180±0.008 
300/60 40 150±11 0.175±0.013 200±12 0.174±0.010 
300/60 28 250±14 0.125±0.008 250±15 0.220±0.008 
300/60 12 275±15 0.123±0.018 250±18 0.250±0.006 
360/60 40 250±11 0.245±0.021 250±10 0.230±0.006 
360/60 28 300±16 0.290±0.011 300±11 0.250±0.010 
360/60 12 375±16 0.310±0.008 325±12 0.275±0.010 
 
This tendency is apparent for both catalysts to the comparable extent. Since the 
sonication time, water oil ratio and the surfactant amount are kept constant, the size of 
the water droplets is most likely not affected by the polymer mass. However, by 
increasing the polymer amount the molar concentration of thiols in each water droplet 
increases. Thus, a higher concentration of the polymer results in increased cross-
linking density which decreases the relative swelling of nanogels and hence also the 
hydrodynamic radius in comparison with nanogels prepared using lower thiol-polymer 
concentration. 
 
5.3.3 Stability of Nanogels and Nanogel dispersions 
A prerequisite for nanoparticles that are intended for biomedical applications is their 
maintained integrity under physiological conditions for at least the time they need to 
actively or passively accumulate in or close to the target cells. For intravenous 
administration this usually occurs rapidly within minutes and hours so that particle 
stability under physiological conditions for 48h is sufficient. Nanogel dispersions were 
incubated in PBS buffer at 37 °C for 60 h and samples were taken at 0 h, 0.25 h, 1 h, 6 
h, 12 h, 24 h and 60 h to assess NP size and aggregation by DLS and cryo-FESEM 
(Figure 5.4). No significant changes in size and polydispersity could be determined by 
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DLS and cryo-FESEM performed with nanogels incubated for 0 h and for 60 h 
demonstrating no conspicuous difference in morphology of both samples after 
incubation at 37°C for 60h. These results show that nanogels remain stable in 
physiological conditions making them appropriate candidates for in-vitro applications.  
 
Figure 5.4: Nanogel stability at pH = 7.4 and 37 °C. Left: hydrodynamic diameter 
determined from DLS after 0 h, 0.25 h, 1 h, 6 h, 12 h, 24 h and 60 h; right: cryo-FESEM 
of nanogels after 60 h incubation. 
 
5.3.4 Biodegradation of Nanogels 
Nanogels degradation was investigated in the presence of GSH, a tripeptide with a free 
thiol group, which readily cleaves disulfides to thiols. It is present in the cytosol of 
mammalian cells with a concentration in the range of 0.5–10 mM and acts as major 
protection against oxidants such as reactive oxygen species. When reacting with 
oxidants, GSH itself is oxidized and forms disulfides (GSSG). In a healthy cell, 90% of 
GSH is present in the reduced form. In contrast to the fluid inside cells, the 
concentration of GSH in blood and the extracellular matrix (ECM) is lower than 20 
μM.23 This high redox potential difference between the neutral or oxidizing extracellular 
space and the reducing intracellular space makes disulfide cross-linked particles 
especially attractive as drug delivery systems due to the possibility of controlled 
biodegradation of the cross-linked network, and thus quantitative drug release in the 
cytosol.7, 8 
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As shown in (Figure 5.5 a, left vial) purified nanogels dispersed in water had a turbid 
appearance. Upon addition of water-soluble GSH as a reducing agent (total GSH 
concentration was 10 mM), the nanogel dispersion turned into a transparent solution 
caused by nanogel degradation into individual polymeric chains (Figure 5.5 a, right 
vial). The nanogel degradation was also further confirmed by optical fluorescence 
microscopy with Alexa Fluor 488 labelled particles. Before the degradation, particle 
aggregates appear as individual bright green spots on the dark background (Figure 5.5 
c).  
 
Figure 5.5: Reductive degradation of the nanogels by 10 mM GSH: (a) vials containing 
PBS nanogel solutions before and after reduction; (b) Transmittance study performed 
by UV-Vis method with different concentrations of nanogel solution. Optical 
fluorescence microscopy images of Alexa Fluor 488 conjugated nanogels (c) before 
and (d) after degradation.  
 
This implies that the dye is conjugated to the particles since the non-bound dye was 
successfully removed by the dialysis. Upon GSH addition, the fluorescent signal is 
spread as shown in Figure 5.5 d, depicting a completely green background, which 
proves disulphide reduction and thus nanogel degradation. Assessment of reduction 
kinetics in the presence of 10 mM GSH was followed by transmission measurements in 
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PBS buffer at 37 °C (Figure 5.5 b). In this experiment the milky nanogel solutions turn 
transparent upon reduction resulting in an increase in the transmittance. Five different 
nanogel concentrations were studied while the GSH concentration remained constant. 
As a control, nanogels without addition of GSH (blank), 10 mM GSH solution as well as 
HS-PG prepolymer solution (c = 15 mg/mL) were used. The transmission of blank 
solutions (without GSH) remained constant, showing no degradation while the 
transmittance of GSH and HS-PG was 100 % throughout the measurement. For the 1, 
2 and 4 mg/mL concentrated solutions the burst reduction was observed within first 40 
min, followed by a plateau, where no further increase in transmittance was monitored. 
The transmittance of higher concentrated 10 mg/mL and 15 mg/mL solutions showed 
an induction period of 50 and 150 min and then reached a plateau after 260 and 600 
min, respectively. The induction period observed in both samples with high 
concentration indicates a mechanism of reduction via surface erosion. The 100 % 
transmittance was observed only for 1 mg/mL solutions, while for more concentrated 
solutions it was below 100 % showing incomplete reduction of the particles. The 
experiments were also performed at lower GSH (1 and 5 mM) concentrations. For three 
different concentration of nanogels (4, 8 and 12 mg/mL) at pH = 7.4 and 37 °C.  
 
Figure 5.6: UV-Vis spectra showing nanogel reduction kinetics in PBS buffer at 37 °C 
with a) 5 mM GSH and b) 1 mM GSH. 
 
Transmission measurements performed by UV-Vis spectroscopy at 500 nm for 1000 
min were used to monitor the kinetics. It was observed that the increase in 
transmittance was in the range of 25-30 % and 10-20 % for 5 mM GSH and 1 mM 
reduced solutions, respectively (Figure 5.6). The plateau, where no further 
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transmittance increase was observed was reached within 100 min for 5 mM and 150 
min for 1 mM solutions, showing incomplete nanogel reduction at such low GSH 
concentrations. 
Subsequently, following the procedure described by Cerritelli et al.24 another test of 
reductive sensitivity was carried out by multiple additions of the same total amount of 
GSH to the nanogels dispersions in the cuvette (Figure 5.7). Thus, in this experiment, 
a stronger reduction effect could be obtained in the presence of a more constant level 
of reduction potential, simulating the situation inside a living cell where the redox-
potential is actively kept constant. The transmission of blank solutions (without GSH) 
remained constant throughout the measurement showing no degradation 
 
 
Figure 5.7: Transmittance measurement of nanogel solutions performed after multiple 
additions of GSH. The final GSH concentration was 1 mM at the beginning of each 
step.  
 
Indeed, addition of 1 mM GSH solution in 200 min steps led eventually to transparent 
solutions within 1000 min in the case of 4 mg /mL concentrated samples (Figure 5.7). It 
is however to be noted that all reduction experiments described in this section are 
qualitative and are only indicative with respect to the in-vivo case, where the total 
particle concentration in the cell will be much smaller then presented in this study. 
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5.3.5 Cytocompatibility of the Nanogels 
Both types of nanogels were assessed for cytocompatibility according to DIN EN ISO 
10993-5 at concentrations of 10 mg/mL, 5 mg/mL and 1.5 mg/mL. After incubating 
L929 cells with nanogels for 48h, light microscopy was used to assess cell morphology. 
There was no difference in cell morphology comparing control cells to nanogel treated 
cells. Counting of live cells indicated more than 90 % viable L929 mouse fibroblasts 
when compared to the untreated control. The viability of L929 mouse fibroblasts cells in 
the presence of nanogels as assessed by the WST test was the same as the cell 
viability of control cells on TCPS in DMEM without nanogels.  
 
Figure 5.8: Nanogel cytocompatibility at three different concentrations after 24 h 
incubation with L929 mouse fibroblasts cells demonstrated through cell numbers (a) 
and cell vitality (b) in comparison to control experiments on TCPS, respectively. 
 
Cells grown in nanogel medium were healthy and not optically different to the control 
cells. No significant difference was observed for nanogels prepared by peroxide or 
alloxan. These results show that during the course of incubation, no endotoxins or 
other cytotoxic compounds were released and that the nanogels as such are 
cytocompatible even at a high concentration of 10 mg/mL (Figure 5.8). 
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5.4 Conclusion 
This study is concerned with the preparation of redox-sensitive nanogels through 
oxidative coupling of thiofunctional polymers in inverse miniemulsion. Comparison of 
hydrogen peroxide and alloxan, a milder oxidation catalyst, with respect to their 
applicability for the preparation of nanogels from thiofunctional poly(glycidols) and 
especially their suitability for precise control over nanogel size and size distribution was 
performed. Multiple parameters such as the sonication time, the amount of catalyst, the 
amount of polymer and the HLB value were systematically changed, and the conditions 
were identified that allow the preparation of nanogels with sizes between 150 and 350 
nm and good size distributions. In vitro degradation of the nanogels under cytosolic 
conditions using glutathione (GSH) as reducing agent as well as cytocompatibility of 
the nanogels with concentrations up to 10 mg/mL using L929 fibroblasts was 
demonstrated. These results demonstrate that also mild oxidation catalysts such as 
alloxan can be used for the preparation of redox-sensitive nanogels that specifically 
degrade in cytosolic conditions, thus broadening the range of possible payloads. 
Current and ongoing studies concern the loading of and release from such nanogels 
with protein drugs as well as studies on cellular uptake and subsequent particle 
degradation and payload release. 
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CHAPTER 6 
 
Embedding of Active Proteins and Living Cells in 
Redox-Sensitive Hydrogels and Nanogels through 
Enzymatic Cross-Linking 
 
Part of this work is published in Angewandte Chemi DOI: 10.1002/anie.201206266 
 
6.1 Introduction  
Redox-sensitive materials have gained interest significantly over the last few 
years.1 Disulfide cross-linked networks are particularly appealing, as disulfides are 
structure-forming groups in proteins as well as in natural processes and conditions in 
cells exists which allows reductive scission of these covalent links. Hence, such 
materials are predetermined for drug delivery, as disulfides are rapidly reduced to thiols 
under the reductive environment inside cells allowing quantitative release of the 
payload incorporated within the particles.2 Disulfide cross-links can be introduced by 
using disulfide containing cross-linkers during particle preparation by polymerization,3 
or by the coupling of thiol functional precursors 4 which allows covalent binding of 
cysteine-terminated drugs (for example peptides) to the particle matrix by the disulfide 
bonds. Oxidation of thiol bearing matrix molecules is possible solely upon exposure to 
air5 but is relatively slow and not useful for many nanoparticle preparation techniques. 
Therefore, different oxidizing catalyst may be applied in order to shorten oxidation 
times.6 Hydrogen peroxide is the one often used but is cytotoxic and due to its strong 
oxidation potential, disulfides are not its sole reaction products with thiols7 as discussed 
in Chapter 5, therefore the number of possible payloads is restricted. Enzymes as 
biological catalysts can be used to mediate hydrogel formation with the advantages of i) 
cross-linking under mild conditions, ii) unique chemo-, regio, enantioselectivity, iii) no 
need for toxic cross-linkers, and iv) biologically controlled gelation. A number of studies 
have thus been reported on enzyme-mediated hydrogelation.8-10 Inspired by the natural 
 111 
 
gelation process of fibrin, Lutolf et al. have used used transglutaminase to cross-link 
polymers to form hydrogels. They used this process to generate cell adhesion peptide 
functionalized hydrogels that are also degradable by matrix metalloproteases.11 
Approaches for the enzymatic cross-linking of hydrogels especially for biomedical 
applications have most recently been reviewed.12 This overview shows that enzymatic 
cross-linking has so far always resulted in networks for which degradation is either 
possible through enzymatically catalyzed cleavage of covalent bonds or rather harsh 
and not cytocompatible chemical conditions like drastic pH changes. Horseradish 
peroxidase (HRP) is one of the most studied oxidation-catalyzing enzyme due to its 
catalytic role on a wide range of substances.13 However, the conventional HRP cycle 
involves its reaction with H2O2 resulting in formation of reactive intermediates, so that 
addition of hydrogen peroxide is necessary for HRP mediated cross-linking.14-16 Herein 
the HRP-mediated preparation of functional, redox-sensitive disulfide-cross-linked 
hydrogels and nanogels through the gelation of thiomers without the requirement of 
H2O2 is described. 
. 
6.2 Experimental 
6.2.1 Materials and Methods 
Linear poly(glycidol) (PG) (Mn = 4500 g/mol, Mw /Mn = 1.17) was synthesized as 
mentioned in Chapter 3. N,N-dicyclohexyl-carbodiimide (DCC, Acros, 99%), 4-
(dimethylamino) pyridine (DMAP, Aldrich, 99%), 3,3’-dithiodipropionic acid (DTPA, 
Aldrich, 99%), tris(2-carboxyethyl) phosphine (TCEP, Aldrich, 99%), dichloromethane 
(HPLC grade, Aldrich), cysteamine (2-mercaptoethylamine, Biochemica), 5,5’-dithio-
bis(2-nitrobenzoic acid) (DTNB, Merck), anhydrous N,N-dimethylformamide (DMF, 
Sigma-Aldrich, 99.8%), Span 80 (Sigma), and Tween 80 (Sigma-Aldrich), pyragallol (≥ 
98%, Sigma), immobilised TCEP (Thermo Scientific), AGBBB015F peptide (3230 
g/mol, AplaGen), glutathione (≥ 98%, Sigma), Caffeine (Sigma) were used as received. 
THF was dried over LiAlH4. Horseradish peroxidase with an initial enzymatic activity of 
320 U/mg was purchased from CalBioChem. Dialysis membranes (MWCO: 3500 Da, 
20,000 and 100,000 Da) were purchased from Spectrum Laboratories. 
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6.2.2 Bulk Hydrogel Synthesis.  
(0.150 g, 3.33 × 10-2 mmol) was dissolved in 350 µL buffer at pH 7.4, 8.0, 8.5 and was 
mixed thoroughly. To this solution HRP was added in different molar ratios. The bulk 
gelation of HS-PG was induced by addition of four different equivalents of HRP with 
respect to thiol functionalities present in the polymer backbone as –SH : HRP: 1:0.01, 
1:0.02, 1:0.04, 1:0.08. In order to test the role of HRP in gelation, samples with PG was 
also monitored for 24 h without addition of HRP. 
 
6.2.3 Rheological Analysis of Bulk Hydrogels 
 Dynamic oscillatory deformation measurements were performed with a Bohlin CVR-50 
(Malvern Instruments Ltd, England) in a cone-plate configuration. The upper plate 
(cone plate 1o, 20 mm) was set at a distance of 150 µm before the onset of the 
reactions. During all the rheological measurements, a thin film of low-viscosity silicone 
oil covering the sample perimeter was used to prevent solvent evaporation. 
Measurements were carried out at a frequency of ω = 1 Hz and a deformation 
amplitude = 0.01 to ensure that the oscillatory deformation is within the linear 
viscoelastic regime. 
 
6.2.4 Reduction of Bulk Hydrogels with GSH 
 The degradation behaviour of HS-PG hydrogel was investigated in presence of water-
soluble reducing agent glutathione (GSH). Prior to reduction, the hydrogels were 
allowed to swelling in a PBS (pH 7.4), followed by addition of 10 mM GSH and 
incubated at 37 °C. The reduction was allowed until the transition of gel to sol was 
observed. 
 
6.2.5 Nanogels Synthesis 
Nanogels were synthesised via inverse miniemulsion method. For the preparation of 
the miniemulsion, surfactant (100 mg of 3:1 weight ratio of Span 80 and Tween 80) 
dissolved in 3.74 mL of n-hexane was used as organic phase. The aqueous phase 
consisted of 150 mg (3.68 × 10-1 mM) of HS-PG dissolved in 300 µL of 0.04 M PBS 
buffer (pH = 8.5). The organic and the aqueous phases were pre-emulsified by 
magnetic stirring for 10 min. After stirring the system was ultrasonicated using a 
Branson sonifier W450 with a ¼  horn at duty cycle of 30% and output control of 90% 
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under ice cooling. Cross-linking was initiated by subsequent addition of HRP (0.0128 g, 
3.2 x 10-6 mmol) dissolved in 30 µL of PBS buffer (pH = 8.5) and the mixture was 
sonicated for another 60 s. The reaction was allowed to proceed for 50 min at room 
temperature with constant stirring followed by quenching of the free thiol groups by 2-
hydroxy acrylate at pH = 8. Any further oxidation was stopped by addition of 1.5 mL of 
acidic water (pH = 3). Separation of the nanogels was achieved by centrifugation at 
10000 rpm for 30 min followed by decantation of the supernatant. Nanogels present in 
the aqueous layer were carefully washed with hexane (2 × 1.5 mL) and THF (4 × 2.5 
mL) in order to remove the surfactants and unreacted polymer. The remaining organic 
solvents and acid were removed by dialysis. Purified nanogels were stored in Millipore 
water at 4 °C for further use. 
 
6.2.6 Peptide Conjugation to HS-PG Nanogels 
Carboxyfluorescein labelled, cysteine terminated CGGKTFFYGGSRGKRNNFKTEEY 
peptide was used as a model peptide for HRP mediated covalent attaching to HS-PG 
nanogels. Prior to conjugation the peptide was reduced using immobilised TCEP. For 
coupling, 1 mg of peptide (3.096 × 10-4 mmol) was dissolved in miniemulsion aqueous 
phase during nanogel formation keeping the rest of the parameters as described 
above. After nanogel purification the amount of conjugated peptide was quantified by 
means of UV-Vis method. The absorption spectra were recorded between 300-600 nm 
with λmax at 475 nm by making a standard curve for increasing peptide concentration. 
Total amount of the conjugated peptide was determined by measuring the absorbance 
of the non-conjugated peptide present in the supernatant and subtracting this value 
from the total amount used for coupling. 
 
6.2.7 Nanogels Degradation 
Peptide labelled nanogels (100 mg) were degraded in the presence of water soluble 
reducing agent GSH (10 mM) in PBS buffer (10 mL pH = 7.4 ) at 37 °C imitating the 
biological conditions. Optical fluorescence microscopy was used for imaging of peptide 
conjugated particles before and after reduction. Images were recorded at 20-fold 
magnification and 50 ms exposure time. 
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6.2.8 HRP Activity Assay 
The enzyme activity assays of the released HRP from the cross-linked networks were 
performed by means of the well-established procedure of HRP mediated pyrogallol 
oxidation to purpurogallin. The purpurogallin which is yellow in color can be readily 
detected spectrophotometrically at 420 nm. One unit of peroxidase is defined as the 
amount of enzyme required to catalyse the production of 1 mg of purpurogallin from 
pyrogallol in 20 seconds at 20°C under the assay conditions described. Prior to 
measurements the release of the HRP from hydro- and nanogels was performed as 
followed. Hydrogel samples were immersed at 25°C in 10 mL of PBS buffer at pH = 6. 
Subsequently after 1, 4, 8, 12, 24 h the buffer solution was carefully replaced by same 
amount of fresh solution. Followed washing steps, nanogel particles were re-
suspended in 10 mL PBS buffer at pH = 6 at 25 °C and were centrifuged. At an interval 
time of 1, 4, 8, 12, 24, 36, 48, 52 and 72 h nanogels were centrifuged and then re-
suspended in fresh buffer solution. The extracted amount of HRP during the washing 
was subtracted from the final value. The release was monitored spectrophotometrically 
for all the supernatants obtained from hydro- and nanogel samples. Since the activity of 
enzyme is proportional to the concentration of active enzyme, this method was also 
used to determine the amount of active enzyme which was not released from the 
hydrogel and nanogels. For measurements, in 3.0 mL of reaction mixture for each 
blank and sample, the final concentration of 14 mM PBS buffer, 0.027 wt% hydrogen 
peroxide and 0.5 wt% pyrogallol was present. To achieve a temperature control both 
mixture in cuvettes were incubated in spectrophotometer at 20 °C for 4 min. Then 100 
µL of PBS and 100 µL diluted HRP were added respectively. The change in the 
absorbance was continuously recorded against the corresponding control containing all 
of the reagents, except peroxidase, at 20 °C. The initial velocity was recorded by the 
absorbance-time curve. The concentration of HRP was kept so dilute that a ∆A/min 
was in the range of 0.02 to 0.04. The measurements were started immediately and 
colour densities of product solution were measured at 420 nm for 3-4 min. The values 
obtained in the blank reactions performed in the absence of enzyme were subtracted 
from all the readings. 
 
6.2.9 Unfolding and Refolding of HRP 
Nanogels (100mg) with remaining 20% of HRP after 72h of its release were reduced in 
presence of 10mM GSH with incubation in PBS buffer for 24h at 37°C. After reduction 
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they were dialysed through dialysis membrane (MWCO 20 kDa) against deionised 
water for 24h under argon. The dialysed sample was divided into two parts, one part 
was directly used to measure the activity of reduced HRP, while the other part was 
again dialysed against PBS buffer pH 7.4 with 1 mM dissolved caffeine to facilitate the 
refolding of HRP for 24h and further dialysed against deionised water under argon prior 
to activity measurement.  
 
6.2.10 β-Galactosidase Loading  
Encapsulation of β-Galactosidase (β-Gal) in the nanogel was performed during the 
formation of the nanogel. The procedure was essentially the same as the preparation of 
unloaded nanogels except that 5wt% and 10wt% of the enzyme with respect to the 
polymer weight were dissolved in the initial aqueous phase while synthesising 
nanogels.  The enzyme encapsulation and activity was determined by using o-
nitrophenyl- β-D-galactopyranoside (ONPG) assay for β-Gal.23 
 
6.2.11 o-nitrophenyl- β-D-galactopyranoside (ONPG) Assay 
The enzyme β-Gal plays an important role in cellular metabolism by breaking down 
lactose into glucose and galactose. Enzymatic activity of β-Gal can be indirectly 
measured using a lactose analog, ONPG which is cleaved by β-Gal to o-nitrophenyl 
(ONP) which has a yellow color. The absorbance of ONP can be measured at a 
wavelength of 420nm spectrophotometrically.  1 unit of β-galactosidase is defined as 
the amount which hydrolyzes 1 µmol of ONPG to o-nitrophenol and D-galactose.The 
assay was performed in a Z-buffer at pH 7.0. For making 500 mL Z buffer: 150 mL 0.2 
M Na2HPO4, 100 mL 0.2 M NaH2PO4, 5 mL 1 M KCl, 5 mL 0.1 M MgSO4 were added in 
240 mL of distilled water. Just before using, β‐mercaptoethanol (35 μL per 10 mL Z 
buffer) was added. ONPG concentration was kept at 4mg/mL while 1M Na2CO3 was 
prepared to stop the reaction. 
A calibration curve was obtained for 0.5, 1.0, 1.5, 2.0, 2.5, 3.0, 3.5, 4.0, 4.5, and 5.0 
mg/mL of β-Gal with the ONPG assay. 200 μL of β-Gal was added to 1000 μL of Z-
buffer and incubated for 2 min at 37°C following which 200 μL of ONPG was added and 
the mixture was again incubated at 37°C. The reaction was allowed to proceed for 3 
min and then was stopped with the addition of 500 μL of 1M Na2CO3. Immediately the 
absorbance was measured at 420 nm. Blank measurements were made in a similar 
way without addition of the enzyme and values were subtracted from all the readings. 
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For estimation of β-Gal loading in the nanogels, supernatant from the washing of 5wt% 
and 10wt% of β-Gal loaded nanogel was taken and analysed in similar way as stated 
above. The unloaded amount calculated from the supernatant was subtracted from the 
amount of β-Gal used for loading and actual loading in the nanogels was estimated. All 
the measurements were performed in triplicate. For activity estimation of loaded β-Gal 
in the nanogel, loaded and unloaded nanogels were reduced as stated before. 
Reduced nanogels solution was dialysed for 12h through a 10,000 MWCO membrane. 
The ONPG assay was performed and absorbance was measured at 420nm. As a blank 
correction, measurements made with unloaded nanogels, were subtracted from the 
loaded once. The activity of the enzyme was calculated by the following equation. 
Activity = (OD420 × 1.9 × 1nmol) / (t × V × 0.0045 mL cm)  
Were 1.9 = total volume in cuvette, t = time of reaction, V = volume of β-Gal used for 
analysis, 0.0045 OD 420/nmol = ε420 ONP, path length = 1 cm 
 
6.2.12 Cytocompatibility Assessment 
Human fibroblast cell line 84-9 derived from a haemophilia patient was seeded in 48 
well tissue culture plates (25000 cells per well in 500 µL DMEM with 10 % FCS, 1 % 
penicillin/streptomycin, 1 % HEPES buffer, all from Invitrogen Life Technologies, 
Karlsruhe, Germany). The cells were incubated for 24 h at 37 °C in a 5 % CO2 
humidified atmosphere. Three different nanogel samples were tested for their 
cytocompatibility: Crosslinking mediated by HRP, as prepared (HRPap), crosslinking 
with HRP catalysis followed by dialysis against distilled water (HRPdia) as well as 
crosslinking with H2O2 as prepared (H2O2ap). All nanogel samples were dialysed 
against DMEM without additives for 24 h. After that FCS, pen/strep, and HEPES were 
added in adequate amount and the samples were diluted 1:10 and 1:100 to reach 
solutions with 1 mg/mL and 0.1 mg/mL of nanogel. In addition, cytocompatibility of HRP 
(0.85 mg/mL solution diluted 1:10 and 1:100 respectively, HRPsol) was determined. 
The culture medium was aspirated from the cells and 500 µL of the dialysed nanogel 
and the HRP solutions respectively were added per well and incubated for 24 and 48 h 
at 37 °C in a 5 % CO2 humidified atmosphere. Cells cultured in DMEM without any 
nanogel or HRP served as control. Cytocompatibility of nanogels with 1 mg/mL and 0.1 
mg/mL concentration was evaluated by means of LIVE/DEAD staining kit (L3224, 
Invitrogen Life Technologies, Karlsruhe, Germany), determination of cell activity using 
the WST reagent (Roche Diagnostics, Mannheim, Germany) according to DIN EN ISO 
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10993-5 as well as cell counting. For LIVE/DEAD staining, cells were washed two times 
with BPS and incubated with 200 µL per well of the staining solution (2 µmol calcein 
and 1 µmol ethidium-homodimer in PBS) for 30 min.  Afterwards, the cells were 
analyzed by means of fluorescence microscopy (Axioimager M1, Zeiss, Germany). For 
WS cell activity test, the cells were incubated with the WST reagent 1:10 in 
supplemented DMEM for 30 min at 37°C. The absorption of the supernatant was 
quantified in a Tecan spectra fluor plus photometer (Tecan, Crailsheim, Germany) at a 
wavelength of 450 nm. Cell counting was performed using a CASY cell counter (Roche, 
Diagnostics, Mannheim, Germany). Samples for cell activity and cell counting were 
measured in quadruplicate. The average and standard deviation were calculated using 
Microsoft Excel.  
 
6.2.13 Cell Encapsulation in the Hydrogel  
Cell Encapsulation in the hydrogel was done layer by layer. First SH-PG (0.025 g, 5.55 
× 10-3 mmol) was dissolved in 70 µL buffer at pH 8.5. To this solution HRP (0.0003 g, 
7.5 × 10-7 mmol) was added. The mixture was mixed thoroughly and was poured into 
the well plate. After 1h of incubation of the hydrogel, SH-PG (0.015 g, 3.34 × 10-3 
mmol) dissolved in 40 µL buffer at pH 7.4 mixed with HRP (0.00018 g, 4.5 × 10-7 mmol) 
and 300,000 L929 mouse fibroblasts (ATCC CCL-1) were added on top of the pre-
gelling hydrogel. Complete gelation of hydrogel with encapsulated cells took place 
within 2h. Afterwards the gel was swelled in 1mL DMEM plus 10 % FCS, 1 % 
penicillin/streptomycin, 1 % HEPES buffer, (Invitrogen Life Technologies, Karlsruhe, 
Germany) and live dead viability staining (LIVE/DEAD staining kit, Invitrogen, 
Karlsruhe, Germany) of the cells was performed according to manufacturers protocol 
after 1h and 18h. 
 
6.3 Results and Discussion 
Herein, HRP-mediated preparation of functional, redox-sensitive disulfide cross-
linked hydrogels and nanogels through gelation of thiomers without the requirement of 
H2O2 is presented. Thiol functionalised linear poly(glycidol) (Mn = 6100 g/mol; HS-PG) 
was chosen as hydrophilic and cytocompatible gel precursor.17 Homogeneous 
thiofunctional prepolymer solutions in PBS (30 wt%, pH=7.4, 8.0, 8.5) did not yield 
hydrogels within 24 h at ambient conditions in the absence of HRP. Upon HRP 
 118 
 
addition, gel formation was observed after 4 h only at pH = 8.5, suggesting the 
occurrence of enzyme-triggered hydrogelation (Figure 1). Hydrogel formation was 
confirmed in situ during the network evolution by rheological analysis using oscillatory 
deformation tests. A typical gelation profile is characterized by two-phases (Figure 1). 
An initial lag phase of about 2 h, during which both moduli (elastic (G´) and viscous 
(G´´)) remain almost unchanged, may be related to the formation of prepolymer 
aggregates in the reaction system. The lag phase is followed by a log phase at which 
rapid increase of G´ is observed, suggesting the occurrence of cross-linking reactions 
in the prepolymer aggregates. The gel point can be assumed at the crossover point of 
G´ and G´´ in the case of low entangled networks and was observed at about 150 min. 
The assessment of gelation kinetics reveals a marked dependence of gelation time on 
HRP content. The gelation time decreased with increasing amount of HRP and reached 
a plateau at 110 min for a molar ratio of -HS : HRP = 0.08. A further increase of the 
HRP amount did not affect the gelation time.  
The conventional HRP cycle involves its reaction with H2O2 resulting in formation of 
highly reactive intermediates acting as powerful oxidants. In the presence of thiol 
groups these intermediate compounds generate active thiyl radicals that may then 
dimerize to disulfide bonds or react with thiolates forming the disulphide radical which 
can transform to a disulphide bond after the reaction with oxygen. Under aerobic 
conditions however, there is no need for H2O2 addition as H2O2 is formed during auto-
oxidation of thiol in stoichiometric ratios.18 It can then act according to the mechanism 
described above as catalyst for disulphide formation, without the need for further 
addition of peroxide. Due to the strictly stoichiometric molar ratio between the 
generated peroxides and thiols, no further oxidation of the forming disulphide groups 
occurs. Strong pH dependence on the gel formation indicates that in this system 
reaction between thiyl radicals and thiolates is a dominating process. 
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Figure 6.1: Hydrogel formation from thiofunctional prepolymers upon HRP addition 
with corresponding pictures of hydrogels. (Right) Changes in elastic G´, and viscous 
modulus G´´ measured at 1 Hz during the cross-linking reactions. (Inset figure) 
Dependency of gelation time on molar ratio of HS-PG to HRP. 
 
 
Figure 6.2: (Left) Elastic (G´) and viscous (G´´) modulus during the gelation of HS-PG 
in the presence of H2O2. (Right) the changes in G´ and G´´ of the same sample after 
time sweep test as a function of frequency.  
 
For comparison, an oscillatory rheological analysis with H2O2 instead of HRP as 
oxidizing agent was performed (Figure 6.2). Gelation of HS-PG precursors in the 
presence of H2O2 is slower than the HRP-mediated process, but the frequency sweep 
tests show that both processes yield elastic network formation. 
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Raman Spectroscopy was performed to qualitatively determine and compare the 
reaction products obtained by the thiomer gelation mediated with HRP and H2O2 
(Figure 6.3). The Raman spectra of HS-PG cross-linked with H2O2 showed 
considerable amount of free thiol (2075 cm-1) in the stipulated time of 4 h in comparison 
of hydrogels formed by HRP cross-linking where almost all the thiol functionalities are 
converted into disulfide (507 cm-1). These results correlate well with rheological tests 
indicating that HRP is more effective catalyst in disulfide bond formation in comparison 
to H2O2.  
 
Figure 6.3: Raman spectra of HS-PG hydrogels cross-linked with H2O2 (0.01 ratio of 
HS-PG) and HRP at different molar ratios, as indicated. 
In order to prove the versatility of the HRP mediated thiomer oxidation nanogel 
particles were prepared by inverse miniemulsion technique.17  
Cryo-scanning electron microscopy (cryo-SEM) and dynamic light scattering (DLS) 
techniques were applied to characterize the nanogel particle diameter in the swollen 
state (Figure 6.4). Particle size analysis with DLS yields a z-average particle diameter 
of 250 nm with a PDI of 0.24. Cryo-SEM images demonstrate that the particles have 
well-defined spherical shapes with particle diameters d in the range of 200 nm < d < 
350 nm. These results show that both techniques correlate well to each other with 
respect to size analysis of the nanogels in the hydrated state 
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Figure 6.4: Cryo-SEM and DLS of HS-PG nanogels in water. 
 
HRP mediated cross-linking of thiofunctional polymers can also be used to generate 
functionalized nanogels in a one step-procedure. It was demonstrated by adding the 
carboxyflourescein (FAM) labeled model peptide sequence 
CGGKTFFYGGSRGKRNNFKTEEY to the nanogel preparation.   
 
Figure 6.5: a) UV - spectra of HRP, the FAM labeled peptide 
CGGKTFFYGGSRGKRNNFKTEEY and peptide conjugated HS-PG nanogels prepared 
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through HRP mediated oxidation; b) cryo-SEM image of peptide labeled nanogels 
(diameter: 200 - 350 nm). Fluorescence microscopy image of the FAM labeled peptide 
conjugated nanogels before (c) and after (d) reduction with GSH. 
 
This peptide bears an N-terminal cysteine that allows HRP-mediated covalent 
conjugation of the peptide to the nanogels. Figure 6.5 (a) shows the UV spectrum of 
native HRP, FAM labeled peptide as well as peptide-conjugated HS-PG nanogels after 
centrifugation and subsequent dialysis. Native HRP shows an intense band at 403 nm 
in aqueous solution (Soret band) which is characteristic for heme containing moieties 
while the peptide exhibits a maximum at 488 nm due to the presence of FAM. In the 
spectra of purified nanogels both bands are present confirming enzyme encapsulation 
and the presence of conjugated peptide. The labeling efficiency of the peptide 
estimated from a standard absorbance calibration curve measured at the 475 nm was 
56 %.  
Redox sensitivity of peptide labelled nanogels was demonstrated through degradation 
in the presence of glutathione (GSH). Due to the presence of FAM in the conjugated 
peptide, this process could be visualized by fluorescence microscopy. It was observed 
that before degradation particle aggregates appeared as individual bright green spots 
on the dark background (Figure 6.6 c). This implies that the peptide is conjugated to 
the particles and the non-bound peptide was successfully removed by dialysis. Upon 
GSH addition to a final concentration of 10 mM, the fluorescent signal is spread as 
shown in Figure 6.6 d depicting a homogeneous green background, demonstrating 
nanogel degradation. 
Release profiles of HRP from the cross-linked networks as well as enzyme activity 
assays were performed by means of HRP mediated pyrogallol oxidation to 
purpurogallin.19 
 
 
Scheme 6.1: Reaction of of HRP with pyrogallol substrate. 
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The purpurogallin is yellow in color and can be readily detected spectrophotometrically 
at 420 nm.  
 
Figure 6.6: Typical UV-Vis spectra of HRP released from HS-PG-nanogels (release 
time was 24 h) (right). The spectra from bottom to top were obtained at 30 s intervals 
(b) linear fit of the absorbance recorded at 420 nm (left). 
 
HRP release analysis from the hydrogels reveals that > 98% of HRP was released 
within 24 h (Figure 6.7 left). 
 
Figure 6.7: HRP release profile and activity assay from (left) bulk hydrogels and (right) 
nanogels. 
 
In contrast, the release from the nanogels was slower and incomplete, reaching a 
plateau at 80% after 36 h (Figure 6.7 right). While for hydrogels ~ 45 % of the 
encapsulated HRP was released within 1 h, in the case of nanogels 45 % release was 
reached after 9 h. Therefore the cross-linking density of hydrogels and nanogel were 
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calculated. This may eventually be exploited for combination therapies with drugs that 
are activated through oxidation with HRP. In the field of drug delivery, recent studies20 
have shown that HRP can be used to convert a non-toxic prodrugs (indole-3-acetic acid 
(IAA) and the halogenated derivative 5-bromo-IAA) to a cytotoxin, which is a very 
promising drug delivery approach for example for tumor therapy, where side-effects of 
traditional drugs are severe. Hence, co-delivery of HRP with such drugs in separate 
particles leads to activation of the drugs only at the site of delivery, which is an 
extremely promising strategy to significantly lower side reactions of anti-tumor drugs. 
HRP released from hydro- and nanogels showed in all cases a catalytic activity above 
90% in comparison to pure enzyme control.  
 
 
Figure 6.8: Nanogel suspensions before (A, C) and after (B, D) reduction with GSH, 
prepared by cross-linking with H2O2 (A, B) or HRP (C, D). The picture of particles 
prepared by the HRP mediated cross-linking was taken after 72 h HRP release studies. 
Slightly brownish color of these particles indicates HRP remaining in the particles. In 
contrast nanogels prepared by the cross-linking with H2O2 show white-milky coloration 
 
Enzymatic activity was thus maintained after the thiol oxidation reactions and the cross-
linked networks provide a suitable environment for enzyme encapsulation. When 
visually observed, a slight brownish color (from HRP) of the nanogels was seen after 2 
days (Figure 6.8) which also indicates that the lacking 20 % of HRP remains in the 
nanogels.  
 
Mesh Size Calculation. The average mesh size (distance between tow entanglement 
points) ξ for bulk hydrogels was calculated from elastic modulus G´ based on Rubber 
Elasticity Theory (RET) through the following equation (Equation 6.1). 
                                                 Eq.6.1 
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Where G´ is the elastic modulus, NA, R and T have their usual meanings. 
There are several methods of estimating the mesh size of a nanogel; however, the 
Flory-Rehner model was selected due to the difficulty of measuring such parameters as 
the relaxed volume for different models (i.e., for the Peppas–Merrill or Brannon–
Peppas equation). Thus, these values are rough estimates of the actual values.  
Following the calculation of the ratio of swollen mass to dry mass, q, the polymer 
volume fraction in the swollen state, v2,s  was calculated with Equation 6.2: 
                                                 Eq. 6.2 
Where m is the mass of dry nanogel particles,   is the specific volume of the polymer 
(0.785 g/cm3), and is the density of water. The average molecular weight between 
cross-links was calculated through the following equation: 
                                     Eq. 6.3 
Where  is the molar volume of the swelling agent (for water; 18 cm3/mol),  is the 
Flory polymer-solvent interaction parameter (0.25 for PG) and the   is the number of 
average of the polymer chains before cross-linking. Once  was known, the mesh size 
can be calculated from Equation 6.4: 
                                                         Eq. 6.4 
Where  is the Flory characteristics ratio (14.6 for vinyl polymers),  is the average 
molecular weight of the repeating units, and  is the length of the bond along the 
polymer backbone (0.154 nm for vinyl polymers).  The mesh size for hydrogels was 
found as 4.9 nm, on calculation the average mesh size of HS-PG nanogels was found 
to be 3.0 nm. Since the radius of gyration of HRP is in the range of 2.5-3 nm, these 
calculations support the different release profiles of HRP. This may eventually be 
exploited for combination therapies with drugs that are activated through oxidation with 
HRP. 
Unfolding and Refolding of HRP 
To see the effect of reduction on released HRP from nanogels, HRP was reduced with 
10mM GSH. On reduction a decrease in its activity was observed. This reduction in 
activity of HRP could be attributed to the reduction of four intramolecular disulphide 
bridges Cys 11- Cys91, Cys 44- Cys 49, Cys 97-Cys 301 and Cys 177- Cys 209 of 
HRP20 which are also responsible for the stabilization of HRP’s conformation and 
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hence resulting in its unfolding. The activity of unfolded HRP was 50% compared to the 
≥ 90% activity of HRP released from the nanogel after 72 h incubation. During the 
course of reduction it was observed that the heme center of HRP was not disturbed. 
This was seen by an unaltered Soret band at 403 nm.  
 
Figure 6.9: Linear fit of the absorbance recorded at 420 nm of unfolded HRP (left) and 
refolded HRP (right). 
 
The activity of HRP was regained up to 65 % after it was dialyzed against PBS buffer at 
pH 7.4 in presence of 1mM caffeine. Caffeine which is a very mild oxidizing agent21 is 
supposed to enhance the process of disulphide bond formation but for enzyme activity 
it is critical that on refolding, the cysteine residues should be correctly paired. Due to 
complexity of measurement it was not determined, so the complete cause for loss of 
remaining 25% activity of HRP could not be estimated. 
 
β-Galactosidase Loading and Activity  
The bacterial enzyme, β-galactosidase, catalyzes the breakdown of the complex sugar 
lactose into its component simple sugars - galactose and glucose. Its a 460 kDa large 
tetrameric protein that loses its function upon intermolecular disulfide bridge 
formation.22  
 
Scheme 6.2: Reaction of of β-galactosidase with ONPG substrate 
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For an assay for β-Gal activity synthetic substrate ortho-nitrophenyl-beta-D-
galactopyranoside (ONPG)23 with a similar structure to lactose was chosen. ONPG 
gets cleaved in presence of β-Gal giving yellow coloured o-nitrophenol (ONP) and 
colourless galactose.The amount of ONP formed can be measured by determining the 
absorbance at 420 nm and is proportional to the amount of β-Gal and the time of the 
reaction. The reaction is stopped by adding Na2CO3 which shifts the reaction mixture to 
pH 11. At this pH most of the ONP is converted to the yellow coloured anionic form and 
β-Gal is inactivated. 
 
Figure 6.10: a) Typical UV-Vis spectra of ONPG assay of β-galactosidase with 
concentrations in range of 0.5mg/ mL to 5 mg/ mL b) Linear fit of the absorbance 
recorded at 420 nm. 
 
Table 6.1 β-galactosidase encapsulation efficiency and activity estimation 
 
β-Gal activity was retained in the range of 83-85%, while encapsulation efficiency of 40-
43% was estimated in the nanogels. Prior to loading of β-Gal in nanogels, stability of 
only β-Gal was checked with and without sonication for 120s, which is the time required 
β-Gal 
loading 
[wt%] 
β-Gal 
loaded 
[mg] 
Loading 
estimated 
[mg] 
Encapsulation 
Efficiency % 
% 
Activity 
 
Z-
Average 
[nm] 
PDI 
 
5 7.5 3.2 43 85 310±35 0.43±0.09 
10 15.0 6.1 40 83 405±25 0.40±0.05 
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for preparation of nanogels via miniemulsion. It was found that, 2.5% activity of the 
enzyme decreased by sonication which can marginally affect enzyme activity. Low 
encapsulation efficiency could be attributed to the steric hindrance caused by HRP 
which also gets encapsulated during the nanogel synthesis. As oxidative conditions 
strongly affect function of this protein, it is shown that by using HRP mediated cross-
linking, β-Gal could be loaded into nanogels and released with ca. 85% activity 
preservation. This demonstrates applicability of HRP cross-linking also to large and 
oxidation sensitive proteins and underlines the importance of this mechanism. 
 
Cytocompatibility   
Nanogels prepared by HRP catalysis (HRPap (undialysed), HRPdi (dialysed)), 
nanogels prepared through H2O2 mediated cross-linking (H2O2ap (undialysed) at 
concentrations of 1 mg/mL and 0.1 mg/mL as well as the used HRP solutions (HRPsol) 
were assessed for cytocompatibility using human fibroblast cell line 84-9. After 
incubating the cells for 24 and 48 h, LIVE/DEAD staining showed no differences in cell 
viability when comparing control cells to nanogel treated cells. 
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Figure 6.11:  LIVE/DEAD staining for cytocompatibility assessment for nanogels 
prepared by HRP catalysis (HRPap, HRPdi), nanogels prepared through H2O2 
mediated cross-linking (H2O2ap) at concentrations of 1 mg/mL and 0.1 mg/mL as well 
as the used HRP solutions (HRPsol) using human fibroblast cell line 84-9. After 
incubating the cells for 24 h(A) and 48 h(B). Scale bar 100μm. 
 
 
Figure 6.12: WST activity per cell after incubation of the different nanogel samples on 
human fibroblasts for 24 h (left) and 48 h (right). 
 
Cell activity as assessed by the WST test was calculated in relation to cell numbers as 
relative absorption per cell. Cells incubated with the three different kinds of nanogel 
showed no significant decrease in cell activity compared to control cells after 24 and 48 
h. Addition of 1 mg/mL of HRPdi) and nanogel with H2O2 (H2O2ap) to the cell culture 
medium resulted in a pronounced increase of cell activity after 24 h that lowered again 
after another 24 h. Cells supplemented with HRPsol showed a decrease of cell activity 
after 24 h. After 48 h cell activity increased again to levels similar to the ones of control 
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cells. Nanogels prepared with HRP and H2O2 did not affect cell activity and viability 
negatively. The results show that during the course of incubation no cytotoxic 
compound was released and that the nanogels are cytocompatible (Figure 6.12) 
 
Cell Encapsulation 
Preliminary studies were performed to see the potential of cell encapsulation in HRP 
crosslinked hydrogel. Figure 6.13 clearly indicates the presence of living cells in the 
hydrogel even after 18 h of encapsulation.  
 
Figure 6.13: Fluorescence microscopic image of the cells encapsulated in the 
hydrogel after 2h (right) and after 18 h (left) with LIVE/DEAD staining. Green- and red-
color cells represent the living and dead cell, respectively. 
 
These first experiments show very high cell survival and proliferation rates, even 
without addition of adhesion sites. LIVE/ DEAD staining was performed to show the 
living cells stained with calcei n-AM (green color) versus the dead cells stained with 
ethidium homo dimer (EthD -1) (red color) by ﬂuorescence microscopy. These results 
suggest that the cell viability in the hydrogel is retained and they can further be 
investigated as scaffolds for tissue engineering. 
 
6.4 Conclusion 
In conclusion, this chapter for the first time reports enzymatically mediated 
cross-linking of a redox-sensitive, reversible hydrogel that can be degraded through 
mild chemical stimuli. HRP can be used for mild enzymatic cross-linking of 
thiofunctional polymers to hydrogels and nanogels without the need for addition of 
hydrogen peroxide and can be degraded through mild chemical stimuli. This allows 
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cleavage of the network under cytocompatible conditions. Suitability of enzyme to 
create hydrogels as well as nanogels is shown which could embed (bio-) functional 
moieties such as peptide sequences. Linking of low molecular weight compounds to 
the network demonstrates that this key (bio-) chemical novelty is not restricted to 
polymers. Self-encapsulation of the enzyme horseradish peroxidase (HRP) into the 
nanogels in functional form, is an extremely interesting aspect for drug delivery, 
sensing and catalysis, and is thus promising candidate as controlled delivery systems. 
Further HRP crosslinked hydrogels also showed potential for cell encapsulation which 
could be later exploited for tissue engineering purposes. 
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CHAPTER 7 
 
Biohybrid Nanogels by Crosslinking of Ovalbumin 
with Reactive Star-PEGs in W/O Emulsions 
 
Part of this work is published in Journal of Polymer Science Part A: Polymer Chemistry 
2012, 50, 4288. 
 
7.1 Introduction 
There has been a great deal of attention toward increasing the chemical 
diversity and the complexity of nanogels to design and tailor them for specific 
applications.1-3 One of the possible strategies is using biomolecules and synthetic 
polymers as building blocks for nanogel synthesis. This allows not only for production 
of biologically active material but also to introduce domains with high degree of spatial 
organization into the polymer based system. The biohybrid nanogel systems can offer 
several benefits. Apart from the tunable dimension and the rapid response, the high 
surface-to-volume ratio of nanogel with incorporated biomolecules like proteins makes 
it useful for sensorics and catalysis as it can load a large amount of compounds (single 
or multiple) within the gel network as well as on the surface, resulting in a variety of 
detection methods with respect to photonic/plasmonic intensity, energy distribution, and 
temporal distribution.4 As drug-delivery carriers they impart good stability, and 
reversible volume change in response to environmental stimuli, such as pH, 
temperature, and glucose level that are unprecedented for common pharmaceutical 
carriers.5 Thus biohybrid nanogels provide a platform based on synthetic polymers 
where the biomolecule can be immobilized by covalent bonding and inherit properties 
of both the synthetic polymer and the biomolecule (secondary structure, functionality, 
hydrophobicity and biocompatibility). A system based on PEG as synthetic unit has 
further known advantages in drug delivery as PEG enhances the solubility of 
hydrophobic drugs or carriers when conjugated with it. It enhances the physical and 
chemical stability of drugs and prevents aggregation of the drugs in vivo, as well as 
during storage.6,7 The main advantages of PEG based nanogel are reduced protein 
immunogenicity, increased residence time of particles in the body and reduced 
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enzymatic degradation. All these features ensure that the drug reaches the site of 
action and is its clearance from the body is prevented. Reactive star-PEG prepolymers 
have recently been used for the synthesis of variety of nanogels. Colloidal particles with 
average size of 100 nm were formed upon Michael-type conjugation between amine 
functionalities of bovine serum albumin (BSA) and vinyl sulfone end-groups of eight-
arm star-shaped PEG8 using phase separation method.  The prepolymer condensation 
concept based on chemical crosslinking methods for biohybrid nanogel synthesis by 
use of reactive polymers with pre-defined architecture, chemical composition and 
functionalities is particularly suitable for incorporating peptides and proteins in particles. 
The selection of reactive building blocks allows very exact adjustment of nanogel 
properties like ability to vary flexibly the swelling and mechanical properties of nanogels 
during crosslinking step. Since the crosslinking reactions can occur at very mild 
conditions, this is probably the best strategy to design biohybrid nanogels or to directly 
load polymer colloids with proteins or enzymes. 
This chapter focuses on nanogels that are constructed by immobilization of protein by 
crosslinking with reactive prepolymer in inverse miniemulsion and hence resulting in 
the formation of biohybrid nanogel. The polymer used was based on acrylate 
functionalized star shaped poly (ethylene oxide-stat-propylene oxide) (Acrylate-sP(EO-
stat-PO)). Two different types of nanogel particles were prepared; one by crosslinking 
the polymer in inverse miniemulsion via Michael addition of its acrylate group with 
PEG-diamine (model system) and the other with free lysine group of Ovalbumin 
(biohybrids), a chicken hen protein with a molecular weight of 45kDa. The purpose of 
making nanogels based on PEG-diamine was to optimize the reaction conditions 
(droplet size, stability of emulsion, reaction time, etc.) and compare their properties with 
the biohybrid nanogels prepared with Ovalbumin. 
Synthesis and characterization of the gel precursor, preparation of the nanogels, and 
their characterization regarding particle size, size distribution in solution and in dry 
state, swelling and chemical composition are herein presented and discussed. 
 
7.2 Experimental 
7.2.1 Materials and Methods 
Hydroxy terminated, six arm, star shaped poly (ethylene oxide-stat-propylene oxide) 
(sP(EO-stat-PO) with a backbone consisting of 80% ethylene oxide and 20% propylene 
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oxide (Mn=12000 g/mol, Mw/Mn=1.12) was obtained from Dow Chemicals (Terneuzen, 
NL). Prior to functionalization, sP(EO-stat-PO) was purified by precipitation in THF/cold 
diethylether as solvent/non-solvent system. n-hexane ( 99%, VWR), Span 80 (Sigma), 
Tween 80 (Sigma), α,ω-Bis-amino octa(ethylene glycol)(Mw: 368.5 g/mol ) (Iris 
Biotech), α,ω--Bis-amino 20(ethylene glycol)(Mw: 897.1 g/mol) (Iris Biotech), 
Polyoxyethylene bis(amine) (Mw: 3000 g/mol) (Aldrich), Poly(ethylene glycol)-bis-amine 
(Mw: 6000 g/mol) (Aldrich), Ovalbumin (Mw: 45,000 g/mol ,Sigma) HCl (38%, VWR), 
NaOH (97%, VWR), NaCl (99%, VWR) CaCl2 (96%, VWR) FeCl3 (97%, VWR) 
Ethanolamine (98%, Fluka), Tetrahydrofuran (99%, Sigma Aldrich) were used as 
received. Dry toluene, pyridine (>99%, Aldrich), acrylic acid anhydride (99%, 
Polysciences) were used without additional purification. BCA Assay kit (Thermo 
Scientific) Dialysis membrane (MWCO = 3.5 kDa, 25kDa and 100kDa) was purchased 
from Spectrum Laboratories. 
 
Fourier Transform Infra-Red Spectroscopy (FT-IR) FTIR spectra were recorded on a 
Nexus 470 FTIR spectrometer with an attenuated total reflectance adapter installed 
(Thermo Nicolet, Madison, WI) by photo acoustic method. The spectrum represents an 
average of 400 to 600 scans with CO2 peaks removed. 
 
Circular Dichroism Spectroscopy CD measurements were carried out with an Olis 
17 DSM; a Cary 17 monochromater was used with a spectral output of 184-260 nm. 
CD spectra were measured at protein concentrations of 0.5 mg/mL using a cell with 
0.090 mm light path in the wavelength range of 190-260 nm with a bandwidth of 2.00 
nm and with number of increments of 50 with an integration time of 20s. CD spectra 
were expressed in terms of mean residue ellipticity (deg cm2 dmol-1). The data 
presented is an average of 5 scans. 
ZetaPotential measurement Measurements were performed using a Malvern 
Zetasizer Nano ZS as a function of pH at 20°C. The electrophoretic mobility was 
measured and the zeta potential was calculated using Henry’s equation. ‘Expert 
System’ software was used for data interpretation. Disposable poly (styrene) cuvettes 
were used for measurement in water. 
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7.2.2 Synthesis of Acrylate Functionalized 6 arm sP( EO-stat-PO) 
The functionalization of 6 arm sP(EO-stat-PO) with acrylate groups was performed 
according to literature.9 In short, 17.11g (1.43 mmol) of 6 arm s(EO-stat-PO) was 
dissolved in 51 mL of dry toluene under N2 and 1.03 mL (13.02 mmol, 1.5 eq.) pyridine 
was added to it followed by drop wise addition of 1.28 mL (10.14 mmol, 1.3 eq.) of 
acrylic acid anhydride for 15 min. The reaction mixture was stirred at room temperature  
for 24 h and the reaction was performed under dark. After the reaction was complete, 
solvents were removed under vacuum. The product obtained was purified by 
precipitation in cold diethyl ether; this process was repeated several times. Yield of the 
final product obtained was 12.4 g (1.03 mmol, 72%). Degree of functionalization was 
determined by NMR. 
1H-NMR(400 MHz,CDCl3): δ = 1.14 (t, 108-H, H1); 3.2-4.0 (m, 964-H, H-3,4,5), 4.23 -
4.45 (m, 10-H, H2), 5.80 - 5.92 (m, 6-H, H7, cis), 6.07 - 6.20 (m, 6-H, H6), 6.38 - 6.48 
(m,6-H, H7, trans) ppm ; 13C-NMR(400 MHz,CDCl3): 70.6, 76.7 - 77.3 ppm ; THF 
,GPC: Mn/Mw = 1.10 
 
Scheme 7.1: Schematic representation of Michael type addition reaction of Acrylate-
sP(EO-stat-PO) with a) PEG-diamine and b) Ovalbumin. 
 
7.2.3 Synthesis of Acrylate-sP( EO-stat-PO)–PEG Diamine Nanogels 
Nanogels were synthesized by crosslinking of Acrylate-sP(EO-stat-PO) with PEG-
diamine (368.5 g/mol) (Scheme1a). The standard procedure for the synthesis of the 
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nanogel is as follows. A 5 vol% w/o miniemulsion was prepared by mixing the aqueous 
phase with Acrylate-sP(EO-stat-PO) (25 mg, 2.1 × 10−3 mmol, 12.5 × 10−3 mmol with 
respect to 6 acrylate functionalities) in 65 μL of phosphate buffer (pH 8) and organic 
phase consisting of Span 80 (6.5 × 10−4 mmol) and Tween 80 (9.0 × 10−3 mmol), 
having a HLB of overall 5.6, in 1.25 mL of n-hexane. After pre-emulsification the 
mixture was ultrasonicated using a Branson sonifier W450 with a ¼  horn at duty cycle 
of 40% and amplitude of 360W for 60 s under ice cooling. The sonication was 
performed under ice cooling to prevent the solution from being heated up during the 
course of sonication. After 60 s of sonication PEG-diamine 368.5 g/mol (2.3 mg, 12.5 × 
10−3 mmol dissolved in 20 μL of pH 8 buffer was added to initiate the crosslinking and 
the solution was sonicated for another 60 s. After sonication the emulsion was stirred 
for 25 min at room temperature. To separate the formed nanogels from the emulsion, 
the emulsion was centrifuged for 30 min at a speed of 10000 rpm. The organic rest was 
decanted and the settled nanogels were washed with 1 ml of THF twice and later 
dispersed in water. Further the nanogels were purified by dialysis (MWCO 25 kDa) for 
24h. 
Utilizing the procedure described above nanogels were synthesized by using PEG-
diamine with four different spacer lengths of 8 (368.5 g/mol), 20 (897.1 g/mol), 67 (3000 
g/ mol) and 135 (6000 g/mol). Preparation of nanogels was carried out according to 
standard procedure. To investigate the effect of sonication parameters like output and 
duty cycle on size of Diamine nanogels, synthesis with output of 200W, 280W and 360 
W with Duty cycles of 30, 40, 50 and 60% were carried out. 
 
Fourier Transform Infra-Red Spectroscopy (FT-IR)  
PEG-diamine (Mw : 368.5 g/mol): IR(KBr): v = 3365 [s, vas NH2], 3302 [s, vs -NH2], 
2868 [s, v(CH2, CH3)], 2131 (w), 1600 [s, δ -NH2], 1455 (s), 1349 (s), 1109 [vs, v(-C-O-
C-)], 993 (s), 948 (s), 850 (w, v NH2 (wag)), 523 (w). 
Diamine nanogel: IR (KBr): v = 3351 (s, vas NH), 2924 (s), 2858 [s, v (CH2, CH3)], 
1763 [m, v(-CO-)], 1458 (s), 1112 [vs, v (-C-O-C-)], 951 (w), 723 (w, δ, NH), 532 (w). 
Acrylate -sP( EO-stat-PO): IR (KBr): v = 3576 (w), 3514 (w), 2868[s, v (CH2, CH3)], 
1964 (w) , 1724 [m, v (-CO)], 1635 [w, v (-C=C)-], 1456 (s), 1349 (s), 1296 (s), 1250 (s), 
1109 [vs, v (-C-O-C-)], 1042 (s), 995 [s, δ (Rs-CH=CH2)oop], 950 [s, δ (R-
CH=CH2)oop], 880 (s), 847 (s), 812 (m), 663 (w), 523 (m). 
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7.2.4 Synthesis of Acrylate-sP( EO-stat-PO) - Ovalbumin Nanogels 
It has been reported in literature 10 that Ovalbumin has 20 lysine groups out of which 15 
are on the surface. Calculation of amount of Ovalbumin required to crosslink Acrylate-
sP(EO-stat-PO) was done taking into consideration these 15 lysine groups 
 
Table 7.1 Amount of Acrylate-sP(EO-stat-PO) and Ovalbumin used for nanogel 
preparation 
Molar Ratio 
[mol:mol] 
Acrylate-sP(EO-stat-PO) 
[mg] 
Ovalbumin  
[mg] 
1.0:0.05 25 1.87 
1.0:0.1 25 3.75 
1.0:0.2 25 7.50 
1.0:0.3 25 11.25 
1.0:0.4 25 15.0 
1.0:0.5 25 18.75 
1.0:0.75 25 28.12 
1.0:1.0 25 37.50 
 
Keeping the same procedure as Acrylate-sP(EO-stat-PO)-diamine nanogels, 
Ovalbumin nanogels with a molar ratio of 1.0:0.05, 1.0:0.1, 1.0:0.2, 1.0:0.3, 1.0:0.4, 
1.0:0.5, 1.0:0.75 and 1.0:1.0 with respect to 6 acrylate group of Acrylate-sP(EO-stat-
PO) to 15 free lysine of Ovalbumin were synthesized. The actual amounts are given in 
Table 7.1. Quantification of Ovalbumin in nanogels was done by standard BCA 
assay.11 
 
Fourier Transform Infra-Red Spectroscopy (FT-IR)  
Ovalbumin: IR(KBr): v = 3297 [vs, v(-NH intramol. H-bond)], 3077 [w, v (OH)], 2962 [w, 
v (-CH)],1652 [vs,v(C=O), δ(OH)], 1540 [s, v(C=N), v(NH)], 1452 [vw, δ (CH)], 1397 [w, 
δ(CH)], 1312 (vw), 1239 [vw, δ(NH)]. 
Ovalbumin nanogel: IR(KBr): v = 3299 [vs, v(-NH intramolecular. H-bond)], 2925 (s), 
2854 [s, v(CH2, CH3)], 1738 [m, v(-CO-)], 1654 [vs, v(C=O), δ(OH)], 1537 [s, v(C=N), 
δ(NH)], 1456 [m, v(-C-O-C-)], 1100 [s, v (-C-O-C-)], 952 (w). 
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Raman Spectroscopy  
Acrylate-sP(EO-stat-PO) : Raman shift: v = 2933 (s), 2874 (s), 1724 [w, v(C=O)], 1636 
(w), 1470 (m), 1285 (m), 1136 (m). 
Ovalbumin: Raman shift: v = 2933 (s), 1666 [s, v(C=N), Amide I mode], 1605 [m, 
v(CC), phenyl stretching mode], 1448 [s, δ (CH2, CH3) scissoring mode], 1339 [m, 
v(C=N), Amide III mode], 1003 [s, v (CC), phenyl stretching mode]. 
Ovalbumin nanogel: Raman shift: v = 2928 (s), 1739 [w, v(C=O)] 1655 [s, v(C=N), 
Amide I mode], 1444 [s, v(CH2, CH3) scissoring mode], 1302 [m, v(C=N), Amide III 
mode], 1003 [s, v(CC), phenyl stretching mode]. 
 
7.2.5 Influence of pH on Nanogel Size and Zetapotential  
Influence of pH on size and zeta-potential of Diamine and Ovalbumin nanogel was 
investigated. For all the measurements disposable polystyrene cuvettes were used. 
The pH was maintained by addition of HCl or NaOH. Measurements were carried out at 
20°C. For size measurement each sample was measured for 15 runs, each run with 15 
repeat cycles. For zetapotential measurement 100 scans were made for each sample. 
Dialysed nanogels with a concentration of 5mg/ml were used for all measurement. 
 
7.2.6 Influence of Mono and Multivalent Salts on Nanogels Size and Zetapotential 
Influence of 0.1M NaCl, CaCl2 and FeCl3 at pH 5.5 on size and zeta-potential of 
Diamine nanogel was investigated. 0.1M solution of M NaCl, CaCl2 and FeCl3 was 
prepared and nanogels were dispersed in different salt solutions so that the final 
concentration of the nanogel was maintained at 5mg/ml. 
 
7.2.7 BCA Assay 
A working reagent (WR) which was a mixture of bicinchoninic acid and sodium tartrate 
in 0.1 M sodium hydroxide plus 4% cupric sulfate was prepared in the ratio of 50:1 as 
described in the protocol.11 Range of Bovine Serum Albumin (BSA) standards were 
added to the WR in the ratio of 1:20 keeping the final concentrations of BSA to 0, 5, 25, 
50, 125 and 250 μg/mL. Thereafter, the standards were incubated at 60°C for 30 
minutes and then cooled back again to room temperature. To assure accuracy of the 
test, absorbance at 562 nm was measured for all samples within 10 minutes of cooling. 
The absorbance measurement of the blank standard was subtracted from the rest of 
the samples and the absorbance value was plotted against the concentration. A linear 
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fit was applied and the slope obtained was 0.00248. Bicinchoninic acid (BCA) assay 
was performed on Ovalbumin nanogels for the determination of mass of Ovalbumin 
crosslinked in nanogels. Acrylate-sP(EO-stat-PO)-Ovalbumin nanogels were 
centrifuged to separate them from the aqueous medium. The supernatant (washing 
cycles repeated until there was no ovalbumin detected) was taken and the amount of 
Ovalbumin present in it was quantified by measuring the absorbance at 562 nm using 
UV-Vis spectrophotometer. The amount of Ovalbumin crosslinked in nanogels was 
determined by subtracting the mass of the Ovalbumin in the supernatant from the initial 
amount of Ovalbumin added in the recipe.  
 
7.2.8 CD spectra of Ovalbumin Nanogels  
CD spectra of nanogels with 1.0:0.3, 1.0:0.4, 1.0:0.5, 1.0:0.75, 1.0:1.0 molar 
equivalents of Acrylate-sP(EO-stat-PO) to Ovalbumin was recorded. The spectra were 
measured at Ovalbumin concentration of 0.5 mg/mL in Millipore water, using a cell with 
0.090 mm light. The values presented are average values of five scans for each 
measurement. 
 
7.3 Results and Discussion 
A variety of tests with PEG-diamines and Acrylate-sP(EO-stat-PO) were made 
before using an actual protein to optimize the conditions for Michael addition reaction. 
The influence of different parameters like pH, different ions, sonication setting and 
spacer length, i.e. molecular weight of the PEG-diamine, on size and polydispersity of 
the nanogels were tested. 
 
Diamine Nanogel  
First, preparation of PEG-diamine (368 g/mol) crosslinked particles from Acrylate-
sP(EO-stat-PO) polymers by Michael type addition in inverse miniemulsion is 
discussed. Generally, Michael type addition proceeds through the deprotonated of 
amine group (Scheme 7.1). Thus, in order to maintain slightly basic reaction 
conditions, 0.04M PBS buffer (pH=8) was used as a dispersed phase. Furthermore, the 
ionic strength of PBS served as osmotic agent in the droplets to stabilize them against 
Ostwald ripening.  
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Table 7.2 Influence of sonication parameters on hydrodynamic diameter and 
polydispersity index of Acrylate -sP( EO-stat-PO)-PEG diamine nanogel  
 
 
Duty 
Cycle 
[%] 
Output 
200 W 280 W 360 W  
Diameter 
[nm] 
PDI 
 
Diameter 
[nm] 
PDI 
 
Diameter 
[nm] 
PDI 
 
30 360±12 0.565±0.008 280±21 0.595±0.012 280±19 0.460±0.020 
40 360±19 0.642±0.011 280±22 0.636±0.019 280±21 0.444±0.021 
50 300±15 0.670±0.016 280±28 0.570±0.020 280±22 0.440±0.013 
60 400±20 0.580±0.020 360±12 0.482±0.021 300±30 0.452±0.014 
 
To optimize the sonication magnitude, Diamine nanogels were synthesized with an 
output of 200, 280 and 360 W. The ultrasonic energy was pulsed using the Duty Cycle 
Control with 30, 40, 50 and 60% in order to obtain uniform nanogels. In pulsed mode, 
ultrasonic vibrations are transmitted to the solution at a rate of one pulse per second. 
Particles were analyzed via dynamic light scattering (Table 7.2). 
On comparing the results for different duty cycles it was observed that with increasing 
duty cycle the hydrodynamic diameter was decreasing from 30 to 50% but duty cycle 
above 50 % showed start of aggregation rather than further decrease of size. This 
result was consistent with an output of 200W, 280W as well as for 360W. This 
observation could be attributed to bulk thermal heating caused due to increase of 
power as violent collapse of cavitation bubbles in an ultrasonic field result in extremely 
high local temperatures. Duty Cycle of 50% appeared to be threshold while an output 
difference of 80 W in the measurements did not influence the particle size significantly. 
However, to avoid harsh sonication condition while using protein medium, duty cycle 
(40 %) and a high power (360 W) appeared most relevant and this setting was kept 
throughout all experiments. 
Cryo-scanning electron microscopy (cryo-FESEM) and Cryo- Transmission electron 
microscopy (Cryo-TEM) were applied to characterize the nanogel particle size in water, 
i.e. in the swollen state, and Transmission electron microscopy (TEM) was used as a 
characterization technique for dry particles. Figure 7.1 shows the cryo-FESEM, cryo-
TEM and TEM analysis of Acrylate-sP(EO-stat-PO)-Diamine nanogels. Particle size 
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analysis with DLS (Table 7.2) gave the z-average particle diameter of 280 nm with a 
PDI of 0.44. 
 
Figure 7.1: a.) Cryo-FESEM, b.) Cryo-TEM c.) TEM (lateral view) d.) TEM (vertical 
view) images showing Acrylate-sP(EO-stat-PO)-Diamine (368.5 g/mol) nanogels 
prepared at duty cycle of 40 % and amplitude of 360 W. 
 
Cryo-FESEM images clearly showed that the particles had well-defined spherical 
shape, as expected for particles synthesized by miniemulsion techniques, with particle 
diameters d in the range of 230 nm < d < 350 nm. Taking into account the freezing-step 
that might have led to partial volume loss of the nanogels during cryo-FESEM, these 
two techniques correlated well with each other with respect to size analysis of the 
nanogels in the hydrated state.  
While DLS and cryo-FESEM correlated quite well with respect to particle size, cryo-
TEM showed an increase of particle size to 500 nm < d < 700 nm although the particles 
were well defined and appeared spherical. To view into detail the morphology of the 
particles, particles were viewed under TEM in dry state. Figure 7.1c and 7.1d shows 
TEM topography images of isolated nanogels in a vertical and a lateral view.The 
picture demonstrates that the nanogels had a fuzzy interface which is indicative of high 
water content and soft particles. They were deformable and adopted a flattened, oblate 
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spheroid shape on the copper grid which apparently gives the perception of increased 
hydrodynamic diameter. 
Figure 7.2 shows a comparison of IR spectra of Diamine nanogel with PEG-diamine 
and Acrylate-sP(EO-stat-PO). The spectrum of PEG-diamine shows two distinct 
bands at 3302 and 3365 cm-1 characteristic of symmetrical and unsymmetrical N-H 
stretch of primary amine, while its N-H bending vibration is observed at 1600 cm-1 
which is in close proximity to C=C stretch of Acrylate-sP(EO-stat-PO) at 1635 cm-1. 
When these two spectra are compared with the spectra of the nanogel only a single 
band at 3351 cm-1 is observed which is characteristic of N-H stretching vibration of 
secondary amine while the bands at 1600 and 1635 cm-1 have disappeared. A strong 
N-H wag band at 735 cm−1 can also be observed in the spectrum of nanogel which 
gives a clear indication of the secondary amine formation and confirms the Michael 
addition reaction for the formation of nanogels. The Raman spectra in this case were 
not very helpful as no significant differences could be observed. 
 
Figure 7.2: IR spectrum for Diamine nanogels with 1.0:1.0 molar ratio of PEG-diamine 
(368.5 g/mol) and Acrylate -sP( EO-stat-PO) (1), PEG-diamine (2) and Acrylate -sP( 
EO-stat-PO) (3). 
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Nanogels Prepared with Diamines of Different Spacer Length 
 
Table 7.3 Influence of spacer length on hydrodynamic diameter of the Diamine nanogel 
PEG-diamine 
[g/mol] 
Diameter 
[nm] 
PDI 
 
368.5 310±12 0.423±0.009 
897.1 300±20 0.435±0.010 
3000 260±23 0.303±0.015 
6000 180±8 0.383±0.017 
 
Particle size analysis of Diamine nanogels in aqueous solution (pH 5.5) are shown in 
Table 7.3. It was observed that with increased spacer length, the nanogel size 
decreased while the size distribution stayed about the same. This could be due to the 
effect where longer PEG chains help to stabilize the emulsion and hence result into 
smaller particles. 
 
Table 7.4 Influence of mono and multivalent salts on hydrodynamic diameter of 
nanogels prepared with diamines of different spacer length. 
 
Salt 
PEG-diamine 
368.5 g/ mol 897.1 g/mol 3000g/mol 6000g/mol 
Diameter 
[nm] 
PDI 
 
Diameter 
[nm] 
PDI 
 
Diameter 
[nm] 
PDI 
 
Diameter 
[nm] 
PDI 
 
- 310±12 0.423 
±0.009 
300±20 0.435 
±0.010 
260±23 0.303 
±0.015 
180±8 0.383 
±0.017 
NaCl 230±21 0.327 
±0.011 
240±17 0.468 
±0.010 
220±12 0.482 
±0.016 
160±22 0.383 
±0.023 
CaC2 175±24 0.232 
± 
0.007 
180±13 0.479 
±0.028 
160±14 0.152 
±0.017 
120±19 0.224 
±0.019 
FeCl3 50±23 0.249 
±0.013 
50±10 0.212 
±0.020 
40±16 0.290 
±0.032 
40±12 0.305 
±0.009 
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DLS measurement data of nanogels with different spacer length in 0.1 M NaCl, CaCl2 
and FeCl3 solution shows a decreases of hydrodynamic diameter compared to the 
particle size in aqueous solution, while there is a difference of 40-60nm due to of Na (I) 
and Ca (II) ions on particle size, the effect of the Fe (III) ion is far greater as particle 
size is reduced to a sixth of the initial size in aqueous solution (Table 7.4). 
This trend was observed for all the Diamine nanogels regardless of the spacer length. 
The valence of ion affects the electrical double layer of the particles. They accumulate 
as counter ions in the electrical double layer and consequently compress it. The effect 
of Na+ was lower than Ca2+ and much lower than Fe3+ A trivalent Fe3+ ion compresses 
the double layer to a greater extent and hence reduces the particle size further. Zhao et 
al. also observed that with an increase in charge of the cation, the swelling capacity 
decreases.12  
 
Table 7.5 Influence of mono and multivalent salts on Zetapotential of nanogels 
prepared with diamines of different spacer length in aqueous solution and ionic 
solutions (pH 5.5, 0.1M) 
Salt 368.5 g/ mol 
[ mV] 
897.1 g/mol 
[mV] 
3000g/mol 
[mV] 
6000g/mol 
[ mV] 
- -30.3 -33.4 -36.3 -34.8 
NaCl -7.19 -8.87 -9.62 -8.90 
CaCl2 -2.67 -2.79 -2.90 -1.98 
FeCl3 2.03 1.15 -0.14 0.75 
 
From Table 7.5 it is seen that the zeta potential increases to become positive with 
increasing the valence of the cation at neutral pH. This is due to the ion to nanogel 
surface interaction which could be ranked in the following order Na+ < Ca2+ < Fe3+ 
corresponding to increasing Gibbs free energy of ion hydration which reflects the 
propensity of ion to interact with water molecule according to their volume to charge 
ratio hence the zeta potential change was observed from negative to positive as the 
valence of cation was increased.13, 14 
 
 
 
 146 
 
Table 7.6 Influence of pH on size and Zetapotential of Diamine nanogels  
(PEG diamine Mw: 368.5 g/mol) 
pH Diameter [nm] PDI Zetapotential [ mV] 
3 260 0.210 13.75 
4 265 0.232 3.56 
5 280 0.201 1.52 
6 280 0.206 -3.81 
7 300 0.263 -6.43 
8 310 0.254 -9.24 
9 310 0.278 -10.20 
 
Table 7.6 shows slight increase in hydrodynamic diameter of the particles with 
increasing pH with zeta potential ranging between 13.78 mV to -10.20mV. It has been 
shown that solvated ions may preferentially adsorb to a solvated surface, imparting a 
strong positive or negative charge to the surface. Poly (ethylene oxide) has been 
shown to preferentially adsorb hydroxide ion over hydronium ion over the surface.15 
Therefore in basic media the ion imparting a negative charge is hydroxide. These 
negative charges at elevated pH values are unlikely due to the hydrolysis of the ester 
group in Acrylate-sP( EO-stat-PO) since the zeta-potential measurements were 
performed from basic to acidic pH values and this negative charging was reversible. 
While the positive charge on the particles at lowers pH is supposed to be mainly due to 
the protonation of secondary amines in the nanogels  
 
Ovalbumin Nanogels  
Ovalbumin nanogels were prepared in the same manner as Diamine nanogels. 
Ovalbumin was taken in 0.05, 0.10, 0.20, 0.30, 0.40, 0.50, 0.75 and 1.0 molar 
equivalents. Particles prepared by using Ovalbumin as a crosslinker showed behaviour 
regarding dispersion stability very similar to Diamine nanogels. However, DLS 
measurements confirm that in water these nanogels possessed a narrower size 
distributions compared to Diamine nanogels with the z-average particle diameter in the 
range of 180 nm to 210 nm for different equivalents of Ovalbumin (Table 7.7). 
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Table 7.7 Hydrodynamic diameter and zetapotential of Ovalbumin nanogels with 
varying amount of Ovalbumin. 
Ovalbumin Molar 
Equivalents 
Diameter[nm] PDI 
Zetapotential*[mV] 
0.05 180 0.345 -30.2 
0.10 200 0.342 -29.2 
0.20 200 0.367 -31.4 
0.30 200 0.367 -30.6 
0.40 180 0.316 -31.7 
0.50 180 0.321 -30.1 
0.75 180 0.300 -29.8 
1.0 210 0.310 -30.9 
* pH=10 
 
Zetapotential of these nanogels are largely attributed to the presence of deprotonated –
COOH residue in Ovalbumin particularly at pH 10. Because of its positive charge in 
physiologic conditions, the primary amines are usually outward-facing (i.e. on the outer 
surface) of Ovalbumin; thus, they are accessible for conjugation without denaturing 
protein structure. Since native Ovalbumin contain compact hydrophobic cores, once the 
crosslinking is initiated, unfolding of Ovalbumin takes place which exposes the 
hydrophobic segments and collapse of particle size occurs in hydrophilic environment. 
This explains the almost constant hydrodynamic diameter of the particles even with 
increasing Ovalbumin equivalents. 
As seen from the cryo-FESEM and cryo-TEM images (Figure 7.3 a, b), the particles 
have well-deﬁned spherical shapes with particle diameters d in the range of 150 nm < d 
< 250 nm. These two techniques correlate well with the particle size what is obtained 
with DLS. In the TEM mode (Figure 7.3c) nanogels show a sharp interface and 
particles appear to be stiffer compared to Diamine nanogels which could be caused 
due to the hydrophobic nature of Ovalbumin. 
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Figure 7.3 a: Cryo-FESEM b.Cryo-TEM and c.TEM images showing Acrylate-sP(EO-
stat-PO)-Ovalbumin nanogels in the ratio of 1.0:1.0 molar equivalents of Acrylate-
sP(EO-stat-PO) and Ovalbumin. 
 
To determine the loaded amount of Ovalbumin in nanogels, BCA assay was performed. 
It is an easy way to determine protein concentration in the use of a bicinchoninic acid 
(BCA) assay. The advantage of this method is its accuracy, easy handling and less 
interference with common disturbing compounds. The BCA protein assay uses two 
reagents, a BCA detection reagent and a 4% copper sulfate solution, which are mixed 
together prior to use in a 50:l ratio.  
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Step 1: Biuret reaction - Reduction of copper ion from cupric to cuprous, in presence of 
protein in alkaline environment 
BCA is a reagent specific for the cuprous ion (Cu+). It is assumed /postulated that Cu2+ 
existing in the alkaline medium, is reduced by protein when the peptide bonds of a 
protein forms a blue coloured complex with the copper atoms. 
 
Step 2: Reaction of BCA with cupreous ions 
 
Scheme 7.2: Schematic of BCA assay reaction 
 
Cu+ then reacts with two bicinchoninic acid molecules to form an intense purple-colored 
chelated complex. This BCA/Cu complex is water soluble and absorbs light at a 
wavelength of 562 nm. The intensity of this absorption increases linearly with 
increasing protein concentration allowing quantification of protein in solution 
spectrophotometricaly.  
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Table 7.8 Amount of Ovalbumin loaded in Ovalbumin nanogel estimated via BCA 
assay 
 
Working reagent for the assay was prepared as described. To assure the accuracy of 
the test the absorbance at 562 nm was measured for all samples within 10 minutes. 
The absorbance measurement of the blank standard was subtracted from the rest of 
the samples and the absorbance value was plotted against the concentration. A linear 
fit was applied to find out the concentration of the unknown samples 
It was confirmed from the results (Table 7.8) that Ovalbumin is crosslinked and not 
adsorbed as we assume that all non bonded Ovalbumin was removed during repeated 
centrifugation and later by dialysis using a dialysis membrane with a MWCO of 
100,000. With increasing amount of loadings a maximum of 48w/w% of Ovalbumin with 
respect to Acrylate-sP(EO-stat-PO) was achieved. The Raman spectra peaks at the 
wavelength 1003 cm−1 are stronger for nanogels prepared with 1.0 eq and 0.75 eq 
Ovalbumin which correlates to the data obtained by the BCA assay. The rapid 
decrease of the Ovalbumin loading efficiency at high Ovalbumin concentrations in 
aqueous droplets can be explained by non-sufficient crosslinking by acrylate-PEG. In 
this situation non-crosslinked Ovalbumin is removed from the nanogels during 
purification step. 
Acrylate-
sP(EO-stat-
PO) [mg] 
Molar 
Equivalents of 
Ovalbumin 
Ovalbumin in recipe 
[mg] 
Ovalbumin 
Loaded 
 [mg] 
Percentage 
Loading 
 [%] 
25 0.05 1.87 1.70 91 
25 0.10 3.75 3.43 92 
25 0.20 7.50 6.68 89 
25 0.30 11.25 6.75 60 
25 0.40 15.0 7.60 51 
25 0.50 18.75 8.10 43 
25 0.75 28.12 10.13 36 
25 1.0 37.50 12.01 30 
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Figure 7.4: IR spectra of Ovalbumin (1) Acrylate-sP(EO-stat-PO) (2) Ovalbumin 
nanogels in the ratio of 1.0:0.50 (3) 1.0:0.75 (4) 1.0:1.0 (5) molar equivalents of 
Acrylate-sP(EO-stat-PO) and Ovalbumin. 
 
IR spectra analysis was performed for Ovalbumin nanogels and was compared with 
Acrylate-sP(EO-stat-PO) and Ovalbumin. All Ovalbumin nanogels show characteristic 
peaks of the polymer and of the Ovalbumin compound. The peaks at 1108 and 2855 
cm−1 in the Ovalbumin nanogel samples show that the polymer was incorporated as 
these vibrations are of the PEG chain. The carbonyl group from Acrylate-sP(EO-stat-
PO) at 1737 - 1739 cm−1 could be seen present in all Ovalbumin nanogel samples. The 
vibrations for the methacrylate group at 1635 cm−1 in nanogels samples show a 
decreasing trend and almost disappear for 1:1.0 molar equivalents of Acrylate-sP(EO-
stat-PO) and Ovalbumin nanogel. While the peak of methacrylate group at 966 cm-1 
overlaps with Ovalbumin peak. Incorporation of Ovalbumin in the nanogels was clearly 
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seen by its characteristic peaks at 3297 - 3299, 1654 - 1655 and 1537 - 1540 cm−1 and 
966 cm−1 
 
Raman Analysis 
Raman spectra analysis was also performed for Ovalbumin nanogels and was 
compared with Acrylate-sP(EO-stat-PO) and Ovalbumin Raman spectra in order to see 
any change in secondary structure changes in Ovalbumin in the nanogel. Ovalbumin 
nanogels with three different equivalents of crosslinked Ovalbumin were analysed. For 
Ovalbumin molar equivalents lower than 0.5, the spectral changes were not very 
distinct so their analysis is omitted here. On comparing the Raman spectra for different 
Ovalbumin equivalents there was a clear indication that Ovalbumin was bonded to the 
polymer with changes in its secondary structure.  
 
Figure 7.5: Raman spectra of Ovalbumin (1), Acrylate-sP(EO-stat-PO) (2) Ovalbumin 
nanogels in the ratio of 1.0:0.50 (3) 1.0:0.75 (4) 1.0:1.0 (5) molar equivalents of 
Acrylate-sP(EO-stat-PO) and Ovalbumin. 
 
Ovalbumin has basically peptide bonds that repeat the conformation of the polypeptide 
backbone forming the secondary structure, like α-helix, β- pleated sheet and random 
coil. From literature15 it is known that these three contributions are observed in Raman 
spectra as a large band centered at 1665 cm-1 through the amide I and amide III 
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contribution. The amide I and amide III modes for the α-helix structure shows a peak at 
1658-1640 cm−1 and 1310-1260 cm−1 respectively. 
For the β-sheet the amide I and amide III modes show peak at 1680-1655 cm−1 and 
1242-1235 cm−1 respectively while for random coil Amide I and Amide III are at 1666-
1660 cm-1 and 1250-1240 cm-1. The phenyl stretching bands at 998, 1027 and 1602 
cm-1 present in the Raman spectra indicates the aromatic amino acids residues of 
Ovalbumin. Since the α-helix, β-sheet and random coil Amide I and Amide III bands lie 
very close to each other, to get a clearer insight into the changes, Circular Dichromism 
Spectroscopy was performed. 
 
Figure 7.6: CD spectra of Ovalbumin before and after crosslinking in a nanogel. 
 
Ovalbumin contains 33 % α- helix, 5 % β-sheet and 62 % random coil in its native form. 
The changes in the α-helix content of Ovalbumin were followed by monitoring the 
ellipticity at 222 nm. A minimum and a shoulder were observed for native Ovalbumin at 
222 nm and 210 nm, respectively. When Ovalbumin was crosslinked, the ampli tude at 
222 nm was attenuated and the shoulder at 210 nm got amplified. The change in CD 
spectra with amount of Ovalbumin in nanogel suggests that the change in the 
secondary structure of Ovalbumin progresses with increase in crosslinking. Increase in 
crosslink density significantly amplified the negative deflection in the region between 
210 and 220 nm. For model peptides and proteins of known three-dimensional 
structures, the helical structure gives minima in CD spectra at 222 and 208 nm and the 
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β-sheet structure gives minimum at 216 nm while a random coil at 200 nm.16 α- helical 
content Fh, of Ovalbumin can be estimated from the mean residual ellipticity at 222 nm, 
θ 222 (in deg.cm
2.dmol-1), using the following equation.17 
Fh = (θ 222 – θc) / (θ h – θc) 
were θh and θc are respectively the mean residual ellipticity values determined for the 
fully α- helical and fully disordered ( random coil ) polypeptide. If values of -36,00018 
and -280 deg.cm2.dmol-1 19are substitute for θh and θc respectively, the α- helical 
content in unmodified Ovalbumin and Ovalbumin –nanogels can be calculated (Table 
7.9). 
 
Table 7.9 Percentage of α- helix in Ovalbumin nanogel with increasing Ovalbumin 
content 
Molar Equivalents of 
Ovalbumin 
θ 222 (deg.cm
2.dmol-1) 
% α- helix 
Ovalbumin -10984.010 30.0 
0.30 -10268.288 28.0 
0.40 -9036.351 24.5 
0.50 -8030.937 21.7 
0.75 -6873.476 18.5 
1.0 -5681.097 15.1 
 
It is seen from Table 7.9 that with increase of Ovalbumin amount in nanogels, the α-
helical content decreases from 30% in case of unmodified Ovalbumin to 15% for 
1.0:1.0 molar ratio nanogel, showing the increase in crosslink density of Ovalbumin in 
the nanogels with its increasing molar ratio. 
To test whether the size of the Ovalbumin nanogel changes in different pH buffers, the 
hydrodynamic diameter of Ovalbumin nanogels with 1.0 molar equivalent of Ovalbumin 
was measured by DLS. It can be observed (Table 7.10) that the size of the Ovalbumin 
nanogels does not increase by any change in pH. 
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Table 7.10 Influence of pH on size and zetapotential of Ovalbumin nanogels 
pH Z-average 
[ nm ] 
PDI 
 
Zetapotential 
[mV] 
3 200 0.207 12.00 
4 200 0.191 2.01 
5 220 0.224 -1.11 
6 220 0.245 -2.24 
7 220 0.206 -7.76 
8 220 0.215 -9.34 
9 220 0.231 -9.29 
 
Looking at the zeta potential of the Ovalbumin nanogels, same zeta potential trend 
which has already been determined for the Diamine nanogels is seen. The Ovalbumin 
nanogels display a positive charge in acidic buffers and a negative charge in basic 
buffers caused by deprotonation of functional groups inside the nanogel network. The 
data also suits to the zeta potential trend which is displayed by Ovalbumin colloids 
alone 20 with an isoeletric point (pI) of 4.6 which is very close to the pI of native 
Ovalbumin at pH 4.9. 
 
7.4 Conclusion 
 In conclusion nanogels by crosslinking six-arm acrylate functionalized star 
shaped P(EO-stat-PO) with different spacer length PEG-diamine and the amine groups 
of the various amino acids of Ovalbumin was synthesized in inverse miniemulsion. The 
size of Diamine-nanogels could be tuned by change in spacer length of diamine, pH 
and cationic valency of the salts. The SEM analysis of particles confirmed that 
nanogels with a diameter of 230 nm < d < 350 nm were formed. The particles were soft 
and took a flat morphology in the dry state. IR spectroscopy data showed the efficient 
crosslinking of diamine to the star polymer. Biohybrid ovalbumin nanogels were 
synthesized with different equivalents of Ovalbumin. It was found that the size of the 
Ovalbumin nanogels was independent of the equivalent of star polymer to the 
Ovalbumin and pH. Microscopy images showed formation of well defined spherical 
particles with particle diameters d in the range of 150 nm < d < 250 nm. The CD 
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spectroscopy and BCA assay proved that the Ovalbumin has been effectively 
crosslinked. From the results of the BCA assay, it can also be concluded that there 
exists a limiting amount of Ovalbumin which can be incorporated into the nanogels. It 
was found that for 25 mg of polymer, up to 12mg of Ovalbumin can be bonded.  
As a result Ovalbumin nanogels represent an extremely interesting field of biohybrid 
nano-hydrogels prepared via simple and mild synthesis route. Introduction of synthetic 
as well as biomolecule into the system further enhances its versatility  
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CHAPTER 8 
 
Elastin Polypeptide Nanogels with Dual Stimuli 
Responsivity 
 
8.1 Introduction 
Elastin as a proteintaceous material with ~50 % of the total vascular ECM weight 
is the primary structural component underlying the elastomeric mechanical response of 
compliant tissues.1,2 It has thus vital role for appropriate function of tissues, especially 
skin, veins, connective tissue proper, and therefore has been involved in numerous 
studies aimed at unrevealing the relationship between its sequence and conformation, 
especially with regard to its influence on the mechanism of extension and recovery.3 Its 
unusual structure comprises of hydrophobic and cross-linked desmosine domains 
which are intellectual driving force for structural investigations of elastin to produce 
novel protein-based materials. Former domain has an abundance of repeating 
polypenta- and polyhexapeptide sequences, some of which are often defined as 
peptide mimetic of elasticity, while its  protein composition is mainly dominated by 
nonpolar amino acid residues, like glycine, proline, alanine, and valine.4 These 
hydrophobic pockets in elastin polypeptide induce reversible, temperature-dependent, 
hydrophobic assembly from aqueous solution resulting in spontaneous phase 
separation of polypeptide above a critical temperature or lower critical solution 
temperature) (LCST) which depends on elastin composition and as well as on its 
surrounding conditions.5,6 This process is called as coacervation and have similarities 
with analogous temperature phase behavior seen in thermo-responsive polymers like 
poly(N-isopropylacrylamide) and poly(N-vinylcaprolactam) as such.7  
Since elastin occurs in its functional chemical cross-linked network, unique functional 
properties of it led to produce solubilized elastin derivatives via scission of chemical 
bonds under relative hard conditions of acid-triggered (α-elastin) or base-triggered (β-
elastin) hydrolysis. Although these processes undoubtedly result in structural 
modifications,8 initial studies on solubilized derivatives provided the evidence of the 
thermally responsive behavior of elastin, preserved biological feature like maintaining 
cell recognition signals and information on its unusual amino acid composition.9-11 
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Soluble elastin derivatives are involved in the production of novel biomaterials, and the 
cross-linking generally performed over lysine chemically, stabilize the polymeric form of 
the protein so that resulting material can be produced in any desired shape and size.4  
Due to the unique functional properties stated above, elastin and its derivatives are 
promising candidates for use scaffolding materials in tissue engineering, in which 
critical properties such as phase behavior, macroscopic mechanical response, 
biocompatibility, and biodegradability are driving forces for introducing of elastin into 
novel emerging polymeric systems. Overall, tunable phase behavior of elastin presents 
an interesting opportunity for encapsulation and controlled release applications. In this 
context, numerous elastin-derivatives based systems were produced for delivery of a 
number of pharmaceuticals, DNA, and proteins.12,13 However, the immunogenicity of 
these materials has not been much explored.14 Beside the elastin like polymers (ELP) 
based nanoparticles, to the best of our knowledge; there is no report on chemically 
cross-linked native elastin based nanogels.  
In this sense, herein we report a novel biohybrid nanogels sy -
elastin polypeptides via facile inverse miniemulsion approach using two different 
amine-reactive cross-linkers; poly(ethylene glycol) diglycidyl ether (PEG-DGE) and 
bis(sulfosuccinimidyl) suberate (BS3). Nanogels were fabricated at various composition 
of precursors (elastin and cross-linker), and nanogel formation was evidenced by cryo-
SEM and dynamic light scattering (DLS). Thermo- and pH responsivity was explored by 
DLS measurements of the hydrodynamic radii of nanogels in water against respective 
stimuli. The experimental data revealed that the elastin nanogels were sensitive 
towards temperature changes with a volume phase transition of 37 and 35.5 °C and pH 
responsivity in the range of 5-7, for nanogels criosslinked with PEG-DGE and BS3 
respectively. Moreover, it was observed that these transitions were mainly influenced 
by cross-linker type and crosslink density. Elastase-triggered degradation profiles of the 
nanogels were explored by DLS measurements against time. Colloidal stability of the 
nanogels was investigated by sedimentation analysis. Texas Red conjugated dextran 
was used as a model drug to load the nanogels and its loading, release kinetics was 
investigated spectrophotometrically. The cytocompatibility test of the gels was 
performed using Human umbilical vein endothelial cells (HUVECs) up to 6 days.  
 
Nomenclature. In this work, cross-linkers; poly(ethylene glycol) diglycidyl ether and 
bis(sulfosuccinimidyl) suberate are respectively named as PEG-DGE and BS3, the 
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nanogels produced with these cross-linkers are named with cross-linker name, e.g. 
PEG-DGE nanogels for elastin nanogels prepared by PEG-DGE cross-linker. 
 
8.2 Experimental 
8.2.1 Material and Methods 
Elastin with molecular weight range of 10-60 kDa was purchased from Elastin 
Company (USA) dissolved in borate buffer (pH 9). Poly(ethylene glycol) diglycidyl ether 
(PEG-DGE) (MW= 526 g/mol) and bis(sulfosuccinimidyl) suberate (BS3) were 
respectively purchased from Sigma Aldrich (Germany) and Piercenet Biotechnology, 
Inc (USA). N-hexane (99%, VWR), Span 80 (Sigma), Tween 80 (Sigma), 
Tetrahydrofuran (99% Sigma Aldrich), Texas Red Dextran (MW= 70 KDa, Invitrogen) 
were used as received. Dialysis membranes (MWCO = 3.5 kDa, 25 kDa and 100 kDa) 
were purchased from Spectrum Laboratories. 
 
 8.2.2 Synthesis of Elastin-PEG DGE and Elastin-BS3 Nanogels 
Nanogels were fabricated via inverse miniemulsion method using aqueous phase in 
1.25 mL n-hexane containing surfactants (37.5 mg of 3:1 weight ratio of Span 80 and 
Tween 80) (Scheme 1). The aqueous phase consisted of 25 mg (4.166 × 10 -4 mmol) of 
elastin dissolved in 125 µL of 0.04 M PBS buffer (pH = 9). The organic and the 
aqueous phases were pre-emulsified by magnetic stirring for 10 min. Following the 
stirring, the system was ultrasonicated using a Branson sonifier W450 with a ¼  horn at 
duty cycle of 30% and output control of 90% under ice cooling. Cross-linking reaction 
was initiated by subsequent addition of PEG-DGE or BS3, and followed by a further 
sonication. Following this procedure, nanogels with various molar ratios of 1:2, 1:1.5, 
1:1 1:0.5 and 1:0.25 (elastin: cross-linker) were produced. The sonication times before 
and after the addition of cross-linker was kept constant to 60 s. The reaction was 
allowed to proceed further for 45 min at room temperature with constant sti rring 
followed by addition of 1.5 mL of acidic water (pH = 3). Separation of the nanogels was 
achieved by centrifugation at 10,000 rpm for 30 min with subsequent decantation of the 
supernatant. Nanogels present in the aqueous layer were then carefully washed with 
hexane (2 × 1.5 mL) and THF (4 × 2.5 mL) in order to remove the surfactants and 
unreacted elastin. The remaining organic solvents and acid were removed by dialysis. 
Purified nanogels were stored in Millipore water at 4 °C for further use.  
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 1:0.25 and 1:0.5 PEG-DGE and BS3 nanogels respectively were loaded with Dextran. 
Loaded nanogels were prepared in similar manner with a loading of 15 and 20 wt% of 
dextran with respect to elastin for each of the nanogels. During nanogels formation 
dextran was dissolved in aqueous phase of the miniemulsion while keeping the rest of 
the parameters as described above. After nanogel purification the amount of 
conjugated Dextran was quantified by means of UV-Vis method.  
 
8.2.3 Influence of Temperature on Nanogels Size. Thermoresponsivity of nanogels 
was investigated by DLS measurements as a function of temperature between 10 °C - 
55 °C. Hydrodynamic radius (Rh) values have been calculated through second order 
cumulative fit via Stokes-Einstein equation. In order to check the reversibility of the 
hydrodynamic radius with temperature transition, five heating and subsequent cooling 
cycles were performed at 20 °C and 44 °C. 
 
8.2.4 Influence of pH and Zeta-Potential. Influence of pH on size and on zeta-
potential of nanogel was investigated. The pH was maintained in the range of 3 - 10 by 
addition of 0.01 M HCl or 0.01 M NaOH. Measurements were carried out at 20 °C. For 
zeta-potential measurement 100 scans were made for each sample. Dialysed nanogels 
with a concentration of 5 mg/ml were used for all measurements. 
 
8.2.5 Influence of Temperature at pH 3 and 8 on Microgel Size. PEG-DGE and BS3 
nanogels with molar ratio of 1:0.25 were swelled at pH 3 and pH 8, and Rh was 
monitored as a function of temperature from 10 °C to 55 °C heating and 55 °C to 10 °C 
cooling. 
 
8.2.6 Sedimentation Analysis Sedimentation of nanogels was investigated with a 
LUMiFuge 114 separation analyser (L.U.M. GmbH, Germany). Measurements were 
performed in glass tubes at acceleration velocities of 500 - 3000 rpm at 20°C. The 
slope of the sedimentation curves was used to calculate the sedimentation velocity and 
the data further used to evaluate the colloidal stability of the samples. 
 
8.2.7 Drug Loading and Release Followed washing steps microgel particles were re-
suspended in 10 mL PBS buffer at pH = 5. The extracted amount Texas Red Dextran 
during the washing was subtracted from the final value to estimate the final loading 
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using a standard calibration curve by measuring the absorbance at 596 nm, of the non-
loaded dextran present in the supernatant and subtracting this value from the total 
amount of dextran used for loading. To study the release of loaded dextran, the 
nanogels were incubated at 20°C and 40°C in tubes. The tubes were then shaken at 
100 rpm on a shaker. At an interval time of 0, 1, 5, 10, 15, 25, 36, 48 and 72 h 
nanogels were centrifuged and then re-suspended in fresh buffer solution at respective 
temperatures. The release was monitored spectrophotometricaly for all the 
supernatants obtained from microgel sample. All studies were performed in triplicate 
and the release behaviour was analyzed in terms of cumulative ratio (%) of released 
dextran. The encapsulation efficiency% of dextran was calculated according to 
Equation 8.1. 
Encapsulation efficiency%  = (Dt / D0) × 100.                                        Eq. 8.1  
Where Dt = actual amount of the dextran in microgel and D0 = theoretical amount of 
dextran in microgel. 
 
8.2.8 Enzymatic Degradation 
Degradation of nanogels was performed in 5 mM elastase in PBS (pH = 8.8) at 37 °C. 
Assessment of reduction kinetics with in the presence of elastase was followed by 
measuring the hydrodynamic radius of the nanogels by dynamic light scattering after 
every 180 s for a total time of 24 h. 
 
8.2.9 XTT Cytotoxicity Test 
The XTT viability assay (Roche XTT Cell Proliferation Kit II, catalog no. 1465015) were 
performed according to the manufacturer`s guidelines. The gels were prepared on the 
bottom of 96-well polystyrene plates. Human umbilical vein endothelial cells (HUVECs) 
(10,000 per well) and 500 µL of 10% fetal bovine serum medium were added to the 
wells (1.77 cm2), and the mixtures were incubated in 5% CO2 at 37 
oC for 96 h. To halt 
the experiment, aliquots of XTT stock solution, 5 mg/mL, were added to the each 
experimental well group at a ratio of 50 µL/100 µL of medium. Experimental plates 
were incubated for 4 h, and samples (100 µL) from each well were transferred to 96-
well plates and quantified using a TECAN reader at a λ of 490 nm and a reference λ of 
655 nm. 
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8.3 Results and Discussion  
Elastin polypeptide nanogels were produced through inverse mini-emulsion 
technique using two different cross-linking routes shown in Scheme 8.1. In the first 
cross-linking approach, elastin microgel formation was carried out over epoxy ring 
opening reaction of diepoxide terminated PEG-based cross-linker at basic pH. In this 
case, basic pH of the polymerization media catalyzes the epoxy/amine reaction, and 
additionally, the reaction is also auto-catalyzed by the hydroxyl groups generated in the 
course of epoxy/amine reactions. 
 
 
Scheme 8.1: Schematic illustration of nanogels/nanogels formation from elastin 
polypeptides through inverse miniemulsion technique using two different chemical 
cross-linking reactions indicated.  
 
The overall mechanism was explained by Rozenberg et al (1986) over nucleophilic 
addition on the epoxy ring, proceeding with preliminary activation of the epoxy ring by 
amine, which acts both as an electrophilic and as a nucleophilic agent.15 In the second 
cross-linking route, cross-linking mechanism go over bis(Sulfosuccinimidyl)suberate 
(BS3) having terminal sulfonyl substituents. In aqueous media, sulfonyl terminal groups 
dissociate in water and N-hydroxylsiulfosuccinimide (NHS) esters at each end react 
predominantly with primary amine forming stable amide bonds through SN2 reaction in 
which the NHS acts as a leaving group. Elastin nanogels were produced with these 
cross-linking routes at different cross-linking compositions, and the effect of cross-
linking degree was determined through size changes on nanogels by DLS analysis. 
Relevant data as the molar ratio of cross-linker with respect to elastin are proved in 
Table 8.1 in which hydrodynamic radii of nanogels are shown at swollen state of 20 oC. 
For both type of cross-linking routes, nanogels with varied hydrodynamic radii in the 
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range of 170 - 890 with polydispersity index of about 0.50 were obtained, changes on 
size were remarkable and it was observed that the microgel size decreased with 
increasing cross-linking density. Lower molar ratio gave nanogels with higher 
hydrodynamic radius due to low cross-linking density and therefore pronounced 
swelling. For instance, eight fold increases in molar concentration of PEG-DGE and 
BS3 (1:2) respectively resulted in ~18 and ~86 folds volumetric decrease in nanogels. 
Since obtained nanogels are temperature responsive, the ratio of their hydrodynamic 
radii measured at 50 °C and 20 °C (Rh
50/Rh
20) reflects to some extent their swelling 
ability. Since in collapsed state nanogels may contain some water, the swelling ratio 
(Rh
50/Rh
20)3 is not equal to the swelling degree. To calculate (Rh
20/Rh
50)3 ratio we used 
average Rh values measured at respective temperature. Further more, we calculated 
swelling in [%] based on change of the hydrodynamic radius upon temperature change. 
As shown in Table 1, for both microgel types similar trend is observed, namely the 
swelling ratio increases with increase of the crosslinker amount, what means that 
microgel swelling ability is reduced due to the increase of the crosslink density. For the 
same elastin concentration with varying PEG-DGE amount the swelling - was around 
180-200% for molar ratio of 1:0.25, 1:0.5 and 1:1 while for 1:1.5 and 1:2 molar ratios 
the swelling % decreased to 150. In case of BS3-cross-linked nanogels 1:0.25 and 
1:0.5 molar ratio particles showed swelling up to 160 % while the nanogels with 1:1, 
1:1.5 and 1:2 molar ratios did not swell remarkably. The difference in hydrodynamic 
radius and swelling ratios of these two types of nanogels can be attributed to the 
different chemical structure of crosslinking agents. PEG-DGE exhibits water-soluble 
hydrophilic PEG spacer, therefore when this crosslinker integrated into microgel 
network it will enhance the swelling in water.  
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Table 8.1 Hydrodynamic radii as a function of cross-linker concentration. (PEG-DGE / 
BS3)  
Elastin : 
Crosslinker 
[mol:mol] 
PEG-DGE BS3 
Rh[nm]/PDI 
at 20°C 
Swelling 
Ratio, 
Vrel 
(Rh50°/Rh 
20°)
3 
Swelling 
% 
(Rh 
20°/Rh 
50°) × 
100 
S.V* 
[µm/s] 
Rh[nm]/PDI 
at 20°C 
Swelling 
Ratio, 
Vrel  (Rh 
50°/Rh 
20°)
3 
Swelling 
% 
(Rh 
20°/Rh 
50°) × 
100 
S.V* 
[µm/s] 
1 : 0.25 878/0.48 0.149 190 8.655 752/0.47 0.239 160 6.053 
1 : 0.5 735/0.47 0.114 206 8.466 431/0.48 0.232 160 6.156 
1 : 1 680/0.49 0.169 180 8.521 225/0.48 0.701 112 6.485 
1 : 1.5 370/0.47 0.265 150 8.232 215/0.38 0.768 109 6.595 
1 : 2 334/0.46 0.223 160 7.102 170/0.47 0.863 104 5.178 
*S.V = Sedimentation Velocity 
 
Contrary, BS3 exhibits short hydrophobic alkyl chain as a spacer, what may enhance 
hydrophobic interactions in microgel network and lead to smaller size and reduced 
swelling in water. Additionally, there is a strong difference in cross-linking mechanism 
of PEG-DGE and BS3 to elastin and their reaction kinetics. In case of BS3 based 
cross-linking, the reaction took place much faster than PEG-DGE based cross-linking. 
This was proved by bulk hydrogels level through rheological analysis revealed that the 
cross-linking was much faster for BS3 (data not shown). This difference in reactivity 
may lead to more efficient incorporation of BS3 into microgel network compared to 
PEG-DGE and finally to the reduction of the size and swelling degree of BS3-based 
nanogels. 
The morphology of nanogels was investigated by FESEM in cryo-mode to characterize 
the microgel size in water, i.e. in the swollen state. Nanogels prepared with elastin to 
cross-linker molar ratio of 1:2 are shown in Figure 8.1. Cryo-FESEM images clearly 
showed that the particles had well-defined spherical shape, as expected for particles 
synthesized by miniemulsion techniques, with particle diameters d in the range of 300 
nm < d < 550 nm for PEG-DGE and 200 nm < d < 300 nm for BS3 based cross-linking 
for 1:2 molar ratio nanogels. Taking into account the freezing-step that might have led 
to partial volume loss of the microgel during cryo-FESEM, DLS and FESEM correlated 
well with each other with respect to size analysis of the microgel in the hydrated state.  
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Figure 8.1: Cryo-FESEM images showing a) elastin-PEGDGE and b) elastin-BS3 
microgel in the molar ratio of 1:2 of respective precursors. 
 
Thermoresponsive Properties of Microgel.  
Thermoresponsivity of both type of elastin nanogels were investigated in aqueous 
solution by DLS in a temperature range of 10 °C to 55 °C. The relative change of 
hydrodynamic radii (Rh) as a function of temperature is shown in Figure 2 for both 
types of nanogels. As expected, elastin undergo a induced by temperature as external 
stimulus. The temperature sensitivity of the nanogels is provided by the phase 
transition temperature of the elastin chains, which occurs at approximately 37 °C (the 
lower critical solution temperature (LCST)).16 This phenomenon occurs due to the 
different solvation of elastin chains by water molecules at temperatures below and 
above the phase transition temperature, and is also influenced by the introduction of 
another co-monomer.17,18 It is believed that the volume phase transition in the microgel 
occurs as a result of reduced hydrogen bonding between water molecules and the 
peptide. The temperature at which this transition occurs is dependent on the sensitive 
hydrophobic/hydrophilic or entropy/enthalpy balance of the protein. Below VPT 
hydrophobic solvation results into undesired entropic changes which are compensated 
by the favorable entropy arising from peptide water hydrogen bonding. But as the 
temperature rises the hydrogen bonding weakens and the peptide chain contracts to 
compensate the effect of unfavorable entropic changes.19 
The temperature dependent hydrodynamic radius shows a continuous decrease when 
approaching the volume phase transition temperature (VPTT). As expected the 
nanogels with lower cross-linker content were more swellable, while the VPTT was 
nearly independent of the cross-linking density. Since the VPT of nanogels is affected 
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by cross-linking density, solvent nature, composition and type of the functional groups 
in the protein, incorporation of hydrophilic species increases and broadens the phase 
transition temperature while incorporation of hydrophobic group generally reduces the 
VPTT. Similar phenomenon was shown for N-isopropylacrylamide (NIPAM) with 
incorporation of hydrophilic co-monomer, acrylamide (AAm) in which the incorporation 
of AAm was significantly influenced the LCST to higher values.20, 21 
 
Figure 8.2: Hydrodynamic radius (Rh) of PEG-DGE (left), and BS3 (right) cross-linked 
microgel as a function of temperature (10°C – 55°C).  
 
Figure 8.2 revealed that VPTT of PEG-DGE nanogels was well defined for 1:0.25, 
1:0.5 and 1:1 while for 1:1.5 and 1.2 samples the transition was not observed. For BS3 
cross-linked nanogels the transition was only observed for 1:0.25 and 1:0.5 molar 
ratios. It was further seen that the VPT for PEG-DGE nanogels was around 37.5 °C 
which is quite close to that of free elastin22 while for BS3 nanogels the VPTT decreased 
and shifted to 35 °C which could be attributed to the introduction of hydrophobicity into 
the system because of the hydrophobic cross-linker and change in polarity balance 
caused by increased in cross-linking density. Also as the cross-linking density 
increased the temperature induced shrinkage decreased for both type of nanogels due 
to their restricted swelling.  
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Figure 8.3: Hydrodynamic radii (Rh) during repeated heating and cooling cycle for 
PEG-DGE (1:0.25, 1:0.5) and BS3 (1:0.25, 1:0.5) microgel between 20 °C and 44 °C.  
 
Four repeated heating and cooling cycles for 1:0.25 PEG-DGE and BS3 nanogels were 
performed at alternate temperatures; 20 °C and 44 °C and the relevant data are shown 
in Figure 8.3. Data reveals that the swelling/deswelling intensity was not weakened as 
the alternate temperature cycles increased. It was found that repeated heating and 
cooling did not significantly affect the Rh and PDI of the microgel. Thus ruling out the 
possibility of non-cross-linked free chains in the nanogels which could escape out of 
the microgel, subjected to such temperature cycling. 
 
Influence of pH and Zetapotential 
The pH sensitivity of the microgel was demonstrated by measuring the Rh in the pH 
range of 3 to 11. The ionization of -COOH group or -NH2 group in basic and acidic pH 
could result in increase of microgel size due to electrostatic repulsion and induced 
particle swelling. Figure 8.4 shows that pH dependent-hydrodynamic radii (Rh) changes 
for both nanogels prepared at different cross-linking density. It was observed that from 
pH 3 to pH 6 the microgel size decreased and then increased from pH 7 to 11 for PEG-
DGE nanogels while for BS3, the decreasing trend was from pH 3 to 7 and increasing 
from 8 to 11. 
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Figure 8.4: Change in hydrodynamic radius (Rh) as a function of pH 3-11 for a) PEG-
DGE (left) and b) BS3 (right) cross-linked microgel. 
 
pH switch was fully reversible in the particle owing to the gel nature of the system at 20 
°C for both type of nanogels. The fractions of positively and negatively groups in the 
microgel play an important role in swelling behavior thus making them amphoteric in 
character. Such nanogels swell at both high and low pH when they possess an excess 
of either positive or negative charge. This swelling is due to electrostatic repulsion and 
osmotic pressure created within the nanogels by the counter ions to the charged 
functional groups.23 The minimum size of the microgel is observed at pH were the net 
charge of the nanogels tends to be zero, that is, when the positive and negative 
charges in the nanogels are exactly balanced, defined as the isoelectric point (pI), and 
corresponds to their smallest size in the zwitterionic regime. In this region a large 
fraction of both cationic and anionic groups in the nanogels exist in their charged state. 
Hence ion pairing between them dominates over repulsion between un-paired like 
charges, leading to microgel shrinkage and a net reduction in charge. However 
flocculated nanogels could be easily re-dispersed by either increase or decrease in pH 
of the medium. It was observed that at low pH and high pH, the extent of swelling is 
enhanced by repulsion between protonated cationic groups and deprotonated anionic 
groups respectively. Two swelling regions on either side of the isoelectric point was 
observed with pronounced swelling at lower pH than at higher pH for lower mole ratio 
(1:0.25), which is believed to be due to outnumbering of –NH2 groups to –COOH 
groups in the protein. The swelling and deswelling of nanogels with high cross-linking 
density showed more symmetric profile. The pI for the PEG-DGE and BS3 nanogels 
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with respect to change in their hydrodynamic radius were in the range of 5-7 and 6-8 
respectively. 
 
Figure 8.5: Zeta-potential of PEG-DGE (right) and BS3 (left) microgel as a function of 
pH. 
 
Zeta-potential also followed the trend as the variation of microgel size with maximum 
value of zeta-potential observed at pH 3 which shows the dominance of Columbic force 
on variation of hydrodynamic diameter. The zeta potential approach to zero in the pH 
range of 5 to 7 with increasing the pH the zeta potential further decreases and 
becomes negative. The distribution of functional groups throughout the nanogels is also 
a very important parameter with determines the swelling extent and value of pI. These 
data coincide well with pH-dependent nanogels swelling at which minimum swelling 
was observed at pH range of 5-7 and 6-8 for PEG-DGE and BS3 microgel respectively 
(Figure 8.5). 
 
CD spectra The change in the α-helix content of Elastin was followed by monitoring the 
ellipticity at 222 nm for PEG-DGE and BS3 microgel with different molar ratios. In all 
the microgel system it was seen that on microgel formation the pure elastin underwent 
a conformational change, which was observed by change in the ellipticity of two 
negative bands near 222 nm and 208 nm. With increase in crosslinking the curves 
become distorted, and in general there was reduction of amplitude at 222 nm. The 
change in CD spectra also suggests that the change in the secondary structure of 
Elastin progresses with increase in crosslinking. 
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Figure 8.6: CD spectra of Elastin before and after crosslinking in a PEG-DGE and BS3 
microgel. 
 
For model peptides and proteins of known three-dimensional structures, the α-helical 
structure gives minima in CD spectra at 222 and 208 nm and the β-sheet structure 
gives minimum at 216 nm while a random coil at 200 nm.24 α- helical content Fh, of 
Elastin can be estimated from the mean residual ellipticity at 222 nm, θ 222 (in 
deg.cm2.dmol-1), using the following Equation 8.2.25 
Fh = (θ 222 – θc) / (θ h – θc)                          Eq. 8.2 
were θh and θc are respectively the mean residual ellipticity values determined for the 
fully α- helical and fully disordered ( random coil ) polypeptide. If values of -36,000 26 
and -280 deg.cm2.dmol-1 27 are substitute for θh and θc respectively, the- helical content 
in unmodified Elastin and Elastin nanogels can be calculated (Table 8.2). The results in 
Table 8.2 show a considerable conformational change with increase in crosslink 
density which could be due to inter and intra-molecular interactions causing changes in 
the homogeneous phase of elastin on crosslinking. 
 
Table 8.3 Percentage of α- helix content in PEG-DGE and BS3 nanogels 
Elastin / Nanogels θ 222 (deg.cm
2.dmol-1) % α- helix content 
Elastin -7925.52 21.4 
PEG-DGE 1:0.5 -5312.14 14.1 
PEG-DGE 1:1 -4126.05 10.8 
BS3 1:0.5 -2795.22 7.0 
BS3 1:1 -1005.31 2.0 
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Colloidal Stability of Nanogels To investigate the colloidal stability of amphoteric 
nanogels, sedimentation velocity measurements were performed on LUMIfuge which is 
a separation analyzer that allows detection of microgel sedimentation in a centrifugal 
field. Higher sedimentation velocity results in lower colloidal stability of particles. 
Amphoteric nanogels with 1: 0.25, 1: 0.5, 1: 1, 1: 1.5, and 1: 2 molar ratio of elastin to 
PEG-DGE / BS3 were analyzed at pH 5. From the Table 8.1 it could be seen that both 
PEG-DGE and BS3 nanogels exhibited high colloidal stability as reflected by low 
values of sedimentation velocity. PEG-DGE cross-linked nanogels exhibited higher 
values of the sedimentation velocity due to their larger size compared to BS3 nanogels. 
PEG-DGE and BS3 (1:0.25) nanogels were also analyzed as a function of pH. The 
experimental results (Table 8.3) show that both nanogels show lower sedimentation 
velocity (and better colloidal stability) in acidic and basic medium. Contrary, at pH 6 and 
7 the PEG-DGE- und BS3-crosslinked nanogels show sudden increase in 
sedimentation velocity due to charge neutralization and reduction of the colloidal 
stability. This is in a good agreement with DLS data presented in Figure 8.4 and zeta 
potential data (Figure 8.5). 
 
Table 8.3 Sedimentation Velocity Data as a function of pH 
Elastin : Cross-
linker 
(1:0.25) 
Sedimentation Velocity [µm/s] 
pH = 3 pH = 6 pH = 7 pH = 11 
PEGDE 3.913 37.453 1.378 6.984 
BS3 2.342 6.546 13.456 4.321 
 
Enzymatic Degradation of Nanogels 
Degradability of nanogels was investigated by DLS in the presence an enzyme 
elastase. Typical degredation profile was shown in Figure 8.6 for nanogels prepared at 
elastin/cross-linker molar ratio of 1: 0.25 were the y-axis corresponds to decrease in 
size in the presence of elastase at time‘t’. The particles were incubated with 5 mM 
elastase at 37 °C and pH 8.8. The dispersion contained 5 wt-% of dried microgel. The 
degradation effect is based on the cleavage of elastin chains between the cross-linking 
points by the enzyme and degradation leads to reduction of size with partial dissolution 
of elastin chain in water. In the early stages of enzymatic treatment the particles 
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showed increase in hydrodynamic diameter due to particle swelling caused by 
loosening of network. In case of BS3 particles with high cross-linking density the 
particle had smaller mesh size which decreased the accessibility of elastin chain in the 
network due to hindered diffusion of the enzyme into the network and lead to enzymatic 
degradation at the surface. Also the relatively large size of the enzyme (60 kDa) is 
assumed to hinder its diffusion into the particle resulting into incomplete particle 
degradation. At 37°C the activity of the enzyme is optimum while the particles are in the 
collapsed state, so degradation is presumed to proceeds mainly with surface erosion.28 
 
Figure 8.6: Degradability of microgel measured with change on the fractional ratio of 
hydrodynamic radius (fRh) as a function of time using 5mM elastase for PEG-DGE 
(1:0.25) (red) and BS3 (1:0.25) ( blue) cross-linked nanogels. 
 
Loading and Release 
Table 8.4 summarizes the loading and encapsulation efficiency of Dextran in four of 
these microgel systems: PEG-DE 1:0.25, 1:0.50 and BS3 1:0.25, 1:0.50. The 
temperature-triggered release of Dextran from loaded nanogels was examined at two 
temperatures one below VPTT (20°C) and other above VPTT (40°) of the nanogels at 
pH 5. At regular intervals the nanogels were centrifuged, followed by their immediate 
removed and separation from the supernatant. 
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Table 8.4 Loading and Encapsulation efficiency % for PEG-DGE and BS3 nanogels 
Elastin : 
PEG-DGE 
[mol:mol] 
Elastin : 
BS3 
[mol:mol] 
 
Dextran 
loading 
[wt% w.r.t 
Polymer] 
Dextran 
loaded 
[mg] 
Loading 
estimate
d 
[mg] 
Encapsulatio
n efficiency 
[%] 
Rh(nm)/PDI 
20°C 40°C 
1:0.25 - 15 3.75 2.41 64.2 890 
∕0.34 
510 
∕0.26 
1:0.5 - 15 3.75 2.89 77.2 750 
∕0.42 
470 
∕0.21 
- 1:0.25 15 3.75 2.75 73.3 765 
∕0.45 
450 
∕0.31 
- 1:0.5 15 3.75 3.01 80.3 456 
∕0.41 
320 
∕0.30 
 
The absorbance intensities of the supernatant were measured for each sample, and 
the concentration of Dextran released was calculated with the help of a calibration 
curve 
 
Figure 8.7: Temperature dependent release of dextran form for PEG-DGE 1:0.25, 
1:0.50 (left) and BS3 1:0.25, 1:0.50 (right) microgels at 20 and 40°C. 
 
Figure 8.7 shows the summarized results of these experiments for four microgel 
systems. An encapsulation efficiency of about 64% and 77.2% was obtained for PEG-
DE 1:0.25 and 1:0.50 nanogels. There was a slight increase in loading of 9% and 3% 
for BS3 1:0.25 and 1:0.50 nanogels. This result was used for the evaluation of the 
cumulative release of Dextran. For PEG-DE 1:0.25 and 1:0.50 nanogels, the amount of 
released drug after 24h at 20°C was 63 and 59%, while for BS3 1:0.25 and 1:0.50 
 175 
 
nanogels, the amount of released after same temperature and time interval was 63 and 
59%, respectively, this difference increased markedly at 40 °C to 86 and 77% for PEG-
DE 1:0.25 ,1:0.50 and 79 and 81% for BS3 1:0.25, 1:0.50. At this temperature, both 
types of nanogels show volume-phase transition and the larger release corresponded 
to a more pronounced shrinking effect occurring in this system (Table 8.4). The dextran 
released by the nanogels was directly related to the swelling state of nanogels. 
Although, a notable amount of Dextran was released before the onset of the VPTT, a 
significantly larger amount of dextran was released during the actual deswelling 
transition at 40°C. The slightly greater amount of released drug than for the BS3 
system was most likely due to the presence of hydrophilic PEG channels throughout 
the hydrophobic network at the transition temperature, which encouraged escape of the 
dextran. In these systems, the deswelling transition acts as a trigger that tends to 
squeeze out the loaded drug into the surrounding medium. 
 
Cytotoxicity 
The cytotoxicity of the BS3-elastin nanogels with molar ratio of 1:0.5 was investigated 
by XTT based cell proliferation assay and the results are summarized in Figure 8.8, 
where the samples showed initial little cytotoxicity and for further days; i.e. 6 days after, 
cell proliferation rate on samples were favourably comparable to the control proving 
that this microgel system is cytocompatible and can further use as in vitro or in vivo 
experiments intra-drug delivery as such. Similar and comparable results were 
obtainable for other microgel systems. 
 
Figure 8.8: Quantitative HUVECs proliferation in elastin gel system. 
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8.4 Conclusion 
        In this work hybrid microgels are synthesized by crosslinking of elastin with by 
amine-reactive cross-linkers; poly(ethylene glycol) diglycidyl ether (PEG-DGE) or 
bis(sulfosuccinimidyl) suberate (BS3) in W/O emulsion. Elastin microgels with various 
sizes and tunable properties were prepared and their properties were explored via 
cryo-SEM, Zetasizer, DLS, and separation analyser (LUMiFuge). Microgels showed 
dual responsive to temperature and pH. Elastase-mediated degradation and XTT-
based cytotoxicity assay evidenced that the resulting microgel were cytocompatible and 
the microgel network can degrade with elastase introduction. High loading of model 
drug dextran could be achieved for the microgels which showed a temperature 
dependent release behavior. Cytocompatible matrices, dual responsivity with further 
degradability with inherited elastin properties makes these microgels a intriguing 
candidate for drug delivery systems (DDS). 
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CHAPTER 9 
 
Radiolabeled Nanogels for Nuclear Molecular 
Imaging 
 
Part of this work is published in Macromolecular Rapid Communication DOI: 
10.1002/marc.201200744 
  
9.1 Introduction 
 
Currently, various types of nanoparticles (e.g. liposomes, nanospheres, 
nanocrystals) are available as tools for drug delivery.1 In recent years, also nanogels 
(nanometer sized hydrogel particles) have gained increased attention as drug delivery 
systems of biologically important molecules.2 These soft and hydrophilic particles have 
a three-dimensional crosslinked network retaining a large amount of water in the 
swollen state, and mimic biological fluids.3 Nanogels can be prepared from a variety of 
chemical structures either by polymerization of monomers or by modification of 
prepolymers to obtain particles with varying size, charge, and surface modification. In 
spite of attractive properties (especially the hydrophilic character combined with the 
retention of water), which promote their long stay in the bloodstream e.g. by avoiding 
the recognition by the mononuclear phagocyte system, there is only little known about 
their behavior in vivo.4 Nanogels based on polyethylene glycol (PEG) as key 
component let expect an additional reduced systemic clearance and increased blood 
circulation time, which has been demonstrated for PEGylated nanoparticles with 
reduced protein immunogenicity.5 Additionally, PEGylation is known to prevent the 
aggregation of nanogels in human plasma.6 
Selective (passive) targeting of macromolecular drugs to tumor tissue is made possible 
by the enhanced permeability and retention (EPR) effect in tumors.7,8 The quick growth 
of tumor cells results in abnormal tumor vessels with poorly-aligned defective 
endothelial cells. This wide fenestration enables the size-driven accumulation of 
macromolecules in tumor cells. The accumulation is increased due to the lack of 
effective lymphatic drainage in tumor cells, the preferred tissue clearance pathway of 
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macromolecules. Small molecules, like most of the anticancer agents, are able to 
penetrate any tissue, whereas macromolecules are not able to diffuse through the 
endothelia cells of normal tissue. Due to the reduction of the systemic side effect the 
EPR concept is now widely accepted as a gold standard for anticancer drug designing 
using macromolecular drugs. 
The use of nanogels as nanocarriers in drug development requires detailed knowledge 
about their biodistribution, pharmacokinetic, and the metabolic pathways of the original 
and degraded probe in vitro and in vivo. Such information can be accessed by 
investigating the influence of size, charge and surface modifications of nanogels via an 
in vivo imaging technique. Among various techniques including MRI, CT, NIR, SPECT 
and PET, the latter has the advantage of monitoring bio-pathways with non-toxic trace 
amounts (in the nmol range) of the probe. This allows an in vivo estimation of the 
biodistribution of biomarkers with high sensitivity and is applicable in animals and 
humans.9 
Although various polymeric materials such as polymers10,11 and nanoparticles12-14 have 
been radiolabeled, investigation using radiolabeled nanogels is limited to (pullulan or 
poly(isopropylacrylamide-co-vinylpyrrolidone)) nanogels as nanocarrier system loaded 
with a radiolabeled drug.15,16 After unloading of the radiolabeled drug in vivo (carrying 
the radionuclide as signal for detection) these constructs are not able to provide the 
essential basic information of the fate of the nanogel. Radiolabeling of macromolecules 
is often performed in aqueous medium by means of metal-chelators attached to the 
macromolecules (usually at the surface) resulting in very high radiochemical yields.17  
The porous nature of the nanogel also allows radiolabeling inside of the crosslinked 
network, whereby modifications at the surface are reserved for an active biological 
targeting. Gallium-68 (68Ga) is an attractive candidate as a positron emitter with a 
physical half-life sufficient for the expected biokinetic, a relatively low positron energy 
(resulting in a sufficient spatial resolution for small animal in vivo imaging using positron 
emission tomography (PET)) and a high availability of the radionuclide 68Ga from a 
68Ge/68Ga-generator. 
Herein synthesis of radiolabeled biodegradable nanogels, and physiochemical and 
biological properties relevant to nuclear molecular imaging is reported. Amphiphilic 
statistical star shaped PEG based prepolymers are used to synthesize nanogels by 
their self-assembly in aqueous medium without using organic solvents and surfactants. 
They are crosslinked via disulfide bonds, which are able to degrade after cell uptake by 
 180 
 
the reductive environment in the cytosol.18 The versatile thiol chemistry is used for both, 
crosslinking and derivatisation for radiolabeling. We used a simple and efficient 68Ga-
labeling procedure to radiolabel nanogels containing chelating groups for 68Ga and 
other trivalent metals. To the best of our knowledge this is the first report on a covalent 
bonding of a PET-radionuclide directly to a nanogel. These results are the prerequisite 
for further in vitro and small animal PET investigations (general biodistribution, fate of 
nanogel, measuring the EPR-effect) yielding a 68Ga-labeled-nanogel as valuable 
nuclear molecular imaging probe. 
 
9.2 Experimental  
9.2.1 Materials and Method 
Hydroxy terminated, six arm, star shaped poly (ethylene oxide-stat-propylene oxide) 
sP(EO-stat-PO) with a backbone consisting of 90% ethylene oxide and 10% propylene 
oxide (Mn= 6100 g/mol, Mw /Mn=1.12) was obtained from Dow Chemicals (Terneuzen, 
NL). sP(EO-stat-PO) was dissolved in tetrahydrofuran and precipitated in cold 
diethylether prior to further use. N,N’-dicyclohexyl-carbodiimide (DCC), (99%, Acros), 
4-(Dimethylamino)pyridine (DMAP) (99%, Aldrich), 3,3’-dithiodipropionic acid (DTPA) 
(Aldrich), tris(2-carboxyethyl) phosphine (TCEP) (99%, Aldrich), dichloromethane 
(HPLC grade, Aldrich), and 5,5’-dithio-bis-(2-nitrobenzoic acid) (DTNB) (Merck), 2,2'-(7-
(1-carboxy-4-((2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)ethyl)amino)-4-oxobutyl)-1,4,7-
triazonane-1,4-diyl)diacetic acid (maleimide NODAGA) (94%, CheMatech), 3,6-
diamino-9-[2-carboxy-4(or5)-[[[5-(2,5-dihydro-2,5-dioxo-1H-pyrrolyl)pentyl]amino]carbo- 
nyl] phenyl]-4,5-disulfo-, inner salt, monosodium salt (Alexa Fluor 488 C5 maleimide) 
(Invitrogen), ammonium salt of 8-anilinonaphthalene-1-sulfonic acid (90%, Sigma), 
water (ultra pure, metal free, Merck), hydrochloric acid (30%, supra pure, Merck), 
ammonium acetate (p.a. Pharm Eur, Sigma), Sephadex G25 (PD-10 column, GE 
Healthcare), Sephadex G100 (fine grade, GE Healthcare), gallium nitrate (gallium ICP 
standard, Merck) were used as received. Dialysis membrane with a molecular weight 
cut off of 3.5 kDa was purchased from Spectrum Laboratories, Inc. The 68Ge/68Ga-
generator was obtained from IDB Holland, where the Germanium-68 is fixed on a 
modified tin dioxide column. The human monocyte cell line THP-1 was from ATCC. The 
cell medium RPMI-1640 and supplementary reagents including fetal bovine serum 
(FBS), L-glutamine, sodium pyruvate and non-essential amino acids (NEA) were 
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obtained from Biochrom, and the chemical reagents like phorbol 12-myristate 13-
acetate (PMA) and dimethyl sulfoxide were from Sigma Aldrich.  
 
Fluorescence Spectroscopy 
Critical micellization concentration (CMC) of the polymers was determined via 
fluorescence spectroscopy on 650-40 Hitachi fluorescence spectrophotometer with a 
slit width of 5 nm. Ammonium salt of 8-anilinonaphthalene-1-sulfonic acid (ANS) was 
used as fluorescence probes. We collected emission spectra of polymer solutions at 
various concentrations ranging from 3.0 to 300.0 mg mL-1 in the presence of 5 × 10−4 
mM (1.58 × 10−7 mg mL-1) ANS at room temperature. The solutions were stirred for 12 
h at room temperature in dark prior to measurements. The emission spectra of samples 
at 510 nm were obtained at a fixed excitation wavelength of 340 nm in triplicate. 
Excitation and emission band widths were 10 nm and 3 nm, respectively.  
 
Radio-High Performance Liquid Chromatography (Radio - HPLC) 
The radiochemical yield and purity were determined by Radio-HPLC. The HPLC-
system assembles a quaternaric HPLC-pump (Knauer GmbH), DAD-detector (Knauer 
GmbH) and NaI-detector (Raytest GmbH) with a recording and analyse software 
(Raytest GmbH). As stationer phase were used a LiChrosorb RP18e column (250 × 
4mm, CS-Chromatographie Service) and a gradient of acetonitrile and 0.1% 
trifluoracetic acid as mobile phase (10% to 90% acetonitrile in 30min, flow 1mL min-1). 
The retention time of free 68Ga3+ was 2.2min and of 68Ga-NODAGA-NG 12.5min. 
 
Radio-Thin Layer Chromatography (Radio - TLC) 
Free 68Ga3+ after radiolabeling was determined by Radio-TLC with ITLC-silica strips 
and citrate buffer as mobile phase. The spreading was analysed by a Radio-TLC-
Scanner (mini-Gita, Raytest GmbH). Free 68Ga3+ could be detected as 68Ga-citrate at 
the front, whereas 68Ga conjugated with nanogels (68Ga-NG) remains at the origin. 
 
9.2.2 Synthesis 
Synthesis of Thiol Functionalized sP(EO-stat-PO) was performed as reported in 
Chapter 3.The free thiol content of the polymer was determined using 1H NMR. SEC 
(THF): Mn = 6500
 g/mol, Mw /Mn = 1.12. 
1H NMR (400 MHz, CDCl3, δ): δ = 1.14 (dd, 27H, CH3), 3.2-4.0 (m, 516-H,-CH2CH2O),  
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4.21 (t, 8-H, CH2-OCO-), 2.61 (t, 2H, CH2CH2SH), 2.73 (t, 2H, CH2CH2SH), 1.5 (t, 
1H,SH). 
 
Synthesis of HS-sP(EO-stat-PO) labeled with NODAGA (NODAGA-HS-sP(EO-stat-
PO).  
HS-sP(EO-stat-PO) (0.500g, 7.69 × 10-2 mmol; w.r.t 2-SH, 1.538 × 10-1 mmol) and 
NODAGA (0.0764g, 1.536 × 10-1 mmol) were reacted in 5mL phosphate buffered saline 
(0.01 M, pH= 7.2) overnight at room temperature under argon. The product was 
obtained after dialysis against water and freeze-drying. It was stored at 4°C until further 
use. Mn = 7500g mol
-1. 
1H NMR (400 MHz, CDCl3, δ): δ = 1.14 (dd, 27H, CH3), 3.2-4.0 (m, 516-H,-CH2CH2O),  
4.21 (t, 8-H, CH2-OCO-), 2.61 (t, 2H, CH2CH2SH), 2.73 (t, 2H, CH2CH2SH), 1.5 (t, 
1H,SH), 2.26(s, 12H, C6H12N3). 
 
 
Scheme 9.1: Synthesis of HS-sP(EO-stat-PO)-NODAGA. 
 
Labeling of NODAGA-HS-sP(EO-stat-PO) with Alexa Fluor 488.  
NODAGA-HS-sP(EO-stat-PO) (1.333 × 10-2 mmol, 0.100g, 2.3 free thiols per 
prepolymer) and Alexa Fluor 488 maleimide (6.666 × 10-3 mmol, 0.0048g) in the molar 
ratio of 1 : 0.5 were reacted in 5mL phosphate buffered saline (0.01M, pH 7.2) in dark 
for 12 h under argon. The product was obtained after dialysis against water and freeze-
drying (calculation of the yield after nanogel formation, see below). 
 
9.2.3 Crosslinking of Polymer Aggregates and Synthesis of Nanogels   
NODAGA-HS-sP(EO-stat-PO) (0.030 g, 4.0 × 10-3 mmol) was dissolved in 1 mL 
phosphate buffered saline (0.04 M, pH 7.4) and was stirred for 15 min. H2O2 (0.020µL, 
1.88 × 10-3 mmol) was added, and the mixture was stirred for 10 min. The resulting 
mixture was dialyzed to yield nanogels (NODAGA-NG). Similarly nanogels from 
 183 
 
NODAGA-HS-sP(EO-stat-PO) labeled with Alexa Fluor 488 (Alexa-NG) were prepared 
and stored at 4 °C until further use. 
 
9.2.4 Fluorescence measurement of Alexa-NG 
Fluorescence measurement were performed for quantification of the conjugated dye by 
illuminating the samples at an excitation wavelength between 400 and 600 nm with 
recording the emission at 515 nm. A calibration curve was obtained with different 
known concentration of Alexa Fluor 488 and conjugation of the dye with the free thiols 
in polymer was calculated to be 0.3 Alexa Fluor 488 per star by fluorescence 
measurement (0.3/0.5 = 60% conjugation yield). This results in an available 
crosslinking capacity of 2.0 thiol groups per prepolymer. 
 
9.2.5 Radiolabeling of NODAGA-NG  
In a typical labeling experiment, 250 µL 68Ga-GaCl3 solution (generator elute, 20-150 
MBq, 0.6M HCl) was added to 10µL NODAGA-NG (30 mg mL-1) in 83µL 3M NH4OAc 
resulting in a pH of 4.0-4.5. In competition experiments Ga(NO3)3 (56-210 nmol) was 
mixed before with the generator elute. After mixing for 10-15 min at RT samples were 
analysed by Radio-TLC and Radio-HPLC. Purification was performed by size exclusion 
chromatography (SEC) on a Sephadex-PD-10 column (GE Healthcare) with saline by 
collecting 100µL fractions for determination of the elution profile.  
 
9.2.6 Phagocytosis Assay 
The THP-1 cells were grown in RPMI-1640 medium supplemented with 10% FBS, 1% 
L-glutamine, 1% sodium pyruvate and 1% NEA. In 12-well plates, 105 THP-1 cells 
were allowed to adhere overnight. Thereafter, medium was replaced by RPMI-1640 
without serum. Monocytes were then stimulated with PMA (8nM) for 24 h in a FBS-free 
medium. To assure opsonisation of nanogels, all phagocytosis assays were conducted 
in the presence of 10% FBS. Monocytes were incubated with 0.1, 0.5 and 1.0 mg mL-1 
of Alexa-NG for 1h at 37°C. Plated were washed twice with PBS to remove excess 
particles. Harvested cells were fixed in 2% paraformaldehyde and analysed by flow 
cytometry (Cytomics FC 500, Beckman Coulter) For additional microscopy analysis, 
nuclear counterstaining was accomplished with Hoechst33342 (1 mg mL -1), before 
being examined by fluorescence microscopy (ZEISS, Axio Scope A1). 
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9.3 Results and Discussion  
The prepolymer for synthesis of gallium-68 labeled nanogels has to bear at least 
2 functionalities, one for formation of crosslinked nanogels and another to complex the 
radiometal. For this purpose we have chosen a six arm, hydroxy terminated, star-
shaped poly(ethylene oxide-stat-polypropylene oxide) (sP(EO-stat-PO); 90% EO, 10% 
PO in molar ratio; Mn = 6100 g mol
-1, Mw /Mn = 1.12) as precursor. At first 4 of the 6 
hydroxy terminals have been functionalized with thiol groups (HS-sP(EO-stat-PO). Half 
of these thiol groups were covalently linked with the chelator NODAGA. The result was 
a new, star-shaped prepolymer (NODAGA-HS-sP(EO-stat-PO)) with an average each 
2 hydroxy, 2 thiol and 2 NODAGA terminated arm. Crosslinked particles, the NODAGA 
containing nanogels (NODAGA-NG), were yielded by oxidation of the thiol groups. The 
remaining hydroxy terminals are reserved for future functionalization modifying 
biodistribution parameters. For biological experiments NODAGA-HS-sP(EO-stat-PO) 
was additionally functionalized (at <1 thiol group) with a dye before nanogel 
preparation. 
In detail, the partially thiolated star shaped prepolymer (HS-sP(EO-stat-PO) was 
prepared according to literature19 via Steglish esterification with the disulfide containing 
dithiopropionic acid followed by reduction of the disulfide cross-linkage to thiol groups. 
Incorporation of hydrophobic alkyl-thiols into the amphiphilic sP(EO-stat-PO), (consists 
of 10% hydrophobic PPO) retains the amphiphilic behaviour of the polymer. Such 
amphiphilic polymer shows spontaneous aggregation in aqueous solution and is able to 
form crosslinked nanogels.20 1H-NMR of HS-sP(EO-stat-PO) indicated a mean of 4.0 
thiol groups per prepolymer (Figure 9.1).  
 
Estimation of Functionalization by NMR 
For calculation of the thiol functionalization and subsequent NODAGA linkage it was 
important to estimate the exact number of repeating units (precise molar ratio) of the 
propylene oxide and ethylene oxide units in polymer backbone.20 CH3 group of 
propylene oxide unit in the backbone of prepolymer was used as a reference. The 
integrals of the CH3- (I5) and the CH2-, CH-groups (I1 – 4) of the sP(EO-stat-PO) 
molecule can be determined with the help of  Equation 9.1. 
  y / x = (44 g mol-1 / 58 g mol-1) × [( I1-4 / I5 ) − 1]                            Eq.9.1 
x/y : molar ratio of ethylene- and propylene oxide 
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I1 – 4,6 : Integral of H-atoms of the CH2-, CH-groups of the sP(EO-stat-PO) 
I5 : Integral of the H-atoms of the CH3 group of the sP(EO-stat-PO) 
The number of repeating units can be calculated with the following Equation 9.2. 
MsP (EO − stat − PO) − Mcore = b ·MEO + a ·MPO                                   Eq.9.2 
As ‘b’ is depending on ‘a’, we can write b = a · y/x and rearrange equation as follows 
              <=>   a = (MsP ( EO − stat − EO ) −Mcore)/(y/x × MEO + MPO)                     Eq.9.3 
MsP(EO − stat − PO ) : Molecular weight of sP(EO-stat -PO) = 6100 g mol
-1 
Mcore Molecular weight of the core of sP(EO-stat -PO) (Sorbitol) = 182 g mol
-1 
MEO : Molecular weight of ethylene oxide = 44 g mol
-1 
MPO : Molecular weight of propylene oxide = 58 g mol
-1 
a : Number of repeating units of propylene oxide 
b : Number of repeating units of ethylene oxide 
The peak at 1.16 ppm was assigned an integration value of 1.0 and an integration 
value of 18.77 was obtained for the peak at 3.2-4.0 ppm (Figure 9.1a). These values 
were put into equation (1.1) and result in y/x = 13.32.  
The value for y/x was used in Equation 9.3: 
                    a = (6100 g mol-1 −182 g mol-1)/ 13.32×44 g mol-1 + 58 g mol-1 
which results in the value of 9 for ‘a’. Therefore sP(EO-stat-PO) has 9 repeating units 
of propylene oxide corresponding to 27 H-atoms (CH3 group) in the sP(EO-stat-PO). 
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Figure 9.1: 1H NMR spectra of a) sP(EO-stat-PO) b) HS-sP(EO-stat-PO) and c) 
NODAGA-HS-sP(EO-stat-PO) 
 
Thiol functionalization via Steglish esterification and subsequent reduction the 2H (H-7, 
CH2 group adjacent to ester) proton shows a triplet at 4.2 ppm. Using the 
corresponding 27 H-atoms from the CH3 group of propylene oxide unit as reference 
integration of these 2 protons comes out to be 8.06 which indicates that out of 6 arm, 4 
arm of the sP(EO-stat-PO) are thiol functionalised (Figure 9.1b).After functionalization 
with NODAGA, a distinct peak of the imine ring protons (H-18) appears at 2.26 ppm.21 
This peak results from 12 protons and on integration it shows that 1.7 (20.7/12) arm out 
of 6 are linked with the chelating agent (Figure 9.1c). Insertion of the chelator 
NODAGA into HS-sP(EO-stat-PO) was achieved via Michael addition of thiols with 
maleimide linked to the NODAGA functionality. The molar ratio of maleimide to thiols (1 
to 2 = 2 NODAGA per prepolymer) ensures the presence of free thiol groups for 
crosslinking. Conjugation of NODAGA into HS-sP(EO-stat-PO) led to incorporation of 
1.7 NODAGA per prepolymer as evidenced by 1H-NMR (Figure 9.1c). The successful 
incorporation of thiol functionality was also confirmed by the signals in the FT-IR 
 187 
 
spectrum positioned at 2559 cm-1 (SH-group) and 1750 cm-1 (C=O stretching, from 
ester bond), respectively (Figure 9.2a). While Raman spectroscopy indicated S-H 
stretching mode at 2578 cm-1 (Figure 9.2b). 
 
Figure 9.2 a): Normalized FT-IR spectra of 1- HS-sP(EO-stat-PO)-NODAGA 2- HS-
sP(EO-stat-PO) and 3- sP(EO-stat-PO) b). Normalized Raman spectra of 1- HS-
sP(EO-stat-PO)-NODAGA and 2- HS-sP(EO-stat-PO) showing –SH stretch at 2700 
cm-1. Inset depicts the C=O stretch of imide group from NODAGA appearing as a sharp 
band near 1780 cm−1 
FT-IR-spectrum of NODAGA-HS-sP(EO-stat-PO) indicated characteristic signals for 
NODAGA-maleimide, showing an amide I band at 1650 cm-1, a band due to the five-
membered imide ring at 1700 cm-1, and an amide II band at 1550 cm-1 involving C-N 
stretching and C-N-H in plane bending22 (Figure 9.2a). Upon NODAGA conjugation, 
the intensity of the -SH band (2578 cm-1) in the Raman spectrum was reduced 
compared to HS-sP(EO-stat-PO) indicating the presence of thiol in NODAGA-HS-
sP(EO-stat-PO). Moreover C=O from imide appearing as a sharp band near 1780 cm-1 
from NODAGA, along with C=O from ester at 1734 cm-1 in NODAGA-HS-sP(EO-stat-
PO) confirms the successful conjugation (Figure 9.2 b, inset). 
 
NODAGA-HS-sP(EO-stat-PO) was further labeled with Alexa Fluor 488 through 
reaction of maleimide functionalized dye with thiols. The conjugation of the dye to thiol 
was calculated by fluorescence measurement to be 0.3 Alexa Fluor 488 per star. This 
results in an available crosslinking capacity of 2.0 thiol groups per prepolymer. 
Amphiphilic statistical polymers can perform both intramolecular and intermolecular 
associations forming simultaneously unimers and multipolymer aggregates. However 
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their molecular associative behaviour is particularly effected by polymer concentration 
and macromolecular architecture.23 For successful self-assembly of NODAGA-HS-
sP(EO-stat-PO) the critical micelle concentration (cmc) was studied using fluorescence 
spectroscopy. Estimation of the cmc of NODAGA-HS-sP(EO-stat-PO) was performed 
using a series of solutions of the functional polymer (concentration varied from 3.0 to 
300.0 mg mL-1) and fluorescence probe (8-anilinonaphthalene-1-sulfonic acid 
ammonium salt, constant concentration of 1.58×10−7 mg mL-1, 5×10-4 mM). Plotting 
concentration dependence of emission intensity of NODAGA-HS-sP(EO-stat-PO) 
yielded the cmc of the polymer as 30 mg mL-1, similar to the native star sP(EO-stat-
PO) with a cmc of 35 mg mL-1 (Figure 9.3). 
 
Figure 9.3: Concentration dependence of emission spectra of NODAGA-HS-sP(EO-
stat-PO) (red line denotes the cmc value) at [ANS (fixed)] = 5 × 10−4 mM, λexcitation= 346 
nm λemission = 510 nm. Points correspond to 3.0, 7.5
 , 15, 22.5, 30, 75, 150, 225 and 300 
mg mL-1 respectively. 
 
Knowing critical micellization concentration (cmc) of the functional polymers is critical to 
determine the concentration of the prepolymers necessary to undergo self-assembly. 
We used 8-anilinonaphthalene-1-sulfonic acid ammonium salt (ANS) as the 
fluorescence probe. To estimate cmc of the NODAGA-HS-sP(EO-stat-PO) a series of 
solutions with functional polymer and fluorescence probe, in which the concentration of 
the polymer was varied from 3.0 to 300 mg mL-1 and the concentration of the 
fluorescence probe was kept constant at 1.58 × 10−7 mg mL-1 were prepared. ANS has 
a fluorescence emission at 510 nm (at 296 K) when excited at 346 nm. Therefore the 
resulting solutions were excited at 346 nm and emission spectrum was collected at 510 
nm (Figure 9.3). With increasing polymer concentration, the number of the formed 
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micelles increases and ANS diffuses inside the particles. In this apolar 
microenvironment, the electron transfer is less limited and the fluorescence is stronger 
so that the emission intensity increases and simultaneously fluorescence emission is 
shifted towards blue light. The emission spectra of the solutions containing both 
NODAGA-HS-sP(EO-stat-PO) and ANS indicated a shift in the emission maximum 
from 510 nm to 482 nm. This blue shift was due to decreased local polarity and an 
increase in the fluorescence lifetime as well as quantum yield arising out of restricted 
mobility of the fluorophore.24,25 
It is worth to note that even in the premicellar concentration there is a slight blue shift in 
the spectrum of ANS which indicates the possibility of the existence of premicellar 
aggregates. Determining the cmc of the functional polymers using fluorescence 
emission requires determining the concentration at which abrupt changes in emission 
intensity takes place. On plotting concentration dependence of emission intensity of 
NODAGA-HS-sP(EO-stat-PO), intercept between the linear extrapolations of the 
horizontal portion at low polymer concentration and of the rapidly varying portion, 
yielded the cmc of the polymer as 30 mg mL-1. Similar measurements were also carried 
out with sP(EO-stat-PO) prepolymers which also showed a amphiphilic behavious with 
a cmc close to 35 mg mL-1. This amphiphilicity induces self-assembling in water and as 
a consequence particles with micellelar type of structure were formed. 
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Scheme 9.2: Schematic representation of 68Ga-labeled nanogel synthesis. 
 
The nanogels (NODAGA-NG) were prepared by self-assembly of NODAGA-HS-
sP(EO-stat-PO) in PBS buffer (0.01M, pH 7.4) followed by crosslinking via thiol 
oxidation with catalytic amount of hydrogen peroxide to ensure the particle stability. 
Alexa Fluor 488 functionalized prepolymer was converted into nanogel (Alexa-NG) in a 
similar (Scheme2). 
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Figure 9.4: Cryo-FESEM image of a),d) uncrosslinked and crosslinked NODAGA-HS-
sP(EO-stat-PO), b),e) Cryo-TEM image uncrosslinked and crosslinked NODAGA-HS-
sP(EO-stat-PO) nanogels, DLS measurement of c) uncrosslinked, f) crosslinked and 
68Ga-labeled NODAGA-HS-sP(EO-stat-PO) nanogels. 
 
The particle sizes of the NODAGA-NG were investigated using dynamic light scattering 
(DLS), cryo-field emission scanning electron microscopy (Cryo-FESEM) and cryo-
transmission electron microscopy (Cryo-TEM). Hydrodynamic diameter and PDI of 
nanogels by DLS was 250±50 nm (PDI 0.145) and 270±50 nm (PDI 0.175) before and 
after crosslinking, respectively. The PDI shows a narrow distribution of the particle size. 
Cryo-FESEM and Cryo-TEM images showed particles with a diameter d in the range of 
200 nm < d < 300 nm. The nanogels were well defined and spherical. These results 
indicated that particle size of nanogels did not change significantly upon crosslinking 
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and they remained monodisperse even after crosslinking. The difference in size 
obtained from scattering and imaging techniques might be due to partial volume loss of 
the NODAGA-NG during the freezing step prior to imaging via Cryo-FESEM/TEM 
(Figure 9.4). The fluorescent labeled Alexa-NG showed morphology and comparable 
size to the unlabeled once, with a hydrodynamic diameter of 310±50 nm (PDI 0.210, 
Figure 9.5). 
 
Figure 9.5: DLS measurement of Ga labelled and unlabelled Alexa NG. 
 
Stability of the Nanogels 
Stability of the NODAGA-NG was tested by following the change in their size and size 
distribution upon incubation in radiolabeling buffer (0.6M HCl + 3M NH4OAc, v/v 3/1; pH 
4.5) via DLS. The nanogels showed no decomposition of either polymer or gel structure 
after remaining 18 days in the buffer (Figure 9.6). 
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Figure 9.6: Stability of 68Ga labelled NODAGA-NG was tested by following the change 
in their hydrodynamic diameter upon incubation in radiolabeling buffer (pH 4.5) for 18 
days via DLS 
 
Radiolabeling of NODAGA-NG with n.c.a. 68Ga 
The 68Ge/68Ga-generator provides no carrier added (n.c.a.) 68Ga as 68GaCl3 in 0.6M 
HCl solution. pH adjustment with NH4OAc to an optimal pH-range of 3-5 ensures a high 
radiolabeling yield of the NODAGA-chelator in a biocompatible buffer. Initial tests with 
the prepolymer (NODAGA-HS-sP(EO-stat-PO)) indicate, that chelation of n.c.a. 
68GaCl3 results in high radiochemical yields at room temperature (RT) (Table 9.1, entry 
1). For radiolabeling the generator elute was added to 250 nmol NODAGA-NG 
dissolved in NH4OAc (3M) resulting in a pH of 4.5. This was allowed to stand at RT for 
15min. 68Ga-NODAGA-NG was purified by SEC on a PD10-Sephadex column 
receiving a pure product in saline. Using this methodology, NODAGA-NG and Alexa-
NG were successfully labeled with nearly quantitative radiochemical yields at RT 
(Table 9.1, entry 2-3). These results for 68Ga-labeling of nanogels confirm the 
advantageous labeling conditions for 68Ga of the chelator NODAGA compared to DOTA 
(e.g. RT vs. 85-95°C for 68Ga-labeling of peptides17). The size of the nanogels is 
preserved by radiolabeling demonstrated by an unchanged hydrodynamic diameter and 
PDI (Figure 9.4f, DLS: 270±30 nm, PDI 0.187 vs. 290±50 nm, PDI 0.175). Reducing 
the amount of NODAGA-NG to 50 nmol (Table 9.1, entry 3-5) has no effect on the high 
radiolabeling efficiency and is comparable with often used amount for NODAGA-
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peptide labeling (5-30 nmol).[17] The specific radioactivity of the 68Ga-NODAGA-NG was 
determinate as up to 1500 GBq/gnanogel, so that no pharmacological or toxic effects are 
expected for in vivo experiments. 
 
Table 9.1 Radiochemical yield of 68Ga-labeling of NODAGA-NG (reaction conditions: 
0.3-1.5µg / 0.05-0.25µmol NODAGA-NG + 83µL NH4OAc (3M) + 250µL 
68GaCl3 (+ x 
nmol Ga3+) in 0.6M HCl, 10-15min room temperature, analysis by radio-TLC and radio-
HPLC) 
 
NG  
[nmolb] 
Ga3+ 
[nmol] 
RCYa  
 68Ga-NODAGA-
NG 
RCYa 
68Ga-
prepolymer 
RCYa  
 68Ga-Alexa-
NG 
1 225   >95%  
2 160    >95% 
3 250  >95%   
4 150  >95%   
5 50  >95%   
6 50 56 88%   
7 50 70 62%   
8 50 98 53%   
9 50 126 38%   
10 50 210 18%   
a) RCY: radiochemical yield; b) nmol prepolymer 
 
In a competition experiment with non radioactive Ga3+ the labeling yield of 68Ga-
NODAGA-NG decreased from >95% to 18% (Table 9.1, entry 5 -10) by increasing the 
amount of Ga3+. Due to the insignificant amount of radioactive 68Ga (5 pmol carrier 
free) the NODAGA concentration attached to the nanogel corresponded to Ga3+ 
concentration at a radiochemical yield of 50% (approx. 100 nmol, Table 9.1). This 
calculates 2.0 NODAGA per NODAGA-HS-sP(EO-stat-PO) (molar ratio of NODAGA-
conjugation was 2:1, NODAGA-maleimide to HS-sP(EO-stat-PO)) and is consistent 
with the value obtained from 1H-NMR (1.7, Figure 9.1c). These results demonstrate a) 
the number of available labeling position correlates well with the estimated NODAGA 
concentration, b) all NODAGA-chelators (both inside and outsides of the nanogel 
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structure) are accessible by diffusion for 68Ga-ions and c) unspecific adsorption of 68Ga 
is insignificant. In short, specific 68Ga-labeling of NODAGA-NG was achieved with an 
efficient procedure resulting in radiolabeled nanogels ready to use for small animal 
PET.  
Biological Properties of Alexa-NG 
As nanoparticles are suitable vehicles for delivery of therapeutic agents, the 
mechanisms determining biodistribution and cellular fate should be carefully evaluated. 
The internalization of nanogels by circulating macrophage precursor cells, the 
monocytes, and mostly tissue resident phagocytosing macrophages is a predictive 
indicator of the blood clearance in vivo. 
The unstimulated THP monocytes only marginally engulfed Alexa-NG, which suggests 
an almost non-existent phagocytosis (Figure 3a). Stimulation with phorbol-12-
myristate-13-acetate (PMA) led to Alexa-NG concentration dependent increase of the 
phagocytosis rate. In contrast to unstimulated THP monocytes, the ingestion of Alexa-
NG in activated macrophages was increased from 9% to 73% by PMA stimulation 
(Figure 3) due to the upregulation of the phagocytosis capacity.  
 
Figure 9.7: Flow cytometric phagocytosis analysis of Alexa-NG particles in a) 
unstimulated THP-1 cells and b) PMA stimulated THP-1 cells after incubation with 0.1 
mg/mL, 0.5 mg/mL and 1.0 mg/mL of Alexa-NG´s for 1h at 37°C. Fluorescence 
microscopy analysis of PMA stimulated THP-1 macrophages after incubation with 1.0 
mg/mL of Alexa-NG´s for 1h at 37°C and counterstaining with Hoechst c) overlay of 
Alexa-NG´s with Hoechst and d) overlay of fluorescence with bright field (100-fold 
magnification). 
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These results visualized an efficient internalization of Alexa-NG by phagocytosing cells 
like macrophages. Importantly, nanogels remain largely unrecognized for monocytes. 
This will probably result in a desired slow clearance and prolonged blood circulation of 
nanogels. No general cytotoxic effects were observed in cells after incubation with 
NODAGA-NG or Alexa-NG. However, for in vivo application, the possible cytotoxic 
effects on liver or kidneys due to the hepatic or renal retention and clearance of 68Ga-
NODAGA-NG have to be considered. 
 
9.4 Conclusion 
Radiolabeling of nanogels is a new approach for nuclear molecular imaging with 
a high scientific potential. Derivatisation of the nanogel with the chelator NODAGA 
results in a highly efficient and specific 68Ga-labeling. The high stability and the mild 
radiolabeling conditions allow a preservation of the nanogel structure evidenced by the 
negligible change of polymer properties. Due to their surface properties the nanogels 
are basically unrecognizable for monocytes. The PEG based radiolabeled-nanogel 
concept allow easily additional modifications with biomarkers (e.g. peptides) for 
additional active targeting in vivo. 
68Ga-nanogels will enable preclinical studies to understand the in vivo behaviour of 
nanogel, especially fate of the nanogel and measuring of the EPR-effect. 
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